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ABSTRACT 
 
Microbial dysbiosis and toll-like receptor (TLR) signaling play a role in colonic 
injury and inflammation. Ulcerative colitis and radiation are known to alter microbiota, 
and diets containing polyphenols impact bacterial populations. We hypothesized that diet 
can mitigate dextran sodium sulfate (DSS) colitis (sorghum bran diets containing 
polyphenols) and space environment-induced alterations (normal iron content) in colonic 
microbiota and TLR signaling. To test this we utilized two experimental paradigms; 
DSS-induced colitis (3% DSS, 48-hr, 3 exposures, 2 wk separation), and three models to 
emulate the space environment: 1) fractionated low linear energy transfer (LET) γ 
radiation (RAD) (3 Gy) and high Fe diet (IRON) (650 mg/kg), 2) high LET Si particle 
exposure (50 cGy) and 1/6 G hind limb unloading (HLU), and 3) 13 d spaceflight. 
Bran diets upregulated proliferation, and repair protein (TFF3 and TGFβ) and 
short chain fatty acid (SCFA) transporter (Slc16a1 and Slc5a8) expression post-DSS. 
Diet significantly affected 24-hr fecal butyrate production, with Cellulose and Black 
bran having numerically higher concentrations. Two predominant phyla were identified, 
Firmicutes and Bacteroidetes, and this ratio was higher in Cellulose DSS. Post DSS#3 
the proportion of Bacteroidales, Clostridiales, and Lactobacillales was reduced compared 
to post DSS#2 for all diets. Black bran non-DSS rats had the highest richness and 
diversity. Colonic injury negatively correlated with the proportion of Firmicutes, 
Actinobacteria, and Lactobacillales, and positively correlated with Unknown and 
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Unclassified groups. Bran diets reduced the severity of epithelial injury, maintained fecal 
butyrate, and prevented microbial dysbiosis and depletion during DSS-induced colitis. 
IRON+RAD decreased SCFA concentrations. Low and high LET radiation, 
HLU, IRON and spaceflight increased Bacteroidetes and decreased Firmicutes. HLU 
and spaceflight increased Clostridiales and decreased Lactobacillales. RAD and 
IRON+RAD animals had increased Lactobacillales and significantly lower Clostridiales 
compared to CON and IRON. TLR9 and IL-6 were downregulated by RAD. TLR4, 
TFF3 and TGFβ differentially changed with IRON and spaceflight. Microgravity 
independently affected the microbiota, regardless of radiation energy or dose. 
Each environmental insult differentially altered the microbiota and mucosal gene 
expression, with distinct diet, microgravity, and radiation effects observed. Bran diets 
mitigated deleterious effects of colitis, maintained barrier integrity, and prevented 
microbiota dysbiosis. 
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NOMENCLATURE 
 
ALT alanine transaminase 
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NF-κB   nuclear transcription factor kappa B  
PBS    phosphate buffered solution 
PC5 phycoerythrin cyanin 5 
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PE   phycoerythrin 
PFA    paraformaldehyde  
RAD control/radiation group 
ROS reactive oxygen species 
RT-PCR   real-time polymerase chain reaction 
SEM    standard error of the mean  
SLC5A8   sodium-coupled monocarboxylate transporter-1  
SCFA    short chain fatty acids  
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SOD superoxide dismutase 
TAC total antioxidant capacity 
TBI total body iron 
TCR T-cell receptor 
TGF    transforming growth factor  
TFF-3    trefoil factor-3  
TLR    toll-like receptor  
TNF    tumor necrosis factor   
TNFR    tumor necrosis factor receptor  
Tollip    toll interacting protein 
UC    ulcerative colitis 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
Chronic inflammation in the bowel is known to increase the risk of colorectal 
cancer, which is the 2
nd
 most lethal cancer worldwide (1-3). During repeated bouts of 
intestinal inflammation, the activation of signaling pathways promotes the release of 
inflammatory cytokines and stimulates cellular proliferation, thereby increasing the risk 
of developing colonic neoplasias (1, 4). The etiology of gastrointestinal (GI) diseases 
such as inflammatory bowel disease (IBD), which includes both ulcerative colitis and 
Crohn’s disease, are not well understood but both are associated with acute or chronic 
bouts of inflammation in the GI tract. Although genome-wide searches have implicated 
some gene loci in disease susceptibility, increasing diagnosis of these GI diseases has 
pointed researchers toward environmental effects such as intestinal microbiota dysbiosis 
and disruptions in signaling through toll-like receptors (TLR) as  mitigating factors (5). 
The intestinal microbiota is composed of trillions of bacteria, and it is estimated 
to be comprised of over 100 different phylotypes (6). It is universally accepted that the 
intestinal microbiota plays an important role in the health status of the host by 
influencing nutrient absorption, providing a defense mechanism against invading 
pathogens, and interacting with the host immune system through TLR signaling. 
However, increasing evidence suggests that initiation and pathogenesis of IBD is caused  
by a disruption in the host immune response to the commensal microbiota, 
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including oversensitization of TLR to bacterial ligands and alterations to TLR expression 
(7-8). Additionally, epithelial cell inflammation and oxidative stress can affect barrier 
function, which if compromised can allow the host to be exposed to bacteria and 
bacterial antigens from the lumen and initiate innate and adaptive immune responses (5). 
Understanding the role of the microbiota in GI diseases might help elucidate 
mechanisms that influence the onset and perturbation of inflammatory bouts. 
   Characterizing how the luminal environment and oxidative stress affect the 
intestinal microbiota is important to understanding its role in IBD.  It is well documented 
that dietary constituents can affect intestinal bacterial populations (9-12), particularly 
dietary fiber (i.e., nondigestible food sources such as resistant starch and plant cell wall 
material), which reaches the colon and serves as substrates for the microbiota (13). 
Additionally, some secondary plant metabolites such as polyphenols can reach the colon 
and undergo bacterial transformations or have a bactericidal effect. Numerous studies 
have been performed that highlight how these dietary bioactive compounds have an 
effect on the predominant bacterial groups that reside in the GI tract (9, 14-16).  As the 
host diet fluctuates, changes in the quality and quantity of bacterial substrates can alter 
the gut environment by affecting transit time and lumen pH (17-18). Additionally, the 
primary and secondary bacterial metabolites produced can shift bacterial populations and 
promote changes to epithelial cell metabolic regulation (19-20). Environmental factors 
that cause oxidative stress, such as radiation exposure and a high oxidant load diet (e.g., 
elevated dietary iron (Fe)), can have deleterious effects on colonic epithelial cells such 
as formation of reactive oxygen species (ROS) and DNA damage (21-22), but little is 
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known regarding the effect on the microbiota. Therefore, studies characterizing how 
dietary components, particularly polyphenols, and environmental insults that cause 
oxidative stress (i.e., radiation exposure and high Fe diet) affect the intestinal microbiota 
are warranted; as alterations to the GI environment and bacterial populations present in 
the intestine could affect the onset and progression of intestinal inflammation.  
Sorghum grain is a common staple in dry, arid areas such as Africa and South 
America. Epidemiological data show that the incidence of colorectal cancer in both men 
and women is lower in countries that consume sorghum daily (23-24). Sorghum grain 
can be decorticated to isolate the bran fraction, which contains concentrated levels of 
bioactive compounds such as anthocyanins and tannins (25-26). These polyphenols have 
been characterized as potent antioxidants, and it has been demonstrated that sorghum 
bran has an in vitro antioxidant capacity (ORAC) higher than that of fruits such as 
blueberries, and pomegranate (27). Additionally, bran is a source of dietary fiber, which 
has been reported to have a positive impact on overall health by improving serum lipid 
concentrations, regulating blood glucose concentrations, lowering blood pressure and 
reducing the risk of developing GI disorders and colon cancer (13, 28). Previous animal 
studies demonstrated that, in comparison to a diet containing cellulose as a fiber source, 
sorghum bran can significantly reduce the occurrence of aberrant crypt foci (ACF), a 
precursor to colon adenomas (24).  
 Based on this evidence it is likely that properties of sorghum bran, including the 
bioactive compounds (anthocyanins and tannins), could be beneficial in suppressing the 
effects of chronic inflammation in the intestine by affecting the intestinal microbiota, its 
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metabolites, and downstream signaling through TLR. Furthermore, characterizing 
alterations to the microbiota caused by environmental insults (i.e., radiation exposure 
and diets containing elevated iron) will elucidate its role in propagating oxidative stress, 
and help identify mechanisms to reduce the risk of intestinal inflammation and cancer. 
Literature Review  
Implications of intestinal inflammation and IBD  
Epidemiological studies suggest that those suffering from chronic intestinal 
inflammation, due to GI diseases such as ulcerative colitis, have between a 2-18% 
increased risk (dependent upon age), of developing colon cancer (1-3), which is the third 
most common diagnosed cancer in males and second highest in females (23). Similar to 
sporadic colon cancer, colitis-associated colorectal cancer can be associated with genetic 
mutations and alterations to molecular patterns in intestinal epithelial cells (4). For 
example, there is increasing evidence that methylation and allelic deletion of genes such 
as p53 are associated with colitis-associated cancer (4).  Additionally, the presence of 
reactive oxygen species (ROS), often elevated in GI diseases such as IBD, can mutate or 
methylate regulatory genes, oncogenes, and those involved in DNA repair (29-30). ROS 
also have been implicated in inducing gene expression of key regulators of the 
inflammatory process such as nuclear factor kappa B (NF-κB), COX-2, and TNF-α (31-
34). It has been reported that neoplastic regions of the mucosa are associated with 
chronic inflammation, and increased levels of NF-κB and its downstream mediators have 
been reported in intestinal biopsies from patients with ulcerative colitis (32). Therefore, 
suppression of these inflammatory cytokines by reducing ROS species in the bowel 
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might provide a reasonable countermeasure to mitigate the effects of GI diseases and the 
increased risk of colitis-associated cancer. 
Commensal intestinal microbiota 
  In healthy individuals the commensal bacteria residing in the intestine, or 
microbiota, plays a major role in the health of the host by affecting the ability to digest 
dietary fiber, altering bowel motility and pH, and interacting with the host immune 
system (35-36). Additionally, these bacterial groups can provide protection against 
invading pathogens by effectively competing for host adhesion sites, secretion of 
bacteriocidal compounds, and improving the efficacy of epithelial cell tight junctions 
(36-37). Dietary fiber remains undigested and intact until it reaches the large intestine 
where the microbiota ferments it to produce metabolites that can influence mucosal 
metabolism (28, 38). These metabolites include SCFA, lactate, ethanol, ammonia and 
nitrates, which can be utilized by other bacteria or serve as a fuel source for the host 
epithelia. It is estimated that 8-10% of energy from the diet absorbed by the host is 
derived from byproducts of bacterial fermentation (39). The SCFA butyrate is a primary 
fuel source for colonocytes and has been shown to stimulate proliferation and affect 
migration in these cells, and is reported to have anti-inflammatory properties (40-42).  
 As mentioned previously, although the etiologies of many chronic enteropathies 
are unknown, there is increasing evidence that points away from genetic influences to 
other factors such as disruption in the homeostasis between the commensal bacterial 
species residing in the bowel and the host. Although in healthy individuals these bacteria 
provide benefits to the host, they can in fact become detrimental and often exacerbate GI 
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diseases (43-46). Additionally it has been reported that alterations in the production of 
SCFA may be involved in the development of colitis and colon cancer (47-48). 
The effect of SCFA on intestinal homeostasis 
SCFA play a major role in normal bowel function, and lumen concentrations 
predominantly consist of butyrate, acetate, and propionate (20, 38, 42). Numerous 
studies have analyzed the pleiotrophic effects of SCFA on colonocytes, in particular 
butyrate, which includes anti-inflammatory activity, the induction of gene expression, 
cellular differentiation, apoptosis, cell cycle arrest, and interference with transcription 
factors critical for pro-inflammatory cytokine production (20, 41-42, 47, 49-51).  
However, the effect of SCFA on the progression of IBD is not well understood. It has 
been reported that patients with ulcerative colitis have impaired fatty acid β-oxidation, 
which could suggest that alterations to butyrate uptake or metabolism in enterocytes is a 
possible pathogenetic mechanism (52-53). 
Differential effects have been reported regarding butyrate’s influence on cytokine 
production and the initiation of inflammation in the bowel. In vitro and in vivo studies 
have reported that butyrate plays a major role in the onset of an inflammatory state in the 
intestine by affecting cytokine production and epithelial cellular migration (54-59), 
however, SCFA supplementation has been reported to improve symptoms of patients 
with GI disorders (50, 60). Several in vitro studies have reported that butyrate suppresses 
(CaCo2) and enhances (HT-29 and LIM 1215) levels of IL-8 in colon cancer cells lines 
(57-59). One potential mechanism for influencing cytokine levels is the modification of 
transcription factors such as NF-κB, which activates the transcription of a multitude of 
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pro-inflammatory genes. It has been reported that butyrate can interfere with NF-κB 
transactivation by increasing IκB production or inhibition of IκB degradation, which 
leads to NF-κB remaining arrested in the cytoplasm (54-56, 61-62). Two in vitro studies 
reported that when intestinal cells were exposed to butyrate, NF-κB dimer activity and 
downstream cytokine production was suppressed (56, 61). Wu et al reported that IκB 
expression was increased in the surface epithelium, further suggesting that butyrate aids 
in suppressing the onset of inflammation through the NF-κB pathway. Similar results 
were reported in two studies by Kanauchi et al , which used both a transgenic mouse and 
dextran sodium sulfate (DSS) colitis rat model to demonstrate that increased levels of 
luminal butyrate (produced by feeding a germinated barley based diet) suppressed NF-
κB activity (54-55). Another in vivo study utilizing a different colitis mouse model (i.e., 
trinitrobenzene sulfonic acid (TNBS)) also reported butyrate’s ability to suppress NF-κB 
activity (62). 
Studies focusing on the effect of SCFA on colon cancer progression reported that 
butyrate inhibited growth and promoted terminal differentiation in a variety of colon 
cancer cell lines and an animal model (47-49, 56, 63). One study reported that, of all the 
SCFA tested (i.e., acetate, butyrate, propionate), only butyrate demonstrated an ability to 
induce differentiation in LIM1215 colon carcinoma cells (48). Using a growth study 
assay, it was shown that the doubling time of these model cancer cells decreased 
markedly with the addition of a 1 mmol/l butyrate solution to the cell culture (48). 
Another study using a rat model reported that when fed diets containing fermentable 
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fibers, which increased the concentration of butyrate in the colon, animals had a 
decreased incidence of tumors (64).  
More recent studies have proposed molecular mechanisms for how SCFA might 
exert cellular effects such as differentiation and apoptosis. It has been established that 
butyrate can enhance apoptosis in colonocytes, and has been reported to have the most 
potent cellular effects in vitro compared to other SCFA such as acetate and propionate 
(48, 65-66). Two studies reported the human colon carcinoma cell line, HT-29, 
demonstrates enhanced levels of differentiation and apoptosis when exposed to butyrate 
(47, 65). Hinnebusch et al further showed that when p21 is deleted in colon cancer cell 
lines SCFA have no effect on proliferation, suggesting that growth arrest in vitro 
requires the p21 gene. Also, it was reported that the effect of butyrate on colon cancer 
cell differentiation is protein kinase C and JNK dependant (65). Similar results were 
reported in YAMC and YAMC-Ras transformed cell lines, where butyrate (5 mM) and 
n-3 polyunsaturated fatty acids (PUFA) supplementation had a synergistic effect by 
significantly increasing apoptosis (66).  
Butyrate is thought to produce these cellular effects, in part, by inhibiting histone 
deacetylase (HDAC), which affects gene transcription by enhancing histone acetylation 
(i.e., DNA relaxation and increased transcription factor access) (47, 51, 67-68). 
Although it was reported that propionate and valerate could inhibit HDAC in vitro, 
butyrate stimulated the greatest increase in overall H4 acetylation (47). These results 
have been confirmed in vivo, where a positive correlation between luminal butyrate 
levels and histone acetylation (H4) was reported (67). In a study published just last year, 
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researchers identified that butyrate can additionally stimulate histone acetylase (HAT) 
activity (69). Although both mechanisms increase histone acetylation, different gene loci 
were up or down regulated depending on how butyrate was utilized in the cell. 
Additionally they demonstrated that butyrate has differential effects on cell lines and this 
effect is dependent upon the cells metabolic state.  Donohoe et al. (69) simulated the 
Warburg effect (i.e., glycolysis followed by cytosolic lactic acid fermentation versus 
oxidation of pyruvate in the mitochondria) in vitro, which is commonly found in cancer 
cells. They observed that butyrate concentrations were not depleted in these cells as 
observed in normal colonocytes, and thereby affected transcription of different gene loci 
(69). This is thought to be due to inefficient metabolism of butyrate due to the Warburg 
effect, allowing for accumulation of butyrate in the nucleus and inhibition of HDACs.  
These studies are a first step in better understanding the butyrate paradox, and how this 
metabolite can epigenetically regulate the expression of different target genes associated 
with proliferation and apoptosis. 
Microbial signaling in the intestine 
In addition to acting as a physical barrier, the intestinal epithelium is very 
important in the regulation of intestinal homeostasis. Microbe-epithelial cell interactions 
are important in maturation of intestinal epithelium and the development of the innate 
and acquired mucosal immune system (35, 70). Bacteria present in the bowel, either 
commensal or pathogenic, can communicate with the host immune system through 
pathogen-associated molecular patterns (PAMPs) or an increasingly used term, microbe-
associated molecular patterns (MAMPs) (71). The most common and characterized 
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receptors are TLR, with over 13 being reported in mice and humans. TLR recognize 
various microbial ligands including lipoproteins, lipopolysaccharide (LPS), flagellin, and 
CpG DNA (72-73). Once activated, TLR can trigger a downstream signaling cascade 
through the MyD88 pathway, which includes NF-κB activation, known to upregulate the 
expression of various chemokines (73-74). In healthy individuals, the host epithelium 
tolerates the presence of luminal bacteria and does not mount an inflammatory response. 
Furthermore, this relationship is required for normal function and involved in various 
beneficial effects such as epithelial cell proliferation, IgA production, mucin gene 
expression, goblet cell dynamics and differentiation, and the maintenance of tight 
junctions (44, 74-75). 
As mentioned previously, the etiology of GI diseases such as Crohn’s and IBD is 
not well established.  However, chronic stimulation or uncontrolled signaling between 
commensal bacteria and the host has been implicated as a cause for the initiation and 
pathogenesis of IBD (5). Alterations to these interactions can lead to acute or chronic 
bouts of inflammation in the bowel, which mentioned previously, can lead to increased 
susceptibility to colorectal cancers. Other references indicate that mutations/differential 
expression of TLR, nod-like receptors (NLR), and downstream mediators of the NF-κB 
pathway can break microbial tolerance and have been implicated in GI diseases such as 
IBD and Crohn’s (7, 76-77). It was reported that patients with IBS had significantly up 
and down regulated expression of TLRs compared to healthy controls, indicating that 
affecting the interaction between these receptors and the commensal bacteria present in 
the bowel could potentiate GI diseases (7).  
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It has been reported that interactions between TLR and the commensal bacteria 
also maintain epithelial cell barrier function and have been implicated in the inhibition of 
colonic inflammation (37, 72, 75). Studies using gnotobiotic or knockout (KO) animals 
(e.g., TLR pathway) or experimental models that induce an inflammatory state in the 
bowel using DSS or TNBS can help elucidate the effect of the intestinal microbiota on 
health and disease states (78-81). It has been demonstrated that animals raised in a germ-
free environment, containing no GI bacterial populations, are more susceptible to DSS 
induced colitis suggesting the interaction between TLR and microbes are essential to 
maintaining intestinal homeostasis (80, 82). Additionally, it has been hypothesized that 
if the intestinal microbiota does not contain species with TLR ligands, there could be an 
increase in epithelium permeability and therefore increased ability for infiltration by 
pathogens (37). To better understand how TLR signaling can affect barrier stability, one 
in vitro study looked at the effect of a synthetic lipopeptide on two different epithelial 
cell lines (37). It was reported that these lipopeptides, which are similar to that of 
commensal bacteria, interact with TLR2 and enhance epithelial cell barrier function by 
activating protein kinase C. Other important interactions of commensal bacteria and 
TLR were demonstrated in a recent in vivo study where transgenic mice were used to 
better understand the relationship between commensal bacteria and epithelial 
inflammation (75). In this study, intestinal inflammation was induced by a chemical 
agent and the effect of TLR signaling (induced by commensal bacteria) in the MyD88 
pathway was shown to confer protection against colonic bleeding and intestinal 
epithelium damage. In addition, mice without commensal bacteria present had a lower 
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survival rate than animals with selected commensal bacteria (by antibacterial 
administration) in the GI tract, which suggests that the commensal bacteria can produce 
these protective effects (37).  
Many studies have been performed to better understand the role of TLR in 
inflammatory and immune disorders in the gut (83-86). One study reported that defective 
IL-10 signaling from TLR causes a constitutive activation of certain inflammatory 
cytokines, and can lead to the development of chronic enterocolitis (86). Another recent 
study also implicated TLR and interleukin activities in the etiology of enterocolitis (83).  
In this study, a variety of transgenic knockout mice were used to understand how the 
absence of IL-10 signaling induces colitis. Kobayashi et al. reported that introduction of 
TLR4 deficiency in mutant mice diminished intestinal inflammation in these animals, 
which demonstrates that TLR recognition of pathogenic ligands in the intestine can 
trigger the development of chronic enterocolitis (83). Two studies performed by the 
same research group demonstrated that TLR9-mediated microbial recognition inhibits 
colonic inflammation in a mouse model (84-85). These two studies induced colitis in 
wild-type and transgenic animals and demonstrated that certain probiotic bacterial 
strains had anti-inflammatory effects when interacting with TLR. In particular they 
demonstrated that TLR-triggered IFN-α/β production, thereby mediating innate 
immunity, can provide a protective effect against colitis (84). It has also been suggested 
that the absence of TLR in epithelial cells might contribute to a hypo- responsive tone 
toward commensal bacteria and lead to inflammation in the GI tract (87). 
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These studies indicate that TLR may play a role in the etiology of different GI 
disorders. It has been suggested that TLR are probably involved in other aspects of 
immune responses, even in the absence of infection (73). Many aspects of the 
interactions between TLR and bacterial ligands are unknown, and additional studies are 
warranted to better understand how their relationship affects the physiology of the host. 
Additionally, a complete phylogenetic characterization of the bacterial groups present in 
healthy and diseased individuals is important and will allow researchers to better 
understand how shifts in the commensal microbiota or activation of pro-inflammatory 
pathways through TLR can affect the onset or progression of IBD. 
Characterization of the intestinal microbiota and its role in IBD 
Early studies characterizing the intestinal microflora used traditional 
microbiological culture techniques, in which samples are plated on selective culture 
media and are grown in an aerobic or anaerobic environment and further identified by 
various morphological and biochemical tests (88).  However, it is established that 
microbiological culture techniques fail to accurately characterize bacterial communities 
in complex environmental samples (e.g., the gastrointestinal tract) (89-90). This is due to 
the fact that only an estimated 10% - 50% of bacteria present in the mammalian gut are 
cultivable due to unknown growth requirements, poor selectivity of culture media, and 
microorganism metabolic plasticity (90). Furthermore, culture-based techniques for 
studying complex biological samples such as intestinal content are laborious and time-
consuming.  
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In recent years, the intestinal microflora in many mammalian species has been 
studied using molecular-based methods that amplify the 16S ribosomal RNA gene (16S 
rDNA) (91-93). Bacterial 16S rRNA genes generally contain nine hypervariable regions 
that demonstrate considerable sequence diversity among different bacterial species and 
can be used for species identification (94). Since these hypervariable regions are flanked 
by conserved regions, universal bacterial primers can be designed that enable PCR 
amplification of target sequences, which results in amplification of all bacteria present in 
a given sample. Therefore, molecular-based methods allow identification of both 
cultivable and non-cultivable bacteria. In many studies, molecular techniques have 
resulted in the observation of an increased bacterial diversity in the intestine compared to 
strictly culture-based methods (89-90, 92). Additionally, next generation sequencing 
techniques have allowed for the rapid and in-depth analysis of complex bacterial 
communities such as the intestinal microbiota. Within the past decade, numerous studies 
have employed a 454-pyrosequencing technique and reported that this method produces 
taxonomic classifications down to phylotypes below the genus level (93, 95). 
Numerous studies have focused on identifying shifts in intestinal bacterial 
populations that might initiate or propagate intestinal inflammation in GI diseases 
(summarized in Table 1). Patients with ulcerative colitis and Crohns disease demonstrate 
a decreased microbial diversity, in particular, depletion of certain bacterial species that 
are thought to be beneficial to GI tract health (e.g., lactic acid producing bacteria) (96-
99). Other organisms thought to be involved are species that are cytotoxic and/or 
possibly adherent or invasive to the gut epithelium, including Escherichia coli (E.coli), 
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Table 1. Documented microbiota alterations in IBD patients and in vivo models of ulcerative colitis. 
 
 
 
Changes in microbiota Phylum Class Order Family Genus Species Method Model Author
↓ Firmicutes FISH, CL CD patients Manichanh et al, 2006
↓ Bacterial species 
richness
T-RFLP IBD patients Sepehri et al, 2007
Firmicutes ↑Clostridia
Diff in CD & UC 
biopsies
CL, qPCR IBD patients Frank et al, 2007
↑Proteobacteria CL, qPCR IBD patients Frank et al, 2007
↓ Bacteroidetes CL, qPCR IBD patients Frank et al, 2007
Firmicutes Clostridia Clostridiales ↓ Lachnospiraceae CL, qPCR IBD patients Frank et al, 2007
Firmicutes Bacilli Bacillales Bacillaceae ↑ Bacillus CL, qPCR IBD patients Frank et al, 2007
↓ Bacteroidetes MA, qPCR IBS patients Rajilic-Stojanovic, 2011
↑ Firmicutes MA, qPCR IBS patients Rajilic-Stojanovic, 2011
Firmicutes Clostridia Clostridiales Clostridiaceae ↑ Clostridium MA, qPCR IBS patients Rajilic-Stojanovic, 2011
Actinobacteria Actinobacteria Bificobacteriales Bifidobacteriaceae ↓ Bifidobacterium MA, qPCR IBS patients Rajilic-Stojanovic, 2011
↓ Bacterial diversity FISH,  FC IBD patients Sokol et al, 2006
↓ Bacterial diversity
CL, T-RFLP, 
qPCR
DSS induced 
colitis
Nagalingam et al, 2011
↓ Bacteroidetes
CL, T-RFLP, 
qPCR
DSS induced 
colitis
Nagalingam et al, 2011
↑ Firmicutes
CL, T-RFLP, 
qPCR
DSS induced 
colitis
Nagalingam et al, 2011
Firmicutes Clostridia Clostridiales ↑ Lachnospiraceae 
CL, T-RFLP, 
qPCR
DSS induced 
colitis
Nagalingam et al, 2011
↓ Bacterial diversity qPCR, DGGE
DSS in WT, 
TLR2 -/-, 
Heimesaat et al, 2007
Firmicutes Clostridia ↑ Clostridiales qPCR, DGGE TLR4 -/- & Heimesaat et al, 2007
Proteobacteria γ-Proteobacteria Enterobacteriales ↑Enterobacteriaceae qPCR, DGGE TLR 2/4 -/- Heimesaat et al, 2007
Firmicutes Bacilli Lactobacillales Lactobacillaceae ↓Lactobacillus qPCR, DGGE Heimesaat et al, 2007
↓ Bacterial diversity T-RFLP IBD patients Andoh et al, 2011
Firmicutes Clostridia Clostridiales Clostridiaceae ↓Clostridium T-RFLP IBD patients Andoh et al, 2011
Firmicutes Clostridia Clostridiales Clostridiaceae ↑Clostridium qPCR UC patients Verma et al, 2010
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides qPCR UC patients Verma et al, 2010
Firmicutes Bacilli Lactobacillales Lactobacillaceae ↓Lactobacillus qPCR UC patients Verma et al, 2010
Actinobacteria Actinobacteria Bificobacteriales Bifidobacteriaceae ↓Bifidobacterium qPCR UC patients Verma et al, 2010
↓ Bacterial diversity DGGE UC patients Noor et al, 2010
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides vulgatus DGGE UC patients Noor et al, 2010
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides uniformis DGGE UC patients Noor et al, 2010
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides ovatus DGGE UC patients Noor et al, 2010
Mucus and feces 
differences
FISH UC patients Takaishi et al, 2008
Firmicutes Bacilli Lactobacillales Lactobacillaceae ↑ Lactobacillus Culture UC patients Takaishi et al, 2008
Actinobacteria Actinobacteria Bificobacteriales Bifidobacteriaceae ↓Bifidobacterium Culture UC patients Takaishi et al, 2008
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides vulgatus qPCR UC patients Takaishi et al, 2008
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides ovatus qPCR UC patients Takaishi et al, 2008
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides thetaiotaomicron qPCR UC patients Takaishi et al, 2008
Bacteroidetes Bacteroidetes Bacteroidales Bacteroidaceae ↓Bacteroides fragilis qPCR UC patients Takaishi et al, 2008
Firmicutes Clostridia Clostridiales Clostridiaceae ↑ Clostridium leptum qPCR UC patients Takaishi et al, 2008
↑ Firmicutes CL UC patients Gophna et al, 2006
↓ Bacteroidetes CL UC patients Gophna et al, 2006
Firmicutes ↑Clostridia CL UC patients Gophna et al, 2006
↓ Bacterial diversity Culture Fabia et al, 1993
↓ Anaerobic Gram (-) 
bacteria Culture
UC patients, 
AA 
Fabia et al, 1993
Firmicutes Bacilli Lactobacillales Lactobacillaceae ↓Lactobacillus Culture Fabia et al, 1993
↓ Bacterial diversity SSCP & qPCR UC patients Ott et al, 2004
↓ Bacteroidetes SSCP & qPCR UC patients Ott et al, 2004
Proteobacteria γ-Proteobacteria Enterobacteriales ↓Enterobacteriaceae SSCP & qPCR UC patients Ott et al, 2004
Firmicutes Bacilli Lactobacillales Lactobacillaceae ↓Lactobacillus SSCP & qPCR UC patients Ott et al, 2004
↑ Increased compared to controls
↓ Decreased compared to controls
CL, clone library; FISH, flourescent in situ hybridization; FC, Flow cytrometry; T-RFLP, terminal restriction length fragment polymorphism; qPCR, quantitative PCR; 
DGGE, denaturing gradient gel electrophoresis; SSCP, single strand conformation polymorphism; CD, Crohns disease; UC, ulcerative colitis; 
IBD, inflammatory bowel disease; TLR, toll-like receptor AA, amino acid induced colitis; WT, wild type
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and Shigella, Streptococcus, Salmonella, and Clostridium species (46, 100). 
Additionally, a dysbiosis of the predominant bacterial phyla, Bacteriodes and Firmicutes, 
has been implicated in the etiology of IBD (101).  
Using a variety of phylogenetic characterization techniques, multiple studies 
showed that the microbiota in patients with a GI disorder (ulcerative colitis and Crohn’s 
disease) differed from the flora of healthy individuals (97-98, 102). One study used 
principal component analysis (PCA) to assess the differences in 155 bacterial species 
from patients with ulcerative colitis, Crohns disease, and healthy controls. They reported 
a clear separation between these groups when comparing the microbiota of fecal samples 
(102). However, varying results from patient to patient and across studies suggest that no 
one particular phyla is responsible for the onset of inflammation in the intestine. For 
example, some studies reported a marked decrease in ‘good’ or beneficial bacteria (i.e., 
bacteria that provide health benefits to the host), such as Lactobacilli and Bifidobacteria, 
compared to healthy controls. These species have also been reported to reduce intestinal 
inflammation in an animal colitis model, further suggesting their role in suppressing 
inflammation in patients with GI diseases (103). Yet another study reported an increase 
in Clostridium species has been reported in biopsies and luminal contents from patients 
with ulcerative colitis. In contrast, Frank et al reported a depletion of the ‘normal flora’, 
namely bacteria belonging to the Bacteriodes and Firmicutes (contains Clostridium spp.) 
phyla in patients with ulcerative colitis and Crohn’s diesase (96). Additionally, 
conflicting results have been reported regarding the bacteria associated with inflamed 
mucosa. When comparing intestinal biopsies from patients with GI disorders, one study 
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cited differences in the bacterial species isolated from inflamed areas of tissue versus 
non-inflamed areas (97), while another study reported no significant differences between 
inflamed or non-inflamed mucosa (98). Differences in these studies could be due to 
disease progression of each patient, sampling technique, or method of phylogenetic 
classification. Therefore, a better understanding of what bacterial populations are present 
in a diseased state is important and should be characterized. 
Alterations to intestinal microbiota by diet and bioactive compounds 
The composition of the intestinal microbiota can be altered by changes in the 
host’s diet, GI disease, antibiotics, and the presence of pathogens. A change in diet 
composition is very influential in altering the bacterial groups that reside in the GI tract 
(11-12). Dietary compounds such as tannins, polyphenols, and other antioxidants have 
been studied within the last few decades because of their numerous beneficial effects for 
the host (i.e., antimicrobial capabilities, elimination of free radicals, and anti-
inflammatory effects) (15, 104-105).  In addition, numerous studies have shown that 
these dietary compounds can have an effect on the survival of certain bacterial taxa, 
which allow certain bacterial groups to thrive while suppressing or eliminating others in 
the gut (9, 14-16, 104-105).  
Tannins are the second most abundant group of plant polyphenols and are 
different from other polyphenols due to their ability to precipitate proteins from solution 
(106). In addition, tannins are bacteriostatic compounds that are able to inhibit the 
growth of certain microorganisms and resist microbial attack (16, 107-109). Tannins are 
found in a variety of fruits, vegetables and other plants and can be found in two different 
 18 
 
forms, hydrolysable and condensed (9). Many studies have been performed to ascertain 
the effect of these tannins on the microbiota in different mammals, including humans (9, 
16).  
Some previous studies used stock bacterial strains, previously identified as 
constituents of the intestinal microbiota, and tested the in vitro effect of tannins using 
culture based methods (9, 14, 107).  One study reported that some hydrolysable tannins 
(gallic acid and methyl gallate) derived from the Galla Rhios plant have inhibitory 
properties against some Clostridium species in culture (14).  They reported that large 
doses of methyl gallate (10 mg) had an inhibitory effect on potentially harmful bacterial 
strains such as C. perfringens, C. paraputriﬁcum, E. limosum, B. fragilis, S. aureus, and 
E. coli, but only had slight effect on some ‘beneficial’ lactic acid bacteria (LAB) strains 
(Bifidobacteria and Lactobacilli) (14). An additional in vitro study showed the effects of 
dietary tannins (gallic acid, tannic acid and its ester forms, propyl gallate and methyl 
gallate) on common human GI microbes that were previously isolated from the human 
intestine (9). Similar to Ahn et al. (14), they reported that gram positive bacterial species 
such as B. fragilis, C. clostridiiforme, E. coli, and S. typhimurium were inhibited by 
these tannins (excluding gallic acid) while LAB species were not (i.e., B. infantis, L. 
acidophilus) (9). Osawa et al reported that Lactobacillus species isolated from human 
fecal samples expressed the enzymatic capability to break down tannin ester bonds, 
suggesting that their presence in the flora could alter dietary tannins ability to effectively 
bind proteins (105). 
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Another study testing the effect of different tannins on the GI microbiota in vivo 
also reported similar gram positive bacteria inhibition (16). This study used denaturing 
gel electrophoresis (DGGE) to elucidate how tannins derived from the Acacia 
angustissima shrub affected the bacterial diversity of the GI tract in laboratory rats. 
Extracted condensed tannins were added to a basal rodent diet (0.7% and 2.0%, low and 
Hi Tannin diet respectively) for 3.5 weeks, with non-supplemented basal diet fed for 3 
weeks prior and 3.5 weeks after tannin supplementation. They reported that there was a 
significant difference in the diversity of fecal samples in rodents fed a diet supplemented 
with tannins based off DGGE fingerprints (16). Predominant bands from the control and 
tannin supplemented animal DGGE gels were excised and sequenced to obtain 
phylogenetic information on these bacterial groups. Phylogenetic classification showed a 
significant decrease in the C. leptum sub-group in rats fed a tannin supplemented diet, 
while other enteric bacteria such as species classified in the B. fragilis and Bacteroides-
Prevotella-Porphyromonas groups increased significantly (16).  
Although the mechanisms that allow some bacterial species to be tannin-resistant 
are not completely known, some have suggested that tannins cause an iron deficiency 
thereby inhibiting the growth of bacterial species that require iron as a cofactor for 
metabolism (107, 110). However, some hydrolysable tannins, such as propyl and methyl 
gallate, do not bind iron; therefore, other mechanisms must be considered to fully 
understand the antimicrobial capacities of tannins (9). 
Other dietary compounds such as tea polyphenols and other antioxidants have 
been reported to alter the composition of the intestinal microbiota (15, 104). One study 
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observed that Xanthohumol, an antimicrobial flavonoid found in hops, had a significant 
effect on the diversity of bacterial groups in rat feces using DGGE fingerprint analysis 
(104). Similar results were observed in a study that characterized how tea polyphenols 
affected GI microbial diversity in humans (15). Using culture based methods, it was 
observed that tea polyphenols had an effect on the bacterial diversity of human fecal 
samples. Those that were administered tea polyphenols had decreased proportion of 
Clostridium spp. and an increased proportion of Bifidobacterium spp. compared to those 
that did not consume these polyphenols (15). 
In addition to dietary bioactive compounds, other dietary constituents (e.g., 
elevated dietary iron) can have a profound impact on oxidative stress in the lumen. 
Dietary iron can be found in heme (predominant Fe form in red meat) and non-heme 
forms (found in plants), with the latter having numerous chemical permutations (e.g., 
ferric citrate) that affect bioavailability and absorption. Studies have demonstrated that 
elevated levels of heme in the diet can have deleterious effects to the luminal 
environment and intestinal epithelium, including production of cytotoxic compounds and 
free radicals, barrier damage, hyperproliferation, downregulating repair mechanisms, as 
well as altering the microbiota and luminal concentration of SCFA (111-113). Although 
no studies directly assess the effect of non-heme high dietary iron on intestinal bacterial 
metabolism, it is known that butyrate producing bacteria strongly depend on Fe as a 
cofactor for butyrate production (110). One study did report that diets supplemented with 
ferric citrate (1.3 umol/g) can suppress SCFA concentrations in fecal water (111), 
however, they didn’t phylogenetically classify the microbiota or perform metagenomics 
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to assess changes to metabolism. Other independent studies have reported that dietary 
iron depletion variably promote and inhibit the microbiota, including taxa that are known 
butyrate producers (114-115). It has been reported that cecum SCFA concentrations and 
the proportion of butyrate-producing bacteria can be increased when iron depleted 
animals are fed diets fortified with iron (115), however, there is little literature that 
describes the effect of non-heme high dietary iron on the microbiota or bacterial 
metabolism. 
Epidemiological data and research based evidence suggests that a diet containing 
bran sources can alter the luminal environment and may be protective against the onset 
of colon cancer (23-24, 27-28, 116). Sorghum bran in particular, has been characterized 
as containing high levels of dietary bioactive compounds that could be beneficial to 
those with GI disorders by removing ROS from the lumen and providing beneficial 
changes to the microbiota and their metabolites (25-27). Black and brown sorghums are 
known to contain high concentrations of 3-deoxyanthocyanins and condensed tannins, 
respectively, and have been reported to have a significantly higher antioxidant capacity 
compared to wheat bran, whole grains, and fruits such as blueberries and pomegranate 
(27, 117).  One study reported that animals fed a diet containing 6% fiber from sorghum 
bran had differential effects on luminal SCFA concentrations and were more protected 
against the promotion of colon cancer (24). Aberrant crypt foci, a preneoplastic lesion 
used as a biomarker for carcinogenesis in animals, were significantly lower in animals 
fed a black or brown sorghum compared to cellulose control animals. Additionally, it 
was demonstrated that these bran diets can affect the proliferation and apoptosis of 
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colonocytes, further suggesting that the differential actions of the sorghum bran may be 
beneficial in suppressing colon cancer (24). 
Studies indicating that bran based diets and high dietary iron can alter luminal 
SCFA concentrations suggest alterations to the intestinal microbiota. In addition, it has 
been reported that bioactive compounds, particularly tannins, have the ability to enhance 
or suppress the growth of different constituents of the microbiota. Furthermore, tannins 
and other polyphenols with antioxidant characteristics can affect intestinal homeostasis 
and could be utilized in a diet to mitigate the effects of chronic inflammation or the 
progression of colon cancer. Additional studies are warranted to better understand the 
interactions and mechanisms that bioactive compounds found in sorghum bran have with 
the microbiota, and their combined effects on the health of the host. 
Effect of radiation exposure on intestinal homeostasis  
When radioactive particles come into contact with the human body, it can affect 
cells by either direct energy absorption or by the production of free radicals. Radiation 
has many deleterious effects on the biological systems including the formation of 
reactive oxygen species (ROS), and DNA damage, which includes base pair loss, single 
or double strand breakage, and chromosomal aberrations (118-119). The GI tract is one 
of the most radiosensitive organs and exposure affects numerous cellular mechanisms 
including membrane stability, differentiation, and apoptosis (118, 120). Additionally, 
preliminary studies suggest radiation exposure can alter the microbiota (114). 
Countermeasures such as antioxidant supplementation and probiotics might be effective 
at counteracting some of the negative effects of radiation on the gastrointestinal tract, as 
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it has been reported they have the ability to reduce intestinal inflammation and mitigate 
symptoms of IBD (108, 121-124). 
When radiation comes into contact with cells, the “biological key substances”, or 
protein, DNA, and RNA, are affected either directly or indirectly and the degree of 
damage directly correlates to the number of transformed molecules (21). In radiobiology, 
understanding linear energy transfer (LET), or the amount of energy that is transferred to 
a substance as the radiation passes through, is important in understanding the effect of 
radiation on biological systems (118). Low LET radiation such as gamma and x-rays is 
more likely to have indirect effects on cells by the formation of free radicals such as H•, 
•OH, H2O2, and e
-
aq , while high LET radiation will directly damage cell membranes, 
organelles and DNA (118, 125). High LET DNA damage is more complex and difficult 
to repair compared to low LET injuries induced by free radicals.  
ROS interactions with DNA can cause a myriad of structural lesions such as the 
base loss, base modification, single or double strand break and the formation of dimers 
and DNA-protein cross-links (21, 118, 125). Direct effects of radiation produce similar 
chromosomal injuries and can influence cell survival. Throughout the cell cycle, check 
points monitor the viability of the DNA and can either repair or shuttle cells into an 
apoptotic, or programmed cell death, pathway. Two main repair mechanisms include 
base pair excision (BPE) and non-homologous end joining (NHEJ) (119). Once a cell 
becomes irradiated (directly or indirectly), the outcome can be mutations, division delay, 
apoptosis, reproductive failure or cellular arrest, and transformation to a possibly 
carcinogenic cell (21, 119).  
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The mucosal surface of the small and large intestine has shown increased 
propensity for radiation induced mucosal injury, and complications are magnified in the 
small and large intestines due to the high proliferative capacity of the mucosal cells (22). 
As mentioned previously, irradiation can cause mitosis to halt in epithelial cells. If 
proliferation is halted at the base of the intestinal crypt, the continued migration and 
sloughing of cells from the villi causes the intestinal wall to become denuded and can 
allow for entry of bacteria and toxins from the lumen (126). Additionally, it has been 
shown that radiation exposure can activate apoptosis in the small and large intestine 
through a variety of pathways. It has been reported that the incidence of apoptosis in the 
small intestine directly correlates to increasing doses of radiation and this induction 
plateaus around 1 Gy (127). However, the type and position of the cells undergoing 
apoptosis differ in the small and large bowel crypts (128). The reason the small and large 
intestine differ so greatly in regards to radiation induced apoptosis is still unknown, 
however, it has been suggested that diet, presence of food, transit time, and the bacterial 
populations populating the lumen could play a role. 
  Radiation induced injury to the intestinal tract has numerous deleterious effects, 
including direct mucosal toxicity, delayed gastric emptying and secretion, release of 
prostaglandins, morphological effects such as villous shortening, and alterations to the 
diversity of the intestinal microbiota (21-22, 120, 129-130). Radiation exposure has also 
been implicated in stimulating the secretion of intestinal fluid and transcellular 
electrolytes, which results in diarrhea. This elevated secretion could be due to the 
epithelial cell loss described above, however, it has been reported that epithelial 
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dysregulation can occur prior to the epithelial cell loss. For example, two animal studies 
reported that responsiveness to secretagogues, or a substance causing another substance 
to be secreted, is reduced in animals with acute radiation enteritis (120, 126). Although 
the mechanisms causing this hyporesponsiveness to secretagogues are unclear, it has 
been proposed that irradiation has an effect on intestinal mast cell populations, which 
control the responsiveness to secretagogues via enteric nerve stimulation (131). 
Additionally, it has been reported that the inducible form of nitric oxide (NO) synthase 
(iNOS) expression, is increased post-radiation (132). Due to the increased permeability 
and decreased responsiveness to secretagogues, it has been suggested that a luminal 
factor, such as the commensal bacteria, might be involved in the etiology of radiation 
induced intestinal dysregulation (120). 
Effect of radiation on intestinal microbiota  
 As mentioned previously, the intestinal bacterial populations, or microbiota, play 
a significant role in gastrointestinal health of both humans and animals and disruption of 
the homeostatic balance between the host and commensal bacteria has been implicated 
in the etiology of gastrointestinal disorders in humans and many animals (18, 35-36, 43, 
45). Although little is known in regards to the effects of the microbiota in an irradiated 
state, early studies in the 1950’s and 1960’s reported that germ-free animals had more 
protection against radiation at differing doses compared to animals with a conventional 
microbiota. McLaughlin et al. reported that with differing doses of radiation (4.82-8.33 
Gy), germ-free mice always had a greater survival rate compared to conventional and 
E.coli mono-contaminated (germ-free mice inoculated with bacteria) animals. It was 
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suggested that the presence of bacteria in the bowel has an effect on proliferation of 
intestinal mucosal cells, and these underlying mechanisms might play a role in the 
protective effect shown (131). These reports have been confirmed in a more recent study 
as well, which reported that germ-free animals exposed to 10-22 Gy showed no signs of 
radiation enteritis induced injury to their small intestine compared to conventional 
(containing a normal microbiota) or conventionalized (germ-free mice inoculated with 
bacteria) mice which showed the classical injury response (133). Additionally, much 
higher doses of radiation were administered to these animals (~16 Gy) and the same 
effect was observed where germ-free animals had a significantly higher survival rate 
compared to animals with a functional microbiota. Both of these studies showed that 
there is an interaction with radiation and the microbiota and further studies are warranted 
to investigate these mechanisms. 
 Described previously, commensal bacteria have been shown to influence the 
response to intestinal injury through the transcription factor, NF-κB, which is activated 
downstream of many TLR pathways (74). It has been reported that disruption of this 
pathway by knocking out IκB kinase, allowing IκB to permanently sequester NF-κB in 
the cytoplasm, causes increased epithelial cell apoptosis in mice exposed to radiation 
(134). This increase in apoptosis corresponded with increased expression and activation 
of p53, similar to reports from Hendry et al (127). Another study used a knockout mouse 
model for the p50 subunit of NF-κB, and reported that animals without NF-κB signaling 
were more susceptible to radiation lethality than wild type animals (135). Additionally, 
production of prostaglandins via TLR activation has been shown to protect intestinal 
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crypts against radiation exposure (136).  These studies show a direct link of the intestinal 
microbiota, NF-κB activation, production of prostaglandins, and the regulation of 
radiation induced apoptosis.  
 To our knowledge, little information is published that characterizes changes in 
the bacterial groups or TLR expression in the intestine after radiation exposure. It has 
been reported that long term effects of radiation enteropathy are associated with an 
overgrowth of gram-negative bacilli and bowel dysmotility, however, no molecular 
analysis was performed to identify a particular bacterial taxa involved with the etiology 
of radiation induced intestinal dysfunction (137). One small pilot study used denaturing 
gradient gel electrophoresis (DGGE) to identify changes in the bacterial diversity of 
fecal samples from patients suffering from acute post-radiotherapy diarrhea, and those 
with no gastrointestinal distress after radiation treatment (total exposure of 4,300-5,400 
cGy) (114). They observed that the microbial profiles of the individuals in each group 
(i.e., control, no diarrhea and diarrhea group), clustered in similar sets, suggesting that 
specific bacterial taxa could be associated with risk or protection after radiation 
exposure. Subjects with clinical signs (i.e., diarrhea) showed a marked modification of 
their microbial profile compared to those that did not have gastrointestinal 
complications. Additionally, it was reported that the proportion of Bacilli species and 
bacteria characterized in the Actinobacteria phylum were markedly higher in individuals 
with diarrhea compared to those without diarrhea following radiation treatment (114). 
Based on the findings, it suggests that the bacterial groups that compose the intestinal 
microbiota could be a determinant if an individual is susceptible to post-irradiation 
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diarrhea. Additionally, these results suggest that radiation might play a role in the 
proportion of different bacterial groups present in the intestine. Unfortunately little 
phylogenetic classification was performed in this pilot study which could provide more 
insight into which specific bacterial taxa might be involved in the etiology of intestinal 
dysfunction caused by radiation, or which bacterial groups might be altered by exposure 
to radiation. 
 The majority of the experiments described above are predominately large, acute 
radiation doses comparable to exposures seen in warfare or accidental exposures. 
Unfortunately, little is known regarding how GI homeostasis can be affected by low 
and/or fractionated radiation doses from medical diagnostic tests, occupational radiation 
exposure, and those encountered by airline and spaceflight crews. NASA is concerned 
with the health risks to astronauts, particularly those associated with radiation exposure, 
and alterations to the luminal environment and intestinal epithelium following large 
radiation doses is an indicator that GI dysfunction may be a risk during and after space 
flight. To our knowledge there are no studies analyzing the effect of fractionated, low 
doses of radiation on the microbiota, SCFA production, and TLR signaling. Results from 
these studies will further elucidate mechanisms responsible for the observed 
perturbations to normal GI function, and will also allow doctors and researchers to create 
more specific countermeasures for gastrointestinal dysfunction for these types of 
radiation exposures.  
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Hypothesis and Specific Aims 
 Our overall goal is to better understand how intestinal inflammation and injury is 
initiated by environmental insults such as chemical exposure, radiation, and a high 
oxidant load diet. Our overarching hypothesis is that each insult will have an effect on 
inflammation and injury by changing the colonic bacterial populations and by affecting 
signaling between the bacterial populations and colonocytes. Our secondary hypothesis 
is that through an appropriate dietary intervention, we can mitigate the inflammation and 
injury caused by these environmental insults.  The experiments designed to test these 
hypotheses will utilize two experimental paradigms; one using a chemical inducer of 
inflammation/injury (DSS) and the other using various forms of radiation, 
weightlessness and diets commonly consumed in the space environment. 
Aim 1: Determine if the perturbations in the intestinal environment leading to 
intestinal inflammation and injury caused by DSS exposure can be mitigated by diets 
containing bioactive compound-enriched sorghum brans. 
Hypothesis 1:  DSS induced colonic inflammation will affect the colon luminal 
environment by altering bacterial populations, their metabolites, and TLR signaling in 
colonocytes. 
Hypothesis 2:  Sorghum brans containing 3-deoxyanythocyanins, condensed 
tannins, or a combination of both compounds, will mitigate the effects of repeated 
inflammation in the bowel by restoring commensal bacterial populations, suppressing 
TLR-induced elevations in pro-inflammatory mediator expression, and upregulating 
epithelial repair mechanisms.  
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Aim 2: Determine how environmental insults associated with space flight (i.e., 
radiation exposure, microgravity, high oxidant load diet) affect intestinal inflammation 
and injury. 
Hypothesis 1:  Exposure to radiation, microgravity, and high oxidant load diets 
will initiate an inflammatory state in the GI tract by altering the microbiota, its 
metabolites, and TLR signaling in colonocytes. 
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CHAPTER II  
NOVEL SORGHUM BRANS ATTENUATE THE SEVERITY OF DSS-INDUCED 
COLITIS AND UPREGULATE EPITHELIAL BARRIER PROLIFERATION 
AND REPAIR PROTEIN EXPRESSION 
 
Introduction 
Chronic inflammation has been shown to increase the risk of numerous forms of 
cancer, and epidemiological studies suggest that those suffering from gastrointestinal 
(GI) diseases such as ulcerative colitis (UC) have between a 2-18% increased risk 
(dependent upon age) of developing colon cancer (138). Ulcerative colitis consists of 
varying degrees of mucosal inflammation that extends proximally from the rectum, and 
these regions of inflammation are commonly associated with ulcerations and mucin 
depletion (5). The complete etiology of UC is still not fully understood, but recent 
research has indicated that a disruption in the host immune response to the commensal 
bacterial populations in the intestine, or microbiota, could be a major factor in the 
progression of this disease (5, 8, 78). 
It is well documented that the intestinal microbiota plays a role in the health of 
the host by affecting the luminal environment and interacting with the host epithelial 
cells. This includes the fermentation of dietary fiber, altering intestinal motility and pH, 
and can provide protection against invading pathogens and increase efficacy of tight 
junctions (35-36, 72). Fermentation of dietary fiber produces metabolites including 
lactate and short chain fatty acids (SCFA) such as butyrate,  which is the preferred fuel 
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source for colonocytes (38, 139). SCFA also have been shown to affect the induction of 
gene expression, cellular differentiation, and have anti-inflammatory activity (20, 139-
140). In addition, the microbiota affects the innate immunity of the host by signaling 
through pathogen-associated molecular patterns such as toll-like receptors (TLR), which 
signal through the NFκB pathway (72-73, 87). This signaling pathway can affect the 
transcription of pro-inflammatory cytokines, and epithelial cell proliferation and 
apoptosis. Furthermore, dysregulation of the TLR pathway has been associated with the 
progression of intestinal inflammation and the pathogenesis of UC (72-74, 84-85). 
The composition of the microbiota can be altered by numerous environmental 
factors including antibiotic use and stress. Additionally, it has been demonstrated that 
changing certain dietary constituents can have a dramatic affect on the proportions of 
certain bacterial taxa in the intestine (11-12, 116, 141). In recent years secondary plant 
metabolites, such as polyphenols, have been reported to alter the intestinal microbiota 
(14, 16, 107, 142-145). Recent in vivo studies have reported the ability of polyphenols 
such as hydrocaffeic acid, tea polyphenols, and tannic acid to have differential effects on 
bacterial populations by enhancing certain taxa and eliminating others in the intestine (9, 
15, 143).  Additionally, numerous polyphenols are known antioxidants and may prove to 
have beneficial effects during inflammatory bouts associated with UC (9, 15, 107, 143, 
145). 
Sorghum is a grain predominately grown in dry, arid areas and is a common 
staple in some African and South American countries. Certain black and brown sorghum 
varieties contain large quantities of 2-deoxyanthocyanins and condensed tannins, which 
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are known antioxidants (25-26, 117). The antioxidant capacity in decorticated bran is 
even higher than other bran sources (i.e., wheat, oat) and fruits such as pomegranates 
and blueberries (27). Additionally, limited research demonstrates that diets containing 
sorghum bran have the potential to protect against the progression of colon cancer and 
can affect the intestinal microbiota and its metabolites (24). Other sources of dietary 
polyphenols have been reported to mitigate some of the deleterious effects of colitis, 
including modulating alterations to the intestinal microbiota (108-109, 121, 146). Based 
on this information, we hypothesize that DSS induced colonic inflammation will affect 
the colon luminal environment by altering bacterial metabolites and TLR signaling in 
colonocytes. Furthermore, we hypothesize that feeding sorghum brans will mitigate the 
effects of repeated inflammation in the bowel by suppressing TLR-induced elevations in 
pro-inflammatory mediator expression and upregulating epithelial repair mechanisms. 
Therefore, in order to elucidate the effects of sorghum grain on the deleterious effects of 
UC, we aim to characterize the effects of consumption of sorghum bran diets containing 
3-deoxyanthocyanins, condensed tannins, or both polyphenols on the production of 
secondary microbial metabolites, TLR signaling and epithelial cell proliferation, 
apoptosis, and repair during repeated dextran sodium sulfate (DSS) exposures. 
Materials and Methods 
Animals and diets 
Eighty male Sprague-Dawley rats (21 d old) were stratified by body weight and 
assigned to one of four experimental diets (n=20/ diet).  The four diets contained 6% 
dietary fiber from 1) cellulose, or bran isolated from sorghum grains that contain: 2) high 
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levels of 3-deoxyanthocyanins (Black bran), 3) high levels of condensed tannins and low 
levels of 3-deoxyanthocyanins (Sumac bran), or 4) both 3-deoxyanthocyanins and 
condensed tannins (Hi Tannin bran). Antioxidant capacity, total polyphenol content, 
tannin content, and proportions of soluble and insoluble fiber were quantified for each 
experimental diet (Table 2). Prior to beginning the experimental diet (at 40 d of age), 
animals were maintained on a standard pelleted rodent diet.  
 
Table 2. Antioxidant capacity, phenol levels, and fiber content for all experimental diets. 
Composite analysis was performed on a sample taken when each experimental diet was 
mixed. Over time analysis was performed on a sample containing fractions of each 
experimental diet collected throughout the course of the study. 
 
 
 
 
 
 
 
 
After 21 d of experimental diets, half of the rats were exposed to three sequential 
48 h dextran sodium sulfate (DSS) (MP Biomedicals, Irvine, CA) treatments (3% DSS) 
in their drinking water, with 14 d between each DSS exposure (Figure 1). Between DSS 
Sample ABTS† Total Phenols‡ Tannins‡ % Total Fiber % Soluble % Insol. 
Cellulose ND ND ND
Sumac bran 172.30 11.92 14.01
Hi Tannin bran 123.50 8.37 13.18
Tx430 Black bran 62.09 4.35 0.01
Cellulose ND ND ND 6.68 0.41 6.27
Sumac bran 182.41 11.56 14.02 5.98 0.71 5.27
Hi Tannin bran 136.31 8.75 13.49 6.4 0.41 5.99
Tx430 Black bran 64.16 5.43 0.15 6.98 0.66 6.32
ND= not determined
†Antioxidant capacity using ABTS method
‡Absorbance measured at 600 nm for Total Phenols and 500 nm for Tannins
Over time
Composite
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exposures, distilled water was supplied to treated animals to mimic remissions 
experienced by human chronic UC patients (147). The remaining half of the animals 
received distilled water throughout the course of the study.  
 
 
 
 
 
 
 
Figure 1. Timeline of DSS treatments for DSS rats in each experimental group. After 21 
d of experimental diets, DSS exposures began (3% DSS for 48 h, 14 d separation, 3 
treatments total). 
 
Body weight and food intake were routinely monitored. Rats were weighed upon 
arrival (d 1), prior to beginning experimental diets (d 19), 48 hr before each DSS 
exposure, and prior to termination (d 82). Additionally, food intake was measured prior 
to the first DSS treatment (d 35), following the second DSS treatment (d 56), and prior 
to termination (d 77, following third DSS treatment). On day 82, animals were 
euthanized by CO2 asphyxiation. The colon was resected, and two 1 cm sections were 
removed for histological preparations and the remainder was scraped. 
Fecal collections and processing 
  Fresh fecal samples were collected for fermentation metabolite analysis prior to 
DSS exposure, and 48 h after each DSS exposure.  
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Fecal samples were thawed and placed into a weighed pan prior to drying in a 
60°C oven for 72 h. Samples were cooled in a vacuum dessicator before being weighed 
and the procedure was repeated until weight became static. 
Short chain fatty acid analysis  
Fresh fecal samples were collected immediately following defecation. Samples 
were transferred to sterile cryotubes, snap-frozen in liquid nitrogen, and stored at -80°C. 
Frozen samples were processed and SCFA extracted and quantified by a Varian 3900 
gas chromatograph (Walnut Creek, CA) as described previously (28). Standards and 
blanks were run to facilitate calibration and to calculate SCFA (acetic acid, propionic 
acid, isobutyric acid, butyric acid, isovaleric acid, valeric acid) concentrations. The 
concentrations were multiplied by the 24 hr feces weight to calculate daily SCFA 
excretion (See Appendix B for calculations). 
Tissue fixation for immunohistological processing 
After fecal material was removed from the colon the two, 1 cm segments 
removed from the distal end of the colon, rinsed with RNase free Phosphate-Buffered 
Saline (PBS), and fixed in either a 4% PFA or 70% EtOH solution prior to embedding in 
paraffin.  
Mucosal samples  
The remaining colon was washed twice in RNase free PBS, scraped on a chilled 
RNase free surface, and 2/3 of the material was transferred to an RNase free 
homogenization tube along with 500 l of Denaturation Solution (Ambion, Austin, TX) 
and the remaining 1/3 transferred to a homogenization tube with 400 l of protein 
 37 
 
buffer. Scraped mucosa for RNA analysis was homogenized in Denaturation Solution 
for 6-7 strokes and then transferred to a 2 ml epitube for storage at -80°C (148). Scraped 
mucosa for protein analysis was homogenized, centrifuged (15,000 g x 30 min at 40°C), 
and the supernatant was stored at -80°C (149). 
Inflammation and injury histological scores 
The degree of inflammation and morphological injury caused by DSS exposure 
was assessed in H&E stained tissue slides. Histologic examination was performed in a 
blinded manner by a board-certified pathologist, and the degrees of inflammation (score 
of 0–3) and epithelial injury (score of 0–3) on microscopic cross sections of the colon 
were graded as described previously (150).  
Activated NF-κB measurement 
Activated NF-κB was assessed from scraped mucosa samples using the 
manufacturer’s protocol for whole cell lysates with the TransAM™ NF-κB Chemi Lysis 
buffer (Active Motif, Carlsbad, CA). Activated NF-κB (p50/p65 subunits) extracted 
from each sample was added to an oligonucleotide coated plate, bound to a primary 
antibody, and identified with a secondary antibody. Only activated NF-κB subunits can 
bind to the oligonucleotide coated plate and are accessible to primary antibodies for 
detection. A nuclear extract of Jurkat cells was used as a positive control for the p65 NF-
κB subunit. An aliquot of protein buffer and lysis buffer was run as a negative control. 
Immunohistological measurement of proliferation and apoptosis 
Cell proliferation was measured using a monoclonal antibody to proliferating cell 
nuclear antigen (PCNA; Anti-PC-10, Covance, Emeryville, CA) as described by 
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Vanamala et al. (151). The total number of proliferating cells, position of the highest 
proliferating cell and total cell number/crypt column (crypt column height) was assessed 
in 25 crypt columns/rat.  
Paraffin sections of the 4% PFA fixed tissues were used to measure apoptosis 
with the TUNEL assay (151). Total numbers of apoptotic cells were determined in 50 
crypt columns/rat, and an apoptotic index (apoptotic cells/crypt column height) was 
determined for each crypt. 
Measurement of gene expression using real-time PCR 
Total RNA was isolated from mucosal samples using Phase Lock Gel™ tubes (5 
Prime, Gaithersburg, MD) and the ToTALLY RNA™ Kit (Ambion, Austin, TX) 
followed by DNase treatment (DNA-free™ Kit, Ambion, Austin, TX). RNA quality was 
assessed using an Agilent Bioanalyzer and mRNA concentrations were measured using 
spectrophotometry prior to storage at -80°C. First strand cDNA was synthesized using 
random hexamers, oligo dT primer (Promega, Madison, WI), and Superscript™ III 
Reverse Transcriptase following manufacturer’s instructions (Invitrogen, Carlsbad, CA).  
Real-time PCR was performed using an ABI 7900 HT thermocycler (Applied 
Biosystems, Foster City, CA) on select genes (TOLLIP, TFF3, ZO-1, Slc16a1, IL-6,  IL-
1β, IL-12b, TNFα, SLC5A8, TGFβ, TLR4, TLR2, MyD88, Rela/p65, COX-2). Selected 
primers were pre-loaded to Taqman® Array Micro Fluidic Cards (Applied Biosystems, 
Foster City, CA) and used for subsequent qPCR analysis (Assay IDs for all primers 
compiled in Appendix B). Expression levels were normalized to 18S gene expression. 
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Statistical analysis  
Data were analyzed using two-way analysis of variance (ANOVA) including 
variables of diet and DSS exposure in SAS 9.1 (SAS Institute, Inc.) considering a p-
value of <0.05 as significant. Sample size in each experimental group for all analyses is 
N=10, except for relative expression of selected gene targets (i.e., TOLLIP, TFF3, 
Slc16a1, IL-6, IL-12b, SLC5A8, Rela/p65) and 24 SCFA production on d 72. Relative 
expression of the aforementioned targets were greater than 2.5 SD from the mean for one 
animal in the Sumac DSS group and therefore excluded from further analysis. Sample 
size for 24 SCFA production on d 72 was N=9 for all experimental groups since 24 hr 
dry weight measurements were not taken at this time point. All data are reported as least 
squares (LS) means ± standard error of the mean (SEM), using a significance of p<0.05. 
Results 
Body weight, intake and fecal moisture content 
There were no significant differences in initial body weights (d 1), d 19 (start of 
experimental diet treatment), d 67, d 77, or at termination (d 82) (Appendix A-1). Hi 
Tannin control rats had higher body weights than Cellulose control rats on d 37 
(p=0.0321), d 39 (p=0.0273), d 53 (p = 0.0248), and d 58 (p=0.0415) (Figure 2); 
however, there were no significant differences for any other experimental groups during 
these time points. On d 37 (prior to DSS#1), we observed a slightly lower food intake in 
Cellulose DSS rats compared to Sumac DSS rats (p<0.05), however, there were no 
significant differences in intake for any experimental groups on d 58 (post DSS#2), or d 
79 (post DSS #3) (Table 3). 
 40 
 
 
 
 
 
 
Figure 2. Mean body weight (g) on d 37, 39, 53, and 58. Values are LS means and 
collection dates with (*) indicate significant differences (p<0.05) between Hi Tannin 
control rats compared to Cellulose control rats. See Appendix A-1 for actual values. 
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Table 3. Intake (g) measured prior to DSS#1 (d 35), following DSS#2 (d 56), and 
following DSS#3 (d 77). 
 
 
 
 
 
 
 
 Fecal moisture content in bran fed rats (i.e., Black, Sumac and Hi Tannin) was 
significantly higher than Cellulose fed rats on d 38 (prior to DSS treatments) and all 
other collections (d 44, 58, 81). These values remained relatively constant throughout the 
study and didn’t markedly increase following DSS treatments for any experimental diet 
group (≤6 %; Table 4). However, on d 44 (post DSS #1) and d 58 (post DSS#2) Sumac 
DSS rats had a slightly higher fecal moisture content compared to Sumac control rats. 
We do not observe any other significant differences in fecal moisture content in DSS rats 
compared to their diet matched control for Cellulose, Black or Hi Tannin bran for this 
time point or on d 58 (post DSS#2) or d 81 (post DSS#3). 
 
Control DSS Control DSS Control DSS Control DSS
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Black branCellulose Sumac bran Hi Tannin bran
Total diet 
consumed 
g/24 hrs
Intake 1 
Pre DSS #1
19.6±0.7ab 19.1±0.7ab19.0±0.7ab 18.1±0.7a 18.9±0.7ab
Intake 2 
Post DSS#2
19.5±0.6a 19.9±0.6a19.6±0.6a 19.1±0.6a 20.2±0.6a
21±0.7a 19.9±0.7a
19.6±0.7ab 20.0±0.7b
Intake 3 
Post DSS#3
20.5±0.7a 20.4±0.7a21.5±0.7a 21.3±0.7a 20.0±0.7a
19.5±0.6a 19.3±0.6a 19.2±0.6a
19.5±0.7ab
21.2±0.7a
Diet DSS 
Diet*
DSS
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Table 4. Fecal moisture was significantly higher in bran fed rats throughout the study. 
DSS exposure increased fecal moisture in Sumac DSS rats on d 44 and d 58, but did not 
increase in any other groups. 
 
 
 
 
 
 
 
 
Immunohistochemical analysis of distal colon 
There was only one significant difference in inflammation scores, with Cellulose 
DSS rats having a significantly lower score compared to all other diet and treatment 
groups (Figure 3A) (p<0.05). Cellulose controls had lower injury scores than Black and 
Sumac bran controls (p<0.05, Figure 3B). DSS treatment elevated injury scores in all 
experimental diets, with significantly higher scores observed in Hi Tannin DSS rats 
compared to Hi Tannin control rats (p=0.0072). DSS treated rats fed bran diets had 
significantly higher injury scores compared to Cellulose DSS rats (p<0.05).  
d 38 d 44 d 58 d 81
Control 39.81±0.89a 38.68±0.83a 40.41±0.89a 43.25±1.11a
DSS 38.87±1.00a 39.98±0.75a 41.53±0.42a 40.89±0.47a
Control 47.60±0.49b 47.74±0.20b 47.91±0.21b 48.05±0.51b
DSS 46.47±0.75b 47.74±0.20b 48.28±0.62b 49.57±0.41bc
Control 52.25±0.57c 50.28±0.55c 51.41±1.03c 53.23±0.54d
DSS 53.05±0.43c 54.98±1.43d 53.79±0.76d 55.61±0.89d
Control 48.40±0.30b 49.43±0.92bc 49.63±0.56bc 50.06±0.39c
DSS 47.89±0.34b 48.90±0.65bc 50.34±0.77c 49.97±0.51c
<0.0001 <0.0001 <0.0001 <0.0001
0.0163 0.0241
0.0062 0.003
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Diet
DSS 
Diet*DSS
% fecal moisture
Cellulose
Black bran
Sumac 
bran
Hi Tannin 
bran
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Figure 3. A) Inflammation score was significantly lower in Cellulose DSS rats 
compared to all other groups (p<0.05). B) DSS exposure elevated injury scores in all 
experimental groups, with Hi Tannin DSS having a significantly higher score compared 
to their diet matched controls. Values are LS mean ± SEM. Means without common 
superscripts differ (p<0.05). 
 
DSS-treated rats for all diets had shorter crypts compared to control rats (p<0.05, 
Table 5). Black bran control rats had the lowest proliferative index, which was 
significantly lower than Black, Sumac and Hi Tannin bran DSS rats (p<0.05, Table 5). 
In addition, Black bran control had a significantly lower proliferative zone compared to 
Cellulose control, and Sumac and Hi Tannin bran DSS rats (p<0.05). In bran fed rats, 
DSS treatment elevated proliferative index and zone; however, we observe the tendency 
for a lower proliferative index and zone for Cellulose DSS rats compared to their diet-
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matched control. Aside from Black bran DSS having a significantly higher proliferative 
index than Black bran controls (p=0.0049), there were no significant differences between 
control and DSS rats in the other experimental diet groups for either proliferative zone or 
proliferative index. There were no significant differences in apoptotic index between 
control and DSS rats for all experimental diets, however, Sumac control rats had a 
significantly higher index than Hi Tannin DSS rats (p=0.0208, Table 5).  
Fecal short chain fatty acid (SCFA) analysis 
 We used fecal SCFA excretion as an indicator of SCFA production. Prior to DSS 
treatments (d 38), we observed a significant diet effect on 24 hr SCFA production 
(umol/24 hr) for all SCFA analyzed (i.e., acetic, propionic, isobutyric, butyric, 
isovaleric, valeric) (Table 6). The proportion of excreted butyrate compared to total 
SCFA produced was lowest in Sumac fed rats (10-11%) compared to Cellulose, Black 
and Hi Tannin bran diets (18-21%, 23-24%, 15-17%, respectively). We observed a 
significant diet effect for all other collections (d 44, 66, 72, 81) for propionic, isobutyric, 
butyric, isovaleric, valeric (except for propionic on d 81, p=0.055) (Appendix A-2, A-3, 
A-4, and Table 7, respectively).  
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Following recovery from DSS#2 and DSS#3, we did not observe a significant effect of 
DSS treatment on 24 hr SCFA production except a significant interaction between diet 
and DSS exposure on d 44 (post DSS#2) for isobutyric and on d 66 (post DSS#3) for 
acetic (umol/24 hr) (Appendix A-2 and A-3).  
 Fecal samples following recovery from all DSS treatments (d 81) represents the 
luminal environment closest to termination. On d 81 we observed the same significant 
diet effects on 24 hr SCFA production as observed on d 38 (prior to DSS treatments) for 
all SCFA except for acetic and propionic acid (umol/24 hr; p<0.05) (Table 7). Diet 
significantly affected 24 hr butyrate production following all DSS treatments (d 81) with 
Cellulose and Black bran rats having numerically higher concentrations (16.4 and 20.1 
µmol/24 hr, respectively) compared to Sumac and Hi Tannin bran (8.8 and 14.1 µmol/24 
hr, respectively). In DSS rats (d 81), the proportion of excreted butyrate compared to 
total short chains produced was lower in Sumac bran rats (9%) compared to Cellulose, 
Black or Hi Tannin rats (19, 23, 15%, respectively) on a wet weight basis (umol/g), 
which is similar to values observed prior to DSS exposure (Figure 4). 
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Figure 4. Prior to termination (d 81), the concentration of butyrate compared to total 
SCFA was lower in Sumac bran fed animals compared to other experimental groups 
(umol/ g wet wt). Values are LS mean.  
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
u
m
o
l/
g 
w
e
t 
fe
ce
s
Butyrate Other SCFA
 47 
 
Table 5. DSS treatment significantly affected proliferative index, with bran fed DSS rats having a higher and Cellulose DSS 
rats having a lower proliferative zone compared to their diet matched controls. DSS treatment significantly affected crypt 
height, with DSS rats in all experimental groups having lower crypt height compared to their diet matched controls (p<0.05). 
Values are LS mean ± SEM. Means without common superscripts differ (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control DSS Control DSS Control DSS Control DSS
<.0001
Apoptotic 
index
0.18±0.01ab 0.18±0.01ab 0.15±0.01ab 0.18±0.01ab 0.29±0.01b 0.22±0.01ab 0.23±0.01ab 0.09±0.01a
32.02±0.72b 27.08±1.01a 31.23±0.68b 26.29±0.98aCrypt height 30.00±0.74b 27.73±0.76a 30.74±0.77b 26.62±0.88a
34.91±5.95ab 37.72±7.04b
Cellulose Black bran Sumac bran
Proliferative 
zone
36.96±6.54b 34.45±6.50ab 31.49±5.39a 35.18±5.08ab 36.29±7.26ab 37.52±5.57b
Hi Tannin bran
Diet DSS 
Diet*
DSS
Proliferative 
index
9.59±2.88ab 9.35±3.44ab 8.15±3.20a 11.18±3.00b 9.83±3.15ab 10.75±3.79b 9.17±3.02ab 10.89±3.35b 0.0112
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Table 6. SCFA production on d 38 (umol/24 hr). Diet significantly affected 24 hr SCFA production for acetic, propionic, 
isobutyric, butyric, isovaleric, and valeric. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control DSS Control DSS Control DSS Control DSS
Acetic 43.01±6.70a 32.55±6.34abc 29.63±2.76bc 26.95±2.16c 32.52±2.97abc 39.96±5.52ab 28.518±2.05c 25.94±2.59c 0.0299
Propionic 8.72±0.92c 7.85±1.11c 11.78±1.22b 11.27±1.20bc 18.53±1.42a 17.60±1.82a 13.641±0.86b 12.409±1.01b 0.0001
Isobutyric 1.44±0.16b 1.35±0.13b 1.49±0.13b 1.48±0.15b 2.91±0.30a 2.82±0.28a 3.164±0.18a 3.02±0.27a 0.0001
Butyric 13.34±2.54ab 12.79±2.30ab 16.13±1.17a 14.36±1.08ab 8.15±0.77c 8.18±0.63c 12.987±0.85ab 11.84±1.16bc 0.0001
Isovaleric 2.89±0.39b 2.74±0.28b 3.70±0.31b 3.65±0.36b 7.73±0.81a 7.49±0.58a 8.463±0.50a 8.176±0.78a 0.0001
Valeric 4.40±0.40b 4.17±0.48b 5.60±0.70b 5.55±1.04b 1.75±0.96b 1.50±0.73b 8.389±0.99b 16.518±7.90a 0.0035
Total 73.80±9.62
a 61.46±9.35a 68.33±5.81a 63.26±5.52a 71.59±4.67a 81.32±7.49a 75.163±3.67a 77.90±8.97a
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Diet DSS 
Diet*
DSS
Total 
SCFA 
prod 
(umol)/ 
24 hr
Black branCellulose Sumac bran Hi Tannin bran
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Table 7. SCFA production on d 81 (umol/24 hr). Diet significantly affected 24 hr SCFA production for isobutyric, butyric, 
isovaleric, and valeric. 
 
 
 
 
 
 
Control DSS Control DSS Control DSS Control DSS
Acetic 49.19±6.70a 48.45±6.33a 26.04±2.76b 33.71±2.17ab 40.33±2.98ab 50.24±5.52a 51.30±2.05b 37.20±2.59ab
Propionic 10.79±0.92b 12.59±1.11ab 9.10±1.22b 22.43±1.20a 22.40±1.42a 23.98±1.82a 22.06±0.86a 17.14±1.01ab
Isobutyric 1.52±0.16c 1.53±0.13c 1.14±0.13c 1.54±0.15c 3.75±0.30b 3.77±0.28b 5.85±0.18a 4.53±0.27ab 0.0001
Butyric 19.67±2.54a 16.45±2.30ab 15.98±1.17ab 20.07±1.08a 9.20±0.77b 8.80±0.63b 20.24±0.85a 14.08±1.16ab 0.0065
Isovaleric 2.83±0.39c 2.94±0.28c 2.99±0.31c 3.78±0.36c 9.48±0.81b 9.28±0.58b 14.91±0.50a 11.35±0.78ab 0.0001
Valeric 4.17±0.40b 4.46±0.48b 3.98±0.70b 5.04±1.04b 0.71±0.96b 0.55±0.73b 14.39±0.99a 12.11±7.90a 0.0001
Total 88.08±9.62
ab 86.41±9.35ab 59.22±5.81a 86.55±5.53ab 85.88±4.67ab 96.61±7.48ab 128.74±3.67a 96.41±8.97ab
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Diet DSS 
Diet*
DSS
Total 
SCFA 
prod 
(umol)/ 
24 hr
Black branCellulose Sumac bran Hi Tannin bran
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Mucosal gene expression and NFκB activity 
 We did not observe any diet or diet*treatment effects for any gene targets except 
COX-2 and IL-12b (diet*treatment effect, p=0.025 and p=0.017, respectively), which are 
both upregulated by signals derived from NFκB pathway activation. We observed a 
significant treatment effect for gene targets involved in the TLR pathway, including 
TLR2 (p=0.0179), TLR4 (p=0.0436), MyD88 (p=0.0098), RelA/p65 (regulatory subunit 
of NFκB) (p=0.0039), Tollip (p=0.0039), cytokines TNFα (p=0.0018), IL-12b 
(p=0.0017), IL-6 (p=0.0042), and COX-2 (p=0.0063), as well as injury repair proteins 
TGFβ (p=0.0069) and TFF3 (p=0.0152) (Table 8). These targets relative expression 
(except TNFα and IL-12b) was upregulated in bran DSS rats and downregulated in 
Cellulose DSS rats compared to their diet matched controls. Relative expression of 
TLR2, TLR4, RelA/p65, Tollip, COX-2, IL-12b, TFF3, and TGFβ was upregulated in Hi 
Tannin DSS rats, with COX-2, IL-12b and TGFβ having significantly higher expression 
compared to all other groups (p<0.05; Figure 5). Relative expression of proinflammatory 
cytokine IL-6 was elevated in bran fed DSS rats, with Sumac and Hi Tannin DSS rats 
having significantly higher relative expression compared to their diet matched controls 
(p<0.05).  
 Relative expression of SCFA transporters (i.e., Slc16a1 and Slc5a8) was 
numerically higher in Cellulose controls and Black, Sumac and Hi Tannin bran DSS rats 
compared to their diet-matched counterparts, and these expression levels paralleled total 
SCFA concentrations observed on d 81 (prior to termination) (Figure 6). Hi Tannin DSS  
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Figure 5. Relative expression (2^-ΔCt) of COX-2, IL-12b and TGFβ was significantly 
higher in Hi Tannin bran DSS rats compared to all other experimental groups (p<0.05). 
Values are LS mean ± SEM. Means without common superscripts differ (p<0.05). See 
Table 8 for actual values. 
 
rats had significantly higher relative expression of Slc16a1 and Slc5a8 compared to their 
diet matched controls (p= 0.0033 and p= 0.0157, respectively).  
 Mucosal NFκB activity was numerically elevated in DSS treated rats for all 
experimental diets, with activity becoming significantly higher in Hi Tannin bran DSS 
rats compared to Cellulose controls (p=0.0278; Figure 7). The relationship between the 
change in injury score and NF-κB activity induced by DSS was determined to assess
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Figure 6. Relative expression (2^-ΔCt) of SCFA transporters, Slc16a1 and Slc5a8, was 
elevated in bran fed DSS rats, which was significantly higher in Hi Tannin bran DSS rats 
compared to their diet matched controls (p<0.05). Values are LS mean ± SEM. Means 
without common superscripts differ (p<0.05). See Table 8 for actual values. 
 
whether these changes were unique to the specific diets. We observed a linear 
relationship between the change in injury score and NF-κB activity (p=0.01, R2=0.98), 
with the Black bran diet resulting in the lowest value compared to Cellulose, Sumac and 
Hi Tannin, respectively (Figure 8). 
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Table 8. Relative expression of selected gene targets (2^-ΔCt). Values are LS mean ± SEM. Means without common 
superscripts differ (p<0.05). 
 
 
 
Control DSS Control DSS Control DSS (n=9-10) Control DSS
TLR2 2.21±0.5ab 2.11±0.57ab 0.83±0.11a 3.29±1.75ab 1.94±0.93ab 4.25±2.01ab 1.06±0.29ab 5.46±2.32b 0.018
TLR4 23.72±4.59ab 19.98±3.67a 18.22±2.73a 50.1±23.04ab 36.45±10.06ab 41.92±11.75ab 20.1±3.77a 56.34±18.18b 0.044
MyD88 36.81±8.93ab 24.77±3.93ab 23.64±3.01a 68.64±28.63bc 30.46±5.17ab 47.81±11.56abc 23.65±4.77ab 82.95±24.48c 0.010
RelA/p65 47.13±11.33ab 38.61±5.62ab 35.06±4.13ab 81.66±25.6bc 45.45±6.65ab 80.52±20.81bc 33.47±6.44ab 112.18±34.75c 0.0039
Tollip 57.24±12.44ab 50.18±9.85ab 31.38±5.03ab 99.09±32.07bc 51.2±11.0ab 117.27±41.5bc 35.22±7.38ab 158.14±62.81c 0.0039
TNFα 1.68±0.42ab 1.84±0.43ab 1.54±0.25a 3.32±0.78abc 1.6±0.42ab 4.3±1.62c 1.18±0.28a 3.8±1.03bc 0.002
COX-2 6.41±1.33a 5.01±0.87a 4.12±0.72a 8.81±2.87a 5.8±1.43a 8.18±2.28a 4.92±0.86a 17.36±4.72b 0.006 0.026
Tff3 647.57±149.62ab 540.8±89.22a 442.63±51.92a 1226.52±515.32ab 629.67±159.77ab 992.00±302.79ab 410.29±89.38a 1492.93±548.66b 0.0152
TGFβ 10.95±3.03a 7.61±1.2a 8.22±1.16a 16.42±5.93a 6.86±1.17a 18.09±6.23a 8.7±2.24a 33.53±11.12b 0.007
Il-12b 0.12±0.03a 0.14±0.03a 0.13±0.03a 0.20±0.05a 0.15±0.03a 0.27±0.07a 0.08±0.02a 0.50±0.15b 0.0017 0.017
Il-1b 83.64±67.48b 0.74±0.23a 0.69±0.20a 2.89±2.23a 0.74±0.32a 1.22±0.30a 0.59±0.17a 3.62±1.36a
Il-6 0.89±0.21a 0.66±0.17a 0.56±0.11a 1.29±0.53ab 0.72±0.21a 2.10±0.83b 0.48±0.13a 2.09±0.61b 0.0042
Slc16a 146.45±30.3a 96.03±16.71a 98.19±13.53a 201.18±54.23ab 104.71±22.81a 219.38±68.19ab 88.22±19.07a 311.93±111.45b 0.0102
Slc5a8 56.27±13.37
a 50.47±10.53a 35.53±5.43a 105.49±50.06ab 62.34±18.78a 119.80±44.07ab 35.83±7.45a 156.88±68.24b 0.0162
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Cellulose Black bran Sumac bran Hi Tannin bran
Diet DSS 
Diet*
DSS
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Discussion 
Observed symptoms and severity of colonic injury 
 With the incidence of GI diseases such as ulcerative colitis (UC) on the rise 
worldwide (138), it is imperative to identify mechanisms to mitigate the onset or 
progression of chronic inflammation in the intestine. Diets containing bioactive 
compounds may provide protection against UC due to their ability to alter the intestinal 
microbiota, as well as provide anti-inflammatory effects and eliminate free radicals (9, 
14-15, 104, 143, 145). Additionally, diets rich in fiber have been shown to reduce the 
risk of developing GI disorders and colon 
 
 
 
 
 
 
Figure 7. NF-κB activity was elevated in DSS rats in all experimental groups. Average 
NF-κB activity was significantly higher in Hi Tannin DSS rats compared to Cellulose 
control rats (p<0.05). Values are LS mean ± SEM.  
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Figure 8. A linear relationship was observed between the change in injury score and 
change in NF-κB activity (p=0.01, R2=0.98) with the Black bran diet resulting in the 
lowest value. 
 
cancer (13, 28). Sorghum bran is a fiber source that has been shown to contain high 
levels of bioactive compounds, particularly, 3-deoxyanthocyanins, condensed tannins, or 
a combination of both compounds (25-26, 117). Previous studies indicate that these 
compounds can reduce the occurrence of preneoplastic lesions in AOM treated animals 
(24), however, the ability of sorghum bran based diets to mitigate UC has not been 
investigated. 
DSS administration is a commonly used technique to induce experimental colitis, 
and it is well documented that exposure can produce symptoms such as watery and 
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bloody stools, weight loss and injury to the colonic mucosa (152). We investigated the 
ability of sorghum bran diets to mitigate the effects of repeated DSS exposure (3% DSS 
concentration for 48 hrs, 3 exposures with 2 wk recovery between bouts). Our 
observations suggest that disease severity in DSS rats was minimal, as we observed no 
significant differences in body weight, diet intake, or marked increases in fecal moisture 
content (≤ 6%) following DSS exposures. Maintenance of fecal moisture content during 
inflammatory bouts could be due to the composition of the sorghum bran, which 
contains a high proportion of insoluble fiber (~95%). Soluble and insoluble fibers are 
both required for optimum health, but carry out different physiological roles in the body. 
Insoluble fibers are known to be beneficial for regularity by increasing fecal bulk, 
reducing diarrhea and binding deleterious compounds such as carcinogens (153). 
Although some soluble fibers are known to ease constipation and have been shown to 
improve symptoms of UC (154), our lab previously reported that rats fed experimental 
diets containing 6% pectin, a predominately soluble fiber source, demonstrated 
significantly higher fecal moisture content and bloody diarrhea following the same DSS 
treatments used in this study (155). Similar to our results, other studies reported that 
insoluble fiber can attenuate the deleterious effects of DSS-induced colitis (2-3.5% DSS 
for 5-6 d) (54-55). These studies reported that experimental diets containing dietary fiber 
from germinated barley provides numerous beneficial effects in vivo including weight 
maintenance, elevated fecal butyrate, reduction in the presence of bloody stool and 
incidence of diarrhea, and attenuating elevations in circulating IL6 and mucosal NFκB 
(54-55). Thus, these results indicate consuming a diet containing insoluble dietary fiber 
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may have the ability to ameliorate negative clinical effects such as weight loss and 
bloody diarrhea associated with UC. 
Immunohistochemical examination of the distal colon revealed that crypt height 
was significantly reduced in DSS treated rats for all experimental diets. However, 
mucosal injury and inflammatory cell infiltration remained confined to the epithelial 
membrane and rarely extended into the submucosa. Injury scores were elevated in DSS 
treated rats for all experimental diets, but, these were generally described as discrete 
lesions with only occasional mucosal erosion. One explanation for differing injury 
scores in bran fed animals compared to Cellulose could be due to the structure of the 
bran particles. Black bran in particular is reported to have a different bran composition 
and larger particle size compared to Sumac and Hi Tannin brans, which could explain an 
elevated injury score in Black bran control rats that did not receive DSS compared to 
control rats from other experimental diets (156). Observations in animals that received 3 
cycles of DSS contrasts other studies that utilized similar DSS treatments (3-5%), which 
reported elevated fecal moisture content, mucosal erosion, complete loss of crypts, as 
well as erosion that extended into the intestinal wall (155, 157-158). Two of these 
studies fed a standard chow, while the other utilized an experimental diet containing 
pectin as the sole dietary fiber source. As mentioned previously, fiber composition has 
numerous implications for gut health and could be one reason for the disparity in these 
results.  
Chronic intestinal inflammation can lead to epithelial barrier dysfunction, and 
preservation of colonocyte proliferation is crucial for maintaining barrier integrity. 
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PCNA analysis indicates that proliferation levels (i.e., proliferative index and 
proliferative zone) were increased at termination (2 weeks post DSS#3) for all bran fed 
DSS rats compared to their diet matched control, with Black bran DSS rats having 
significantly higher proliferative index than Black bran controls (p=0.0049). This 
observation could be due to the presence of 3-deoxyanthocyanins in this bran. Other 
studies reported diets containing anthocyanin rich blueberries reduce epithelial injury, 
bacterial translocation, and inflammation in multidrug resistance gene deﬁcient mice and 
during DSS induced colitis (5% DSS for 10 d). Although proliferation was not measured 
in these studies, the authors hypothesize the ability to maintain epithelial barrier integrity 
could be, in part, by modulating epithelial proliferation (121, 159).   
In addition to maintaining epithelial cell proliferation, proteins responsible for 
epithelial migration and tight junction formation allow for restitution of the epithelial 
barrier and wound healing following colonic injury (160-163). We observe upregulated 
expression of apical (trefoil factor 3, TFF3) and basolateral (transforming growth factor 
β ,TGFβ) repair proteins in colonic mucosa of bran DSS rats compared to their diet 
matched controls. Moreover, relative expression of TGFβ was significantly higher in Hi 
Tannin DSS rats compared to their diet-matched controls. Trefoil factor proteins are 
expressed on the apical side of colonic epithelial cells, and have been shown to be 
produced by intestinal goblet cells and be associated with excreted mucins. Although the 
complete mechanism of TFF3 in colonic epithelial repair has not been elucidated, TFF3 
has been shown to be involved in cellular migration and suppressing apoptosis (162-
164). It has been reported that TFF3 expression is suppressed in TNBS models of 
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experimental colitis (161, 165), and the absence of TFF3 expression in DSS induced 
colitis (2.5% for 5d) significantly delays healing of mucosal injury up to 12 d post DSS 
exposure (166). Our results contrast these reports, as we observe elevated relative 
expression of this protein in colonic mucosa of bran DSS rats following repeated DSS 
treatments (14 d post DSS#3). Furthermore, we observe a significant elevation in TGFβ 
in Hi Tannin DSS rats compared to all other experimental groups. TGFβ is expressed on 
the basolateral side of the colonic epithelial membrane and is thought to play a major 
role in epithelial cellular differentiation, migration, and has been implicated in the 
restitution of monolayer would healing in vitro (160, 167). Furthermore, it has been 
reported that TGFβ induces the expression of COX2 in vitro (167), which is similar to 
our findings in Hi Tannin DSS rats that demonstrated significantly higher relative 
expression of TGFβ and COX2 in colonic mucosa. 
In general we observe that repeated DSS exposure does not cause drastic 
mucosal damage as described in similar experimental colitis models (155, 157-158). 
Although injury scores were higher in bran fed DSS rats, our results indicate that bran 
based diets could have the ability to repair the mucosal damage associated with UC by 
modulating epithelial cell proliferation and the expression of repair proteins. 
Interestingly, we do not observe enhanced proliferation or increased relative expression 
of repair proteins in Cellulose DSS rats, which could be an indicator that properties of 
sorghum bran diets (i.e., presence of bioactive compounds) could be a factor in 
upregulating epithelial repair mechanisms. Additionally, examination of distal colon 
using TUNEL revealed no significant differences in apoptotic index between healthy and 
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diseased animals and we observe no distinct link between apoptosis and mucosal TNFα 
expression.  
Historically, diets containing condensed tannins (similar to those found in Sumac 
and Hi Tannin bran) have been used to treat patients with UC (168). More recent studies 
have shown that plant polyphenols such as anthocyanins and condensed tannins can 
mitigate colonic injury and improve UC symptoms, however, the mechanism behind 
these benefits have not been elucidated (9, 16, 143, 169-170). The beneficial properties 
of bioactive compounds could be, in part, due to modulating the luminal environment 
and microbiota, which is well documented to have a profound effect on the progression 
and severity of UC. Therefore, we sought to elucidate how sorghum bran diets can alter 
the luminal environment and microbiota by analyzing fecal short chain fatty acids 
(SCFA) and mucosal gene expression of toll-like receptors (TLR) and downstream 
mediators of this signaling pathway. 
Bacterial metabolites and mucosal gene expression 
The intestinal microbiota has a profound impact on the host immune system, and 
dysbiosis of these bacterial populations has been implicated in UC (35, 75, 96-97). 
Patients with UC have demonstrated alterations to the predominant bacterial populations 
(i.e., Bacteroidetes and Firmicutes) as well as decreased species diversity, which can 
have a major impact on the luminal environment by altering the concentrations of 
microbial metabolites such as SCFA (6, 19, 43, 45, 99, 171-173). Of particular 
importance is butyrate, which is not only the preferred fuel for colonocytes, but has other 
plieotrophic effects including anti-inflammatory activity and the ability to induce gene 
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expression and cellular differentiation in epithelial cells (38, 47, 69, 174-175). 
Additionally, it has been demonstrated that butyrate supplementation can improve 
symptoms of UC (54, 62, 174).  
We observe very few significant treatment or diet*treatment differences in fecal 
SCFA concentrations and no distinct patterns between control and DSS rats for any 
experimental diets following DSS#1, DSS#2 or DSS#3 (d 44, d 66, and d 72 
respectively). We observe a diet*treatment effect on d 44 (post DSS#2) for isobutyric 
and on d 66 (post DSS#3) for acetic (umol/24 hr). Throughout the study we observe a 
significant effect of diet on numerous SCFA. Following recovery from all DSS 
treatments and just prior to termination (d 81), we observe similar fecal SCFA 
concentrations as observed prior to DSS treatments (d 38). We do not observe a 
significant reduction in fecal butyrate or other SCFA (umol/24 hr) in bran fed rats during 
an active disease state, which suggests DSS induced inflammation did not affect 
microbial fermentation patterns in these animals. In contrast, Cellulose DSS rats had 
significantly lower 24 hr butyrate production following DSS#2 & DSS#3 compared to 
their diet matched controls (p=0.032 and p=0.015, respectively). In DSS rats, the 
proportion of excreted butyrate compared to total short chains produced was lower in 
Sumac and Hi Tannin bran rats (9% and 14% respectively) compared to Cellulose and 
Black bran rats (19% and 23%, respectively) prior to termination (d 81). One possible 
explanation for lower fecal concentrations of butyrate is enhanced uptake and utilization 
by coloncytes. Although we did not directly measure butyrate absorption, we observe an 
upregulation of SCFA transporter (i.e., Slc16a1 and Slc5a8) expression in bran fed DSS 
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rats. Interestingly, Tannin DSS rats had significantly higher relative expression of both 
Slc16a1 and Slc5a8 (p<0.05) compared to their diet matched controls, which could 
explain the reduced fecal butyrate observed in these animals. 
It has previously been reported that patients with UC have suppressed SCFA 
production and impaired butyrate oxidation (176-177). Although we did not measure 
butyrate oxidation in this experiment, we do not observe a significant decrease in fecal 
butyrate following DSS exposure when fed a bran based diet. Additionally, studies have 
shown a decrease in SCFA transporter expression in diseased tissues and patients with 
IBD (52-53, 178-179), but in our study DSS induced colitis did not suppress relative 
expression of Slc16a1 or Slc5a8 when fed bran based diets, particularly Hi Tannin. We 
observe suppressed 24 hr butyrate production and expression of these transporters in 
Cellulose DSS rats, suggesting that properties of bran diets could be protective against 
suppression of both SCFA production and SCFA transporter expression commonly 
associated with intestinal inflammation and UC (177-180). 
In addition to affecting the luminal environment and influencing epithelial cell 
metabolism, the microbiota also plays a major role in the status of the epithelial barrier 
by interacting with pattern recognition receptors (PRR) such as TLR. TLR signaling, 
mediated through the NFκB pathway, provides homeostatic interactions between the 
microbiota and host. However, in a disease state this pathway has been shown to 
upregulate the immune response as well as cause hyperproliferation which increases the 
risk of tumorigenesis (34, 181-182). Studies have shown that experimental models of 
UC and patients with chronic intestinal inflammation have differential TLR expression 
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(183), and in our study we observe a significant effect of DSS treatment on TLR2 and 
TLR4 (p=0.0179 and p=0.0436, respectively). Furthermore, we observe a significant 
effect of DSS treatment on other targets associated with the TLR signaling cascade (i.e., 
MyD88, RelA/p65 (regulatory subunit of NFκB), TNFα, IL-12b, IL-6, and COX-2). 
Relative expression of these gene targets was numerically elevated in colonic mucosa of 
bran DSS rats but not Cellulose DSS rats. Compared to their diet matched controls, Hi 
Tannin DSS rats had significantly higher relative expression of TLR4 (p=0.0365), which 
has been previously reported to be upregulated in patients with UC (7). TLR4 has been 
reported to regulate COX-2 expression in DSS induced colitis (184), which is similar to 
our results in Hi Tannin DSS rats which had upregulated TLR4 and significantly higher 
relative expression of COX-2 (p<0.05) compared to all other experimental groups. 
Activated NFκB was elevated in colonic mucosa of DSS treated rats; however, we 
observe no significant differences between healthy and diseased animals for any 
experimental diet. Upregulation of TLR signaling pathways and NFκB activity is more 
severe in DSS rats fed bran based diets that contain condensed tannins (i.e., Sumac and 
Hi Tannin bran) compared to bran containing 3-deoxyanthocyanins (Black bran). Black 
bran DSS rats had relative expression and activated NFκB that was closer to their diet-
matched controls. To elucidate the relationship of NFκB activation and epithelial injury, 
the relationship between changes in injury and NFκB within each diet was assessed. We 
observe a linear relationship (p=0.01, R
2
=0.98) in activated NFκB and epithelial injury, 
with the Black bran diet resulting in the lowest value. As mentioned previously, Black 
bran DSS rats had significantly higher proliferative zone than their diet matched control 
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and this upregulation could explain why we observe very little difference in injury score 
between these groups. 
Additionally, upon immunohistochemical examination of distal colon, DSS 
treated rats fed a bran based diet demonstrated no significant differences in 
inflammatory infiltration compared to their diet matched controls. The inflammation 
score observed for all experimental groups in this study demonstrate the presence of 
increased number of inflammatory cells in the lamina propria, but little infiltration into 
the submucosa. These results suggest that feeding a bran diet may modulate an immune 
response and infiltration of inflammatory cells into the colonic mucosa during an 
inflammatory challenge. Surprisingly, Cellulose control rats have a significantly higher 
inflammation score than Cellulose DSS rats. One explanation for this disparate result 
could be mucosal gene expression of pro-inflammatory cytokine IL-1b, which was 
significantly higher in Cellulose control compared to all other experimental groups.  
Conclusions 
Although we observe significantly higher expression of certain gene targets 
associated with TLR signaling in DSS rats, we do not observe a drastic upregulation in 
the relative expression of proinflammatory cytokines and changes in NFκB activity 
between healthy and diseased animals is relatively low. These relatively small 
differences could be due to the number of days between the last DSS treatment and 
tissue collection in our study (14 days). Other studies using DSS induced experimental 
colitis observed that expression of IL-1b peaked following DSS treatment and decreased 
progressively and returned to baseline just four days after treatment (183). These results 
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suggest that we may observe a more severe upregulation of the TLR/NFκB signaling 
pathway during a more active disease state immediately after DSS exposure. Our SCFA 
observations indicate that there may be differences in the bacterial populations or their 
metabolism between experimental groups, and previous studies have identified 
anthocyanins and hydrolysable tannins from other dietary constituents (e.g., tea leaves, 
grapes, Galla Rhois plant) that have differential effects on intestinal bacterial 
populations (14-16, 185-186). Additionally, since TLR expression has been shown to be 
dependent upon microbiota composition (74, 187), phylogenetic classification of the 
intestinal bacterial populations in this study is warranted to further elucidate changes 
caused by inflammation and bran based diets on microbial metabolites and TLR 
signaling. 
To our knowledge this is the first study to analyze the effects of sorghum bran 
based diets on UC. We observe distinct differences among bran diets that contain 
differing bioactive compounds (i.e., 3-deoxyanthocyanins, condensed tannins, or a 
combination of both compounds) and a Cellulose control diet, suggesting that the 
presence of these dietary constituents may influence the luminal and colonic mucosal 
environments. Our results indicate that by feeding bran based diets, it is possible to 
reduce the severity of epithelial injury and alleviate symptoms such as diarrhea that have 
been observed in similar DSS induced colitis models and patients suffering from UC. 
We demonstrate these diets may be able to mitigate colonic injury and epithelial 
dysfunction associated with repeated colonic inflammation by upregulating epithelial 
repair protein (i.e., TFF3 and TGFβ) and SCFA transporter (i.e., Slc16a1 and Slc5a8) 
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expression. Furthermore, we do not observe a drastic inflammatory cell infiltration in the 
distal colon nor fold changes in relative expression of mucosal proinflammatory 
cytokine gene expression (i.e., TNFα, COX2, Il-12b, Il-1b, IL6), which is commonly 
associated with an overactive TLR/ NFκB signaling cascade in experimental colitis 
models and patients diagnosed with UC. Further classification of the microbiome and 
metabolomics will help elucidate mechanisms by which bioactive compounds in 
sorghum bran may alter the luminal environment and mitigate UC.
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CHAPTER III 
NOVEL SORGHUM BRANS ALTER COLON MICROBIOTA AND 
DIFFERENTIALLY RESTORE SPECIES DIVERSITY AND SPECIES 
RICHNESS IN RESPONSE TO DSS-INDUCED COLITIS 
 
Introduction 
The incidence of inflammatory bowel disease (IBD), which encompasses 
Crohn’s disease and ulcerative colitis (UC), affects nearly 1.4 million people in the 
United States alone (188), and the incidence is increasing worldwide (138). 
Complications include abdominal cramping, constipation, abnormal bowel movements, 
and it is associated with an increased risk in colorectal cancers (1, 4, 189). Although the 
complete etiology of these diseases are unknown, factors point to dysbiosis of the 
inherent bacterial populations residing in the gastrointestinal (GI) tract, or microbiota, as 
being a significant factor in the progression and severity of these diseases (5, 78, 96). 
Numerous studies over the past decade have sought to elucidate alterations to the 
microbiota or identify which bacterial populations might be associated with the onset or 
perturbation of GI diseases (5, 78, 188, 190). Although some studies have implicated an 
increase in pathogenic bacteria or a depletion of beneficial bacteria such as lactic acid 
bacteria (LAB) (191-193), it is becoming more apparent that not one particular bacterial 
group can be implicated in the cause of IBD. However, studies have reported alterations 
in the ratio of the predominant bacterial phyla, Firmicutes and Bacteroidetes, in patients 
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affected with IBD compared to controls (190, 194-195). Another common observation in 
patients with IBD is a reduction in bacterial diversity and species richness (99, 171).  
It is well documented that diet can also have profound effects on the intestinal 
microbiota. Alterations to the diet can affect the luminal environment by affecting transit 
time, luminal pH, and the production of microbial metabolites (e.g., butyrate) (12, 18, 
196). Additionally, dietary constituents containing secondary plant metabolites such as 
polyphenols have been reported to differentially affect luminal bacterial populations, 
suppressing certain taxa while allowing others to thrive, by affecting bacterial 
metabolism or evoking a bactericidal effect (9, 15, 142). In recent years diets containing 
bioactive compounds, such as polyphenols and tannins, have been identified as probable 
interventions for IBD due to their antimicrobial and antioxidant capacity. In vitro studies 
have shown that tannins, the second most abundant plant polyphenol, and other bioactive 
compounds can dramatically affect the survival of bacterial groups typically present in 
the GI tract (14, 185, 197). Moreover, numerous in vivo studies have also characterized 
how these compounds can enhance certain  beneficial or probiotic bacteria (i.e., 
Bifidobacterium & Lactobacillus spp.), while suppressing or eliminating other 
pathogenic bacteria such as C. perfringens  and C. difficile in the intestine (15-16, 145). 
Additionally, one study demonstrated that hydrocaffeic acid, a polyphenol metabolite 
derived from colonic microbiota, produced anti-inflammatory affects including 
suppression of pro-inflammatory cytokine production (i.e., TNFα, IL-8, IL-1β) and a 
reduction in oxidative DNA damage in rat colonic mucosa (143). 
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Bran from specific varieties of sorghum has been characterized as containing 
high levels of dietary polyphenols, including 3-deoxyanthocyanins and condensed 
tannins, and certain strains are reported to have a significantly higher antioxidant 
capacity compared to wheat bran and “super fruits” such as blueberries and 
pomegranates (25-27, 117). Research based evidence demonstrates that certain black and 
brown varieties of sorghum can affect the colonic mucosal environment by altering 
concentrations of fecal microbial metabolites (e.g., short chain fatty acids (SCFA)), 
which indicates a change to the intestinal microbiota (24, 198). Based off these results, 
we hypothesize that DSS induced colonic inflammation will affect the colon luminal 
environment by altering the microbiota, and by feeding sorghum bran diets we can 
mitigate this dysbiosis. Therefore the aim of this study was to characterize the effect of 
sorghum bran based diets containing 3-deoxyanthocyanins, condensed tannins, or both 
polyphenols on the intestinal microbiota. Furthermore, we aim to ascertain if sorghum 
bran diets can mitigate alterations to the microbiota during repeated inflammatory bouts 
produced by dextran sodium sulfate (DSS) challenge.  
Materials and Methods 
Animals and diets 
Eighty male Sprague-Dawley rats (21 d old) were stratified by body weight and 
assigned to one of four experimental diets (n=20/ diet).  The four diets contained 6% 
dietary fiber from cellulose, or bran isolated from sorghum grains that contain high 
levels of 3-deoxyanthocyanins, high levels of condensed tannins and low levels of 3-
deoxyanthocyanins, or both 3-deoxyanthocyanins and condensed tannins. Prior to 
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beginning the experimental diet, animals (40 d old) were maintained on a standard 
pelleted diet for 19 d in order to adjust to the new environment. 
After 21 d of experimental diets, half of the rats were exposed to three sequential 
48 h dextran sodium sulfate (DSS) (MP Biomedicals, Irvine, CA) treatments (3% DSS) 
in their drinking water, with 14 d between each DSS exposure. Between DSS exposures, 
distilled water was supplied to treated animals. The remaining half of the animals 
received distilled water throughout the course of the study.  
Body weight and food intake were routinely monitored (Chapter II). Rats were 
weighed upon arrival, prior to beginning experimental diets, before and after each DSS 
exposure, and prior to termination. Additionally, food intake was measured prior to the 
first DSS treatment, following the second DSS treatment, and prior to termination 
(following third DSS treatment). On day 63, animals were euthanized by CO2 
asphyxiation.  
Inflammation and injury histological scores 
A 1 cm segment was removed from the distal end of the colon and fixed in 70% 
EtOH solution prior to embedding in paraffin. The degree of inflammation and 
morphological injury caused by DSS exposure was assessed by H&E staining. 
Histologic examination was performed in a blinded manner by a board-certified 
pathologist, and the degrees of inflammation (score of 0–3) and epithelial injury (score 
of 0–3) on microscopic cross sections of the colon were graded as described previously 
(150) (Appendix B).  
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Sample collection and microbial DNA isolation 
Following recovery from the second (d 47 N=9 or 10 for Cellulose & Black or 
Sumac & Hi Tannin DSS rats, respectively) and third (d 62 N=5/diet for control rats and 
N=10/diet for DSS rats) DSS exposures, and fresh fecal samples were collected 
immediately following defecation. Samples were transferred to sterile cryotubes, placed 
on ice, then stored at -80°C. DNA was isolated from homogenized fecal samples using a 
FastDNA SPIN kit according to the manufacturer’s instructions (MP Biomedicals, 
Solon, OH) (Appendix B). Purified DNA was stored at -80°C. A negative control 
containing H2O instead of sample was purified in parallel to each extraction batch to 
screen for contamination of extraction reagents.   
16S rRNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) 
Initial amplification of the V1-V2 region of the bacterial 16S rDNA was 
performed on total DNA isolated from fecal samples. Master mixes for these reactions 
used the Qiagen Hotstar Hi-Fidelity Polymerase Kit (Qiagen, Valencia CA) with a 
forward primer composed of the Roche Titanium Fusion Primer A (5’-
CCATCTCATCCCTGCGTGTCTCCGACTCAG -3’), a 10 bp Multiplex Identifier 
(MID) sequence (Roche, Indianapolis, IN) unique to each of the samples, and the 
universal bacteria primer 8F (5'-AGAGTTTGATCCTGGCTCAG-3') (199).  
Incorporation of MID sequences to the PCR amplicons essentially “barcodes” samples 
and allow for multiplexed assays. Samples are pooled prior to the pyrosequencing 
reaction. The reverse primer was composed of the Roche Titanium Primer B (5’-
CCTATCCCCTGTGTGCCTTGGCAGTCTCAG -3’), the identical 10 bp MID 
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sequence as the forward primer and the reverse bacteria primer 338R (5’-
GCTGCCTCCCGTAGGAGT-3’) (200) which span the V1-V2 hypervariable region of 
the bacterial 16S rDNA.  The thermal profile for the amplification of each sample had an 
initial denaturing step at 94°C for 5 minutes, followed by a cycling of denaturing of 
94°C for 45 seconds, annealing at 50°C for 30 seconds and a 90 second extension at 
72°C (35 cycles), a 10 minute extension at 72°C and a final hold at 4°C.  Each sample 
was individually gel purified using the E-Gel Electrophoresis System (Life 
Technologies, Invitrogen).  To ensure equal representation of each sample in the 
sequencing run, each barcoded sample was standardized by calculating equimolar 
amounts prior to pooling. Pooled samples of the 16S rDNA multiplexed amplicons were 
sequenced on a Roche 454 Genome Sequencer  FLX Titanium instrument (Microbiome 
Core Facility, Chapel Hill NC) using the GS FLX Titanium XLR70 sequencing reagents 
and protocols.   
bTEFAP data analysis 
Analysis of deep sequencing data was carried out using the QIIME pipeline 
(201). Briefly, the combined raw sequencing data plus metadata describing the samples 
were de-multiplexed and filtered for quality control. Next, data were denoised using 
Denoiser software as described previously (202).  Chimeric sequences were depleted 
from the trimmed data set using Chimera Slayer (203). Sequences were grouped into 
OTUs (Operational Taxonomic Units) at a 97% level to approximate species-level 
phylotypes using Uclust (204). OTU sequences were aligned and OTU tables containing 
the counts of each OTU in each sample were used to calculate mean species diversity of 
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each sample (alpha diversity) and the differentiation among samples (beta diversity). 
Alpha and beta diversity measures were used to calculate a Chao species richness 
estimate and a Shannon Weaver diversity index for each OTU. To evaluate the 
similarities between bacterial communities a combination of Unifrac significance, 
principal coordinate analysis (PCoA) using Fast Unifrac (205) and network analysis 
(206-207) were performed to compare samples based on sample time and treatment. 
ANOVA, the G test of independence, Pearson correlation, or a paired t-test were used 
within Qiime to identify OTUs that are differentially represented across experimental 
treatments or measured variables.  
Statistical analysis  
Data were analyzed using two-way analysis of variance (ANOVA) including 
variables of diet and DSS exposure in SAS 9.1 (SAS Institute, Inc.) considering a p-
value of <0.05 as significant. Relationships between microbial populations and colonic 
injury score were assessed by calculating Pearson’s product moment correlation 
coefficient. 
Results 
Body weight and experimental diet intake 
There were no significant differences in initial body weights (d 1 of experimental 
diet treatment), d 14, d 70, d 81, or at termination (d 84) (Chapter II). Hi Tannin control 
rats had significantly higher body weights than Cellulose control on d 39 (p=0.0321), d 
42 (p=0.0273), d 56 (p = 0.0248), and d 60 (p=0.0415); however, there were no 
significant differences for any other experimental groups during these time points. On d 
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39 (prior to DSS#1), we observed a significantly lower food intake in Cellulose DSS 
animals compared to Sumac DSS rats (p<0.05), however, there were no significant 
differences in intake for any experimental groups on d 60 (post DSS#2), or d 81 (post 
DSS #3) (Chapter II). 
Multivariate analysis of bacterial populations 
Unifrac and principal components analysis (PCA) of all sequences for each 
sample, represented as a discrete data point without overlap, revealed distinct clustering 
of samples based on experimental diet (Figure 9). Variation of data points along PC2 
(10.3%) indicates clear clusters and therefore distinct differences in bacterial 
communities between rats fed the Cellulose, Black, Sumac, and Hi Tannin bran diets, 
with Black bran diet samples having the smallest variation from Cellulose followed by 
Hi Tannin and Sumac bran, respectively. Hi Tannin bran, which contains both 
condensed tannins and 3-deoxyanthocyanins, had bacterial communities that clustered 
near both Black bran (contains 3-deoxyanthocyanins) and Sumac bran (contains 
condensed tannins). Additionally, rats fed bran diets that contain condensed tannins (i.e., 
Sumac and Hi Tannin bran) had bacterial communities that clustered together. Spatial 
relation of data points along PC3 (6.28%) revealed that rats consuming the Sumac bran 
diet had samples with the least amount of variation, or clustered tightly together, 
compared to other experimental diets. Furthermore, samples collected on d 47 (post 
DSS#2) predominately clustered in the right half of the plot, whereas samples collected 
on d 62 (post DSS#3) clustered on the left half. Differences in the spatial relation of 
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samples suggest distinct differences in bacterial communities based on diet and the 
number of DSS exposures. 
 
 
 
 
 
 
 
Figure 9. PCA plot of samples from d 47 and d 62. Green squares (Cellulose), red 
triangles (Black bran), light blue circles (Hi Tannin bran), and blue triangles (Sumac 
bran), illustrate differences in bacterial populations due to experimental diet treatment. 
Samples collected on d 47 and d 62 clustered in the right and left halves of the plot, 
respectively. 
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Microbial taxonomic structure analysis 
Phylogenetic classification of OTUs revealed two predominant phyla, 
Bacteroidetes and Firmicutes, for all experimental diets on d 47 (post DSS#2) and d 62 
(post DSS#3) (Figure 10). OTUs were also classified in the Actinobacteria and 
Proteobacteria phyla, but proportions did not exceed 5% for any experimental group at 
either time point. We observed a significant diet effect for all classified phyla at both 
time points (Appendix A-5). For all experimental diets at both time points there were 
OTUs that did not match any known sequences in the RDP database, and the proportion 
of OTUs classified as “Unknown” or “Unclassified” was elevated in all experimental 
diets on d 62 compared to d 47 (≥2 fold increase).  
We observed a significant effect of DSS on both the Firmicutes and 
Bacteroidetes phylum (p=0.0006 and p<0.0001, respectively) on d 62, and patients with 
IBD have been shown to have elevated Firmicutes to Bacteroidetes ratios. Thus, ratios of 
these phyla were calculated to characterize any dysbiosis to the predominant bacterial 
groups on d 47 and d 62 (Table 9). The highest ratio was observed in Cellulose control 
rats (112.02), and was markedly higher than that of Black (26-fold), Sumac (114-fold), 
and Hi Tannin bran control rats (35-fold). The ratio of Firmicutes to Bacteroidetes was 
higher in Cellulose DSS rats on d 47 and d 62 compared to Black, Sumac, and Hi Tannin 
bran DSS rats (Table 9).  
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Figure 10. Phylogenetic classification of OTUs at the phylum level for control rats d 62 
(-) and DSS treated rats (d 47 and d 62) for all diets. Data are LS±SEM. Actual values in 
Appendix A-5. 
 
Table 9. Firmicutes/Bacteoridetes ratio on d 47 and d 62. The highest ratio was observed 
in Cellulose control rats and was markedly higher than that of Black, Sumac, and Hi 
Tannin bran control rats. 
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Further phylogenetic analysis of OTUs revealed three predominant bacterial 
orders (Bacteroidales, Clostridiales, and Lactobacillales) in all collected samples (Table 
10, Figure 11).  We observe significant diet effects on d 47 for bacteria in the 
Bacteroidales (p<0.0001), Clostridiales (p=0.0205) and Lactobacillales orders 
(p=0.0417). Sumac DSS rats had significantly higher proportion of OTUs classified in 
the Bacteroidales order, and Hi Tannin DSS rats had significantly higher proportions of 
Lactobacillales compared to all other experimental diets (p<0.05).  
On d 62, proportions of OTUs classified in the predominant bacterial orders (i.e., 
Bacteroidales, Clostridiales, and Lactobacillales) were reduced in DSS treated rats 
compared to d 47 (post DSS#2) for all experimental diets (Figure 11), with the highest 
reduction observed in the Clostridiales order (56%-79%, Figure 12). Additionally, we 
observe significant diet, treatment and diet*treatment effects for the Bacteroidales 
(p<0.0001, p<0.0001, and p=0.0005, respectively) and Clostridiales (p=0.0387, 
p=0.0005, and p<0.0001, respectively) orders at this time point (Table 10). In Sumac 
control rats, we observe a significantly higher proportion of OTUs classified in the 
Bacteriodales order, and a significantly higher proportion of Clostridiales in Hi Tannin 
control rats compared to other experimental diets (p<0.05). We observe a significant 
effect of diet and treatment for OTUs classified in the Lactobacillales order (p<0.001 
and 0.0377, respectively). Cellulose controls had a significantly higher proportion of 
OTUs classified in this order (p<0.05) compared to all other experimental groups. 
Additionally, DSS treated rats fed Cellulose, Sumac and Hi Tannin bran diets had lower 
proportions of the Lactobacillales order compared to their diet matched controls.  
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When comparing Sumac and Hi Tannin DSS treated rats to their diet matched 
controls, we observe a significant reduction in numerous bacterial orders (Table 10). 
Sumac DSS rats had significantly lower proportions of the orders Bacteroidales, 
Clostridiales, and Burkholderiales, and Hi Tannin DSS lower proportions of orders 
Bacteroidales, Clostridiales, and Eryspelotrichales compared to their diet matched 
controls (p<0.05). In contrast, Black bran DSS rats had numerical elevations in the 
proportion of bacteria classified in the Bacteroidales, Lactobacillales, Clostridiales, and 
Burkholderiales orders, and Cellulose DSS rats had numerical elevations in 
Bacteroidales, Clostridiales, and Erysipelotrichales orders compared to their diet-
matched controls. 
Diversity and species richness comparisons 
To analyze the effect of diet and DSS induced inflammation on bacterial species 
richness and diversity, sequences from each sample were used to perform alpha and beta 
diversity analysis and calculate a Chao species richness estimate and Shannon Weaver 
diversity index.  We observe a significant diet effect on species richness and diversity 
(p<0.0001 for both) on d 62, with Black bran controls having a significantly higher 
species richness (p<0.05) compared to Sumac and Hi Tannin bran controls, and a 
significantly higher diversity index (p<0.05) compared to all other controls (Table 11). 
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Figure 11. Proportion of OTUs at the order level in DSS treated animals over time. On d 
62 (post DSS#3), proportions of OTUs classified in Bacteroidales, Clostridiales, and 
Lactobacillales were reduced in DSS treated rats compared to d 47 (post DSS#2) for all 
experimental diets. Actual values found in Table 10.
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Table 10. Phylogenetic classification of samples at the order level on d 47 and d 62. On d 62, proportions of OTUs classified 
in as Bacteroidales, Clostridiales, and Lactobacillales were reduced in DSS treated rats compared to d 47 (post DSS#2) for all 
experimental diets, with the highest reduction observed in the Clostridiales order. Means without common superscripts differ 
(p<0.05). 
 
 
 
 
DSS   (n=9) DSS   (n=9) DSS (n=10) DSS (n=10) Diet
Bacteroidales 1.31±0.60a 8.59±2.71b 19.29±2.75c 7.30±2.37ab <0.0001
Lactobacillales 18.19±6.73ab 14.08±3.44ab 6.54±2.17a 24.18±4.14b 0.0417
Clostridiales 41.90±5.68b 34.26±3.30ab 30.96±3.32ab 23.72±3.04a 0.0205
Erysipelotrichales 1.93±0.52a 3.95±0.79ab 4.95±1.33b 4.23±1.23ab
Burkholderiales 0.69±0.18a 1.48±0.32ab 1.99±0.50b 2.24±0.54b
Unknown 7.97±1.43a 10.88±1.69ab 16.49±2.38b 13.31±2.90ab
Unassignable 4.50±0.51a 8.51±0.91ab 15.95±1.73c 12.44±2.88bc 0.0007
Control 
(n=5) DSS (n=10)
Control 
(n=5) DSS (n=9)
Control 
(n=5) DSS (n=10)
Control 
(n=5) DSS (n=9) Diet DSS
Diet* 
DSS
Bacteroidales 0.44±0.23a 0.76±0.17a 4.83±0.84ab 4.81±1.66ab 23.59±4.72d 11.19±0.80c 15.85±3.36c 6.69±0.58b <0.0001 <0.0001 0.0005
Bacillales 0±0.00b 0±0.00b 0±0.00b 0±0.00b 0±0.00b 0±0.00b 3.22±3.22a 0±0.00b
Lactobacillales 30.73±3.90d 17.96±5.00c 6.87±3.55ab 10.27±3.25bc 3.20±1.68ab 1.11±0.43a 19.61±2.21cd 9.94±1.94bc <0.0001 0.0377 0.1019
Clostridiales 12.37±4.25bc 16.61±1.60c 14.24±1.09bc 13.21±1.98bc 16.41±2.95c 5.80±0.45a 23.46±2.2d 10.29±0.78ab 0.0387 0.0005 <0.0001
Erysipelotrichales 0.22±0.16a 0.51±0.18a 0.93±0.44abc 0.64±0.26ab 2.14±0.60c 1.17±0.26abc 4.2±1.23d 1.71±0.46bc
Burkholderiales 0.14±0.09a 0.11±0.04a 0.37±0.10a 0.81±0.28ab 2.99±0.54d 0.87±0.27ab 1.72±0.43bc 1.82±0.60c
Unknown 20.61±3.28a 27.51±2.39b 39.43±2.55d 33.28±1.84cd 28.10±4.10bc 45.15±0.63de 15.80±2.35a 36.37±1.40d <.0001 <.0001 <.0001
Unassignable 16.92±0.93
b 21.44±1.19c 27.48±1.03de 25.68±1.22d 19.80±3.41bc 29.50±1.26e 10.38±1.41a 26.28±0.87de <.0001 <.0001 <.0001
†Data represents predominant phylogenetic groups (>1%) and are LS mean±SEM
Sumac bran Hi Tannin bran
Day 47     
(Post DSS#2): 
Order level 
classification 
(% OTUs)
Day 62     
(Post DSS#3): 
Order level 
classification 
(% OTUs)
Cellulose Black bran
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Figure 12. Proportion of OTUs classified in the Clostridiales order. On d 62 (post 
DSS#3) the Clostridiales order was reduced in DSS treated rats compared to d 47 (post 
DSS#2) for all experimental diets. Data are LS±SEM. Means without common 
superscripts differ (p<0.05). Actual values found in Table 10. 
 
 
Sumac controls had numerically lower species richness and diversity indices compared 
to all other experimental diets. Following DSS#2 (d 47), we observe no significant 
differences in bacterial diversity between Cellulose, Black, Sumac or Hi Tannin bran 
DSS rats. Sumac DSS rats had a significantly lower species richness compared to 
Cellulose, Black and Hi Tannin bran DSS rats (p<0.05) at this time point. DSS treated 
rats on d 47 had numerically lower species richness and diversity indices. However, on d 
62 there was an increase in diversity (13.6-25%) and species richness (39-62%) 
compared to d 47 for Cellulose and Black, Sumac and Hi Tannin bran DSS rats (Table 
11).  
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On d 62, we observe a significant diet*DSS effect on species richness and 
diversity (p<0.0001 and p=0.0003, respectively), in which Cellulose and Black bran 
DSS rats had a significantly lower Chao compared to their diet-matched controls 
(p<0.05). Sumac bran DSS rats had significantly higher richness (p=0.0199) and 
numerically higher diversity index compared to Sumac controls, and Hi Tannin DSS rats 
had significantly higher richness and diversity indices (p<0.001 and p=0.013, 
respectively) compared to Hi Tannin controls at this time point (Table 11).  
DSS induced injury of distal colon 
DSS treatment elevated injury scores in rats consuming all experimental diets, 
with significantly higher increases in scores observed in Hi Tannin DSS rats compared 
to Hi Tannin control rats (p=0.0072, Chapter II). DSS treated rats fed bran diets had 
significantly higher injury scores compared to Cellulose DSS rats (p<0.05). Cellulose 
controls had the lowest injury scores, which were significantly lower than Black and 
Sumac bran controls (p<0.05). 
Correlation between phylogenetic data and colonic injury score 
 The proportion of OTUs classified in each taxa were correlated to colonic injury 
score and significant correlations were observed for three phylogenetic groups (Table 
12). At the phylum level, both Firmicutes and Actinobacteria negatively correlated to 
colonic injury (p=0.003 and p=0.019). Within the Firmicutes phylum, all classified taxa 
at the order level (i.e., Clostridiales, Erysipelotrichales, Lactobacillales) negatively 
correlated to colonic injury and was significant for Lactobacillales (p=0.045). The  
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Table 11. Chao and Shannon Weaver indices for all treatment groups on d 47 and d 62. Sumac DSS rats had significantly 
lower species richness compared to Cellulose, Black and Hi Tannin bran DSS rats on d 47. On d 62 Cellulose and Black bran 
DSS rats had a significantly lower and Sumac and Hi Tannin had significantly higher Chao compared to their diet-matched 
controls.  Black bran DSS had a significantly lower and Hi Tannin DSS rats had a significantly higher diversity index 
compared to their diet matched controls on d 62. Means without common superscripts differ (p<0.05). 
 
 
 
 
 
 
 
 
DSS   (n=9) DSS   (n=9) DSS (n=10) DSS (n=10) Diet
Chao 117.33±4.78b 124.74±6.23b 92.76±2.12a 112.98±5.91b 0.0005
Shannon 
Weaver index
4.00±0.18a 4.35±0.16a 4.17±0.08a 4.17±0.12a
Control (n=5) DSS (n=10) Control (n=5) DSS (n=9)
Control 
(n=5) DSS (n=10) Control (n=5) DSS (n=9) Diet DSS
Diet* 
DSS
Chao 207.32±14.08d 169.29±5.45c 222.91±12.47d 173.79±14.27c 118.27±6.85a 155.08±6.87bc 133.45±13.05ab 210.40±9.17d <0.0001 <0.0001
Shannon 
Weaver index
4.79±0.33cd 4.86±0.15c 5.82±0.04a 5.13±0.15bc 4.39±0.14d 4.78±0.08cd 4.73±0.16cd 5.5±0.10ab <0.0001 0.0003
Data are LS mean±SEM
Cellulose Black bran Sumac bran Hi Tannin bran
Day 
47
Day 
62
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abundance of OTUs classified as “Unknown” or “Unclassified” (OTUs that did not 
match any known sequences in the RDP database) both positively correlated to colonic 
injury (both p=0.003, Table 12). 
Discussion 
The intestinal microbiota is composed of trillions of bacteria and over 400 
individual species have been identified thus far. These bacterial populations provide 
numerous benefits to the host including immune system development, epithelial barrier 
maintenance, and providing fuel for colonocytes (6, 35-36, 71, 110). It is now 
understood that perturbations to the microbiota is involved in the onset and recurrence of 
intestinal inflammation and an important factor in the etiology of inflammatory bowel 
diseases (IBD) such as ulcerative colitis (UC) (45, 96-97, 171, 173).  Another 
environmental input that has been shown to affect the microbiota is diet composition, 
and recent focus has been put on bioactive compounds and their possible role in 
mitigating the deleterious effects of intestinal inflammation (16-17, 19, 39, 143, 208-
209).  
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Table 12. Correlation of intestinal microbiota and colonic injury score with significant 
coefficients indicated (p<0.05). 
 
 
 
 
 
 
 
Previous work in our lab demonstrated that sorghum bran diets containing 
bioactive compounds can alter fecal short chain fatty acid (SCFA) concentrations, a 
microbial metabolite, suggesting the ability to alter the composition of the microbiota or 
microbial fermentation (198). PCA analysis from this study suggests that there are 
distinct bacterial communities in animals fed experimental diets containing Cellulose, 
Black, Sumac or Hi Tannin bran diets. Additionally, samples collected at different time 
points (post DSS#2 and DSS#3) also grouped in different quadrants of the plot, 
suggesting DSS treatment and colonic inflammation also creates distinct microbial 
Correlation 
coefficient
Actinobacteria -0.308†
Bacteroidetes 0.076
Bacteroidales 0.049
Firmicutes -0.387†
Clostridiales -0.123
Erysipelotrichales -0.096
Lactobacillales -0.264†
Proteobacteria -0.012
Burkholderiales 0.08
Unknown 0.382†
Unclassified 0.387
†
†Indicates phylogenetic groups which proportion 
correlated significantly to injury score
Taxon
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populations. Little research has been done to understand how the bioactive compounds 
found in sorghum (i.e., 2-deoxyanthocyanins and condensed tannins) can alter the 
luminal environment, particularly the intestinal bacterial populations. Therefore the goal 
of this work was to characterize alterations to the microbiota during DSS induced colitis 
and determine if these diets have the ability to mitigate the dysbiosis associated with UC.  
Intestinal microbiota composition in UC 
Although ample research has been done to understand the role of the microbiota 
in UC, it is becoming more apparent that not one constituent of the intestinal flora is to 
blame. However, global shifts and overall dysbiosis in the ratio of predominant bacterial 
populations (i.e., Firmicutes and Bacteroidetes phylum) have been observed in patients 
with IBD. An increased Firmicutes to Bacteroidetes ratio has been documented in both 
feces and biopsies of IBD patients and experimental models of obesity and UC (194-
195, 210-211). In our study we do not observe an elevated Firmicutes/Bacteroidetes ratio 
in DSS treated animals fed a bran based diet at either time point, suggesting that DSS 
exposure didn’t drastically alter these phyla. Furthermore, when comparing healthy and 
diseased animals fed a bran diet we do not see a marked difference in this ratio. The 
Firmicutes/Bacteroidetes ratio observed in Cellulose fed animals (both control and DSS) 
was at least ten fold higher than that of bran fed animals, which could be in part due to 
the presence of cellulose fermenting bacterial species within this phylum (e.g., 
Ruminococcus spp.) (212). Additionally, this result could suggest that properties of bran, 
such as the presence of bioactive compounds, may be involved in maintaining a healthy 
distribution of bacteria during colonic inflammation. 
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A recent review documented the numerous changes observed in experimental 
models and patients with IBD, and no agreement has been reached on the association of 
specific microbial groups and UC (213). Studies have documented elevated levels and 
enhanced epithelial adherence of pathogenic bacteria species (e.g., E. coli) in patients 
with IBD and DSS induced colitis (100). Our study contrasts this report, as we observe 
less than 5% of OTUs classified in the Proteobacteria phylum at both time points. A low 
proportion of this phylum following DSS exposure is positive, since it includes 
numerous pathogenic genera such as Escherichia, Salmonella, Vibrio, and Helicobacter. 
Previous studies in experimental models and patients with UC have also 
documented a depletion in bacterial species that provide benefit to the host such as 
Bifidobacterium and Lactobacillus (96, 100, 195), which produce antimicrobial 
substances and compete with pathogens for epithelial and mucin binding sites (214). 
Furthermore, it has been demonstrated that supplementation of these probiotic species 
has helped attenuate symptoms and maintain remission of UC (123-124, 215). In this 
study, we observe virtually undetectable levels of OTUs classified in the Actinobacteria 
phylum (≤0.80%), suggesting Bifidobacteria is not a major constituent of the microbiota 
in any of our experimental groups. However, we do observe significant diet and 
treatment effects on the proportion of OTUs classified in the Lactobacillales order. 
During an active disease state (following DSS#2), we observe significantly higher 
proportion of this order in Hi Tannin DSS animals compared to Cellulose, Black and 
Sumac bran DSS animals. However, following DSS#3, we observe a suppression of the 
Lactobacillales order in DSS treated animals fed Cellulose, Sumac and Hi Tannin bran 
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diets, which is similar to other reports in patients and experimental models of UC that 
documented a suppression of LAB (100). In contrast, Black bran DSS animals had 
numerically elevated proportion of Lactobacillales compared to their diet matched 
controls at both time points, suggesting that the presence of 3-deoxyanthocyanins may 
have a positive influence on maintaining this bacterial population. 
Alterations in other bacterial populations that are prevalent constituents of the 
commensal intestinal flora have been reported in experimental models and patients with 
UC, and both an elevation and suppression have been observed in species such as 
Bacteroides and Clostridium in feces and colonic tissue (172, 216-219). Similarly, when 
comparing healthy and diseased animals in our study we observe both increased and 
decreased proportions of numerous bacterial populations at the order level that differ 
across experimental diets. For example, following DSS treatments (both d 47 and d 62) 
diseased animals fed Sumac and Hi Tannin bran had a lower proportion of bacterial 
populations such as Bacteroidales and Clostridiales, while DSS animals fed Black bran 
had an elevated proportion of these and other bacterial groups (i.e., Bacteroidales, 
Lactobacillales, Clostridiales, and Burkholderiales) compared to their diet matched 
controls. Previous studies reported elevations in Clostridiales and Lachnospiraceae (a 
bacterial family within Clostridiales) during DSS induced colitis, which is similar to our 
observations in Black bran DSS animals (100, 211). To better understand how the 
predominant bacterial populations were fluctuating during different stages of 
inflammation, we compared DSS treated animals on d 47 (post DSS#2) to d 62 (post 
DSS#3) and observe distinct differences across experimental diets. Decreased 
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proportions of the Bacteroidales, Clostridiales, and Lactobacillales orders were observed 
in DSS animals for all experimental diets following DSS#3, with the highest reduction 
observed in the Clostridiales order (56%-79%). The Clostridiales order is of particular 
importance, as it harbors bacterial species that have the ability to produce important 
bacterial metabolites such as butyrate (220-221). Alterations to this particular population 
could be detrimental to colonic health, as butyrate is not only the predominant fuel for 
colonocytes, but suppressed availability and uptake of this metabolite have been 
implicated in the etiology of IBD (177, 179-180, 222). 
As demonstrated in this study and the literature, both elevated and suppressed 
proportions of various bacterial populations have been observed in patients and 
experimental models of UC (100, 211, 213, 216-219). Observed differences could be 
due, in part, to the progression of inflammation or severity of epithelial barrier injury in 
these subjects and the animals in this study. It has been previously reported that areas of 
inflammation harbor different bacterial populations than non-inflamed tissues from the 
same individual, suggesting that the variations we observe could be dependent on 
disease state (96-98). Additionally, previous studies have shown correlations between 
bacterial populations and disease severity which can further elucidate the relationship 
between the microbiota and UC. We report a negative correlation between colonic injury 
and numerous phylogenetic groups, including significant correlation to Firmicutes, 
Actinobacteria, and Lactobacillales. Similar to our results, one study reported that the 
abundance of certain taxa in the Firmicutes phylum (i.e., Clostridium clusters IV and IX) 
were negatively correlated to disease symptom score (e.g., abdominal pain, distention) in 
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patients with irritable bowel syndrome (194). In contrast to our results, another study 
illustrated a positive correlation between the abundance of cecal E. coli and histologic 
colon score in HLA-B27 transgenic rats (223). Our results could differ from previous 
studies due to the experimental model utilized, tissue analyzed (i.e., feces versus colonic 
tissue), and phylogenetic characterization technique differences (e.g., FISH, T-RFLP, 
DGGE, microbiological culture). Further analysis can be done to further characterize the 
composition of bacterial populations, particularly probiotic bacterial taxa such as 
Bifidobacteria and LAB. Utilizing species specific PCR probes and identifying closest 
neighbors to unclassified and unidentified OTUs will further elucidate the significance 
of these bacterial groups and their relation to colonic injury in our experimental groups. 
Although we observed a decrease in the predominant bacterial orders on d 62, 
there was not a reduction in bacterial diversity and species richness at this time point, 
which is a common observation in patients with UC and DSS induced colitis (99-100, 
172, 193, 211). Following the second DSS treatment, we observed a decrease in both 
species richness and diversity; however, the values of these indices are elevated 
following recovery from DSS#3. Furthermore, following all DSS exposures diseased 
animals fed brans containing condensed tannins (i.e., Sumac and Hi Tannin bran) had 
bacterial richness and diversity that was higher than their diet matched controls. Black 
bran DSS rats were unable to fully restore richness and diversity, but Black bran controls 
had numerically higher indices compared to other experimental diets and perhaps more 
recovery time would allow for complete restoration. A diminished flora could be 
detrimental due to decreased colonization resistance, imbalances in microbial-host 
 92 
 
signaling through pattern recognition receptors such as toll like receptors (TLR), as well 
as allowing for pathogenic bacteria to thrive (224). This data suggests that even though 
the bacterial populations may be affected during an active disease state, feeding bran 
based diets, particularly those containing condensed tannins, may be useful to restore 
diminished bacterial species richness and diversity associated with UC.  
Effect of diet and polyphenol composition on the microbiota 
In addition to intestinal inflammation, differences in fecal microbial populations 
in our study could be due to the bioactive compound composition of these sorghum 
brans. Previous research and analysis of each experimental diet in this study (Chapter II) 
indicates that bran from these sorghum varieties contain concentrated levels of 3-
deoxyanthocyanins, condensed tannins, or a combination of these compounds (Black 
bran, Sumac Bran and Hi Tannin bran, respectively) (25-26, 117). Due to their high 
antioxidant capacity and bacteriocidal effects, plant polyphenols similar to those utilized 
in this study have been studied to mitigate the effects of IBD and also been found to 
affect the microbiota (9, 14, 16, 121-122, 145, 208, 225). Two previous studies used 
stock bacterial strains, previously identified as constituents of the intestinal microbiota, 
and reported that hydrolysable tannins (i.e., gallic acid, methyl gallate, propyl gallate) 
have inhibitory properties against some Clostridium species and potentially harmful 
bacterial strains such as C. perfringens, C. paraputriﬁcum, E. limosum, B. fragilis, S. 
aureus, and E. coli in culture (9, 14). This inhibitory effect could be one reason for the 
lack of bacterial species characterized in the Proteobacteria phylum in our study 
(≤4.29%), which as mentioned previously harbors numerous pathogenic bacteria species 
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such as S. aureus and E. coli. Furthermore, these studies reported hydrolysable tannins 
only had slight effect on LAB strains (e.g., B. infantis, L. acidophilus) (9, 14), which 
parallels Hi Tannin DSS animals having a significantly higher proportion of 
Lactobacillales compared to Cellulose, Black, and Sumac DSS animals on d 47. Another 
study testing the effect of condensed tannins on the GI microbiota in vivo also reported 
similar gram positive bacteria inhibition (16). This study used denaturing gel 
electrophoresis (DGGE) and reported that tannins derived from the Acacia angustissima 
shrub significantly increased murine fecal bacterial diversity (16). Phylogenetic 
classification of DGGE bands showed a significant decrease in the C. leptum sub-group 
in rats fed a tannin supplemented diet, while other enteric bacteria such as species 
classified in the B. fragilis and Bacteroides-Prevotella-Porphyromonas groups increased 
significantly (16). Our observations are similar to these reports, as animals fed a bran 
diet containing tannins (i.e., Sumac and Hi Tannin) had higher proportions of bacteria 
classified in the Bacteroidales order compared to Cellulose and Black bran fed animals. 
Interestingly Sumac bran not only contains the highest concentration of tannins, but 
animals fed this experimental diet had significantly higher proportions of Bacteroidales 
in controls and on d 47 (Sumac DSS animals) compared to other experimental groups. 
Other dietary compounds such as tea polyphenols and other flavanoids have been 
reported to alter the composition of the intestinal microbiota (15, 104). One study 
observed that Xanthohumol, an antimicrobial flavonoid found in hops, had a significant 
effect on the diversity of bacterial groups in rat feces using DGGE fingerprint analysis 
(104). Similar results were observed in a study that characterized how tea polyphenols 
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affected GI microbial diversity in humans (15). Those that were administered tea 
polyphenols had decreased proportion of Clostridium spp. and an increased proportion 
of Bifidobacterium spp. compared to those that did not consume these polyphenols (15).  
Previous studies and our results indicate that plant polyphenols not only have the 
ability to alter bacterial populations and intestinal diversity, but their effects vary 
substantially and may be dependent upon the polyphenolic structure and the ability of 
microbes to metabolize these compounds. Very little is known regarding microbial 
metabolism of the 3-deoxyanthocyanins and condensed tannins found in sorghum bran. 
In general, polyphenols are poorly absorbed and therefore available to be catabolized by 
the colonic microbiota. Microbial metabolism of polyphenols is extremely complex and 
numerous microbial catalytic and hydrolytic enzymes have been identified [76], 
therefore a complete description is beyond the scope of this paper. However, unlike 
other flavonoids, many anthocyanins do not undergo extensive metabolism and their 
structure is stabilized in acidic conditions (226). Furthermore, condensed tannins such as 
those described in this study are large non-hydrolysable proanthocyanindins, with three 
or more polymerizations, that are not easily fractionated by water and tannases (227). 
One study demonstrated that condensed tannins isolated from sorghum bran were only 
isolated in excrement and not absorbed in chickens (228). Furthermore, both animal and 
human studies have shown that anthocyanins from berries (i.e., bilberry & raspberry) are 
poorly absorbed in the small intestine and typically <0.1% of the quantities ingested are 
detected in urine within 24 h of consumption (229-230). This implies that although the 
gut and its microbiota may be closely involved in the metabolism of some polyphenols, 
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previous studies report that compounds similar to those found in this study may not be 
absorbed or metabolized and therefore concentrated in the intestinal lumen. Metagenome 
and metabolomics analyses may help elucidate the relationship of the microbiota and the 
bioactive compounds found in sorghum, however, due to the large number of genes and 
metabolites identified in these analyses it could be quite difficult to elucidate the 
biomolecular mechanisms involved in the observed beneficial effects. 
Conclusions 
To our knowledge, there are no studies that describe the effect of sorghum bran 
on the microbiota. We demonstrate that sorghum bran diets may be able to mitigate 
some of the deleterious effects associated with UC, such as preventing an overall 
dysbiosis of predominant bacterial populations and decreased microbial diversity. 
Furthermore, we observe distinct differences among experimental diets suggesting that 
the presence of bioactive compounds such as 3-deoxyanthocianins and condensed 
tannins may be a factor in these diets ability to alter the luminal environment and 
microbial populations. Additional analysis such as species-specific bacterial primers 
could elucidate additional population changes not captured in this study. Future studies 
elucidating mechanisms by which these bioactive compounds affect the intestinal 
microbiota during a healthy and diseased state are warranted.
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CHAPTER IV 
INCREASED DIETARY IRON AND RADIATION IN RATS PROMOTE 
OXIDATIVE STRESS, INDUCE LOCALIZED AND SYSTEMIC IMMUNE 
SYSTEM RESPONSES, AND ALTER COLON MUCOSAL ENVIRONMENT 
 
Introduction 
Iron is a micronutrient involved in many cellular processes, including oxygen 
binding and electron transport, and it serves as a cofactor for hundreds of enzymes. As 
with many nutrients, a sensitive balance exists between the deleterious effects of iron 
deficiency and iron excess (231). Physiological adaptations to microgravity and an iron-
rich food supply contribute to altered iron homeostasis during space flight (232-233). A 
decrease in red blood cell mass during flight, an increase in serum ferritin, and a 
decrease in transferrin receptors after long-duration flight provide evidence for increased 
iron storage as a result of space travel (233-236). Additionally, the astronauts’ diet may 
also contribute to increased iron stores because the iron content of many items on the 
International Space Station (ISS) menu is very high due to fortification (232).The 
standard ISS menu contains 20 ± 6 mg iron/d (232, 237), with some crews’ intake 
occasionally being as high as 47 mg iron/d (232). The current U.S. Dietary Reference  
Intake (DRI) is 8 mg/d for males and 10 mg/d for females, and the tolerable upper limit 
of intake is 45 mg/d (238). For ISS astronauts, the defined space flight requirement is 8-
10 mg/d for both men and women (232, 237). It is worth noting that the typical 
American consumes 30 - 120% more than the DRI depending on gender (239), making 
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chronic subclinical iron overload a potential issue for the general public. Elevated iron 
stores have been associated with a number of diseases, including cardiovascular disease 
and cancer (240-242), and reduced stores (related to blood donation) have been 
associated with lower disease risk (243-244). Thus, maintenance of iron homeostasis 
within normal ranges is extremely important for human health on Earth, and in space. 
In addition to the physiological effects of microgravity on the human body, 
radiation exposure is a major concern for space travel.  The free radicals, including 
reactive oxygen species (ROS), which are generated in cells immediately after radiation  
exposure are responsible for deleterious effects on cell function and survival (245). In 
animal models, exposure to ionizing radiation (ranging from 0.1 Gy to 8 Gy) increases 
oxidative damage in many tissues (246-248). Risks associated with radiation exposure in 
space include central nervous system effects, carcinogenesis, and other degenerative 
tissue defects such as cataracts, heart disease, and digestive diseases (249-251).  
Elevated iron stores and radiation are expected to promote oxidative stress and 
damage, as both generate ROS (252-253). Elevated oxidative stress associated with 
increased body iron stores may increase radiation sensitivity by decreasing cellular 
oxygen radical scavenging capabilities of enzymes like superoxide dismutase (SOD), 
glutathione peroxidase (GPX), and catalase (254-256). Evidence also exists that some 
types of radiation exposure and oxidative stress can release ferrous iron (Fe
2+
) from 
ferritin (257-258), further adding to free iron load. 
The effects of oxidative stress on immunity can be both localized and systemic. 
The local immune response in the gut is an important defense against pathogens. The 
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intestinal immune system must recognize commensal bacteria while preserving its 
capacity to respond to pathogenic species (259). The gut monitors bacterial populations 
by recognizing pathogen-associated molecular patterns (such as bacterial ligands 
including lipopolysaccharide, ligand presenting assembly, and flagellin), thereby 
inducing innate and adaptive immune responses (260-261) that are mediated through 
toll-like receptors TLR (262-263) and downstream activation of NF-κB. Changes in the 
molecular patterns produced by the commensal colon microflora or the ratio of 
pathogenic to beneficial bacteria (dysbiosis) caused by elevated dietary iron and 
radiation may perturb these activation pathways, inducing transcription of 
proinflammatory cytokines (e.g., TNFα, IL-1b, IL-6, and COX-2) that initiate 
inflammatory reactions with systemic implications (264-265). Interestingly, previous 
research has shown that agonists of the TLR5 pathway have radioprotective effects 
against lethality (266). Colonic dysbiosis has long-term implications because an 
increased inflammatory tone is thought to play a role in the etiology of gastrointestinal 
disorders such as inflammatory bowel disease, which promotes colon carcinogenesis 
(267-269). Changes in the microbiota and their functional state can be monitored by 
measuring their metabolites, such as short-chain fatty acids (SCFA) (270). In addition to 
indicating changes in the microbiota, the concentrations of SCFA, such as butyrate, 
influence colon health and ability to maintain epithelia barrier functions, because 
butyrate is the preferred substrate for colon epithelial cell metabolism (271-272). 
Persistent alterations to the immune system may also have adverse systemic 
effects on immune function.  Reactive species are produced as a normal consequence of 
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immune activation or inflammation. In the immune system, these reactive molecules are 
actually beneficial, supporting pathogen elimination through respiratory bursts that are 
balanced by antioxidant production by immunocytes. Chronic inflammation, however, 
may overwhelm antioxidant defenses and lead to cellular damage as described above. 
Persistent exposure to space radiation may induce a chronic low level of inflammation in 
astronauts. Plasma cytokine data during long-duration space flight suggests this, with 
levels of IL-8, CXC5, and IL-1ra significantly elevated for the duration of a 6-month 
orbital flight. Oxidative stress also negatively affects T-cell function (273), and 
diminished T-cell function was recently documented to occur during space flight (274). 
Investigators have also found reactivation of latent herpes viruses during short-duration 
flight (275-276), and oxidative injury is a component of several neurotropic viral 
infections (277). The extent to which oxidative damage plays a beneficial role, versus a 
pathologic role, in viral infection is an emerging area of investigation. Dysregulation of 
other hematologic and immunologic variables has also been found to occur immediately 
after space flight (278-279), and altered cell-mediated immunity has occurred during 
long-duration flight (280). Any persistent immune dysregulation during exploration 
deep-space missions might result in specific clinical risks for crewmembers (281).  
In this study, we characterized the combined effects of radiation exposure and 
high dietary iron on multiple physiological systems. Specifically, we investigated the 
effects of these treatments on: 1) iron status and oxidative stress markers, 2) systemic 
immune responses, 3) production of colon bacterial metabolites, and 4) colon mucosal 
gene expression and inflammatory markers.  These systems will be used to develop an 
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integrated physiological response to the effects of radiation and high dietary iron as they 
relate to space flight.  
Materials and Methods 
 Animals used in this study were housed, irradiated, and terminated at the animal test 
facility at Johnson Space Center. Following tissue collection, described below, feces and 
colonic mucosa was transported to the Turner lab at Texas A&M University for analysis. 
Remaining analyses, including biochemical analyses and immune system assays of liver, 
blood, and serum, were completed at Johnson Space Center. 
Animals  
This project was approved by the NASA Johnson Space Center Institutional 
Animal Care and Use Committee. Four groups (n=8/group) of 4-month-old Sprague 
Dawley male rats (Charles River Laboratories, Wilmington, MA, USA) were fed a 
control iron diet (45 mg iron/kg diet) and exposed to sham (0 Gy) radiation 
(control/sham, designated CON), fed a high-iron diet (650 mg iron/kg diet) and exposed 
to sham radiation (high iron/sham, designated IRON), fed the control iron diet and 
exposed to fractionated (0.375 Gy of Cs-137 every other day for 16 d for a total of 3 Gy) 
radiation (control/radiation, designated RAD),  or fed a high-iron diet and exposed to 
fractionated radiation (high iron/radiation, designated IRON+RAD). 
After arrival at the animal test facility at Johnson Space Center, rats were 
acclimated to the environment and control diet (AIN-93G; Research Diets, New 
Brunswick, NJ, USA) for 20 d (Day -20 to Day 0). They were housed individually with a 
12-h light/dark cycle, in a temperature- and humidity-controlled room (21 ± 1°C). After 
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20 d (defined as study day 0), half the animals were given the high-iron diet (AIN-93G 
with 650 mg iron /kg; Research Diets, New Brunswick, NJ, USA). Food intake was 
determined three times per week to ensure that food consumption and animal weights 
were similar between groups, and that pair-feeding was not required. On study day 14 
the first radiation dose was administered to the radiation groups. Animals in both the 
sham and radiation groups were placed in a restraint tube (Battelle, Geneva, 
Switzerland) for about 10 min per session to be either irradiated or sham treated. The last 
irradiation was performed on study day 28. 
Treatments 
The dietary iron content of 650 mg iron/kg has been used by others as a 
moderately high iron intake known to induce oxidative damage (282). The low, 
fractionated dose of gamma radiation was intended to provide enough total dose (3 Gy) 
to induce an oxidative stress signal, and also to approximate the level of radiation 
exposure expected over a long-duration space mission outside low Earth orbit (283). 
Based on recent radiation measurements taken during the rover Curiosity’s trip to Mars, 
the calculated radiation exposures of the shortest round trip to Mars are estimated to be 
0.66 ± 0.12 sievert (or about 0.66 Gy of gamma irradiation) (284).  
Tissue collection 
At the time of termination (24 h after the last radiation exposure) all animals had 
been fasted for 12 hours, and were anesthetized with isofluorane before blood was 
collected by cardiac puncture. Samples of liver, colon mucosa, and feces were collected. 
The liver was removed, weighed, rinsed with phosphate-buffered saline (PBS), sectioned 
 102 
 
into small pieces, placed in cryovials, and flash frozen in liquid nitrogen. All tissues and 
samples were stored at -80ºC until further processing. Samples of the blood were placed 
in lithium-heparin, ethylenediaminetetraacetic acid (EDTA), or serum separator tubes. 
Whole blood (EDTA) was used for erythrocyte count and leukocyte analyses. Samples 
were centrifuged at 3500 RPM (1780 x g) for 15 min, then aliquoted for individual tests.
 The colon was resected, feces were removed and snap frozen at -80°C, and the 
colon was washed twice in RNase-free PBS and scraped on a chilled RNase-free surface. 
Half of the scraped mucosa was homogenized by pipetting with 500 L of denaturation 
solution (Ambion, Austin, TX) and transferred to a 2-ml Eppendorf tube for RNA 
isolation. The remainder was snap frozen in liquid nitrogen, and both samples were 
stored at -80°C. Scraped mucosa for RNA analysis was homogenized in denaturation 
buffer (285). 
Biochemical analyses 
Biochemical analyses and immune system assays were performed at Johnson 
Space Center. 
Liver protein and mineral analysis  
 For protein assays, a ~0.2-g section of liver was homogenized in buffer (20 mM 
HEPES, 1 mM ethylene glycol tetraacetic acid, 90 mM mannitol, and 70 mM sucrose). 
Samples were centrifuged at 3500 RPM (1780 x g) for 15 min, and the supernatant was 
aliquoted for SOD, catalase, GPX, and total protein analysis. Samples were stored at -
80°C until assays were performed. For mineral analysis, a ~0.2 g section of liver was 
dried at 70°C for 24 h (Fisher Scientific Isotemp oven) and the dry samples were 
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weighed and then placed in acid-washed Teflon microwave digestion vials with 2 ml of 
ultrapure nitric acid (Aldrich, St. Louis, MO, USA). Samples were digested using a 
CEM MARS XP1500Plus microwave digestion system using the method designed for 
bovine liver (ramp to 200°C over 15 min and hold at 200°C for 15 min). Samples were 
clear with low surface tension after cooling. Samples were transferred to centrifuge 
tubes, using 3 ml of 18 MΩ water to rinse the Teflon digestion vessels, and weighed. 
Samples were diluted 1:50 with 10% nitric acid and 10% ethanol for mineral analysis on 
an inductively coupled plasma mass spectrometer (SCIEX ELAN DRC II, Perkin Elmer 
Inc., Waltham, MA, USA). Copper, iron, selenium, and zinc were measured using 
gallium as the internal standard. Process blanks revealed that there was no significant 
contamination of Cu, Fe, Se, or Zn during processing.  
Oxidative stress and iron status analyses 
 Whole-blood SOD and catalase were measured colorimetrically using 
commercially available kits (Cayman Chemical Company, Scottsdale, AZ, USA). 
Whole-blood GPX was measured on an Ace Alera autoanalyzer using the Randox GPX 
method and reagents (Randox, Crumlin, United Kingdom). Serum ferritin was measured 
using a commercially available rat ferritin ELISA assay (Alpco Immunoassay, Salem, 
NH, USA). Plasma iron was measured using a Beckman Coulter AU analyzer. Plasma 
heme was measured using the Quantichrom Heme Assay Kit, from BioAssay Systems 
(Hayward, CA, USA). Serum C-reactive protein was measured using the Rat C-reactive 
Protein ELISA kit from EIAab (Wuhan, China). Serum n-telopeptide was measured 
using a Rat NTX ELISA Kit from Cusabio (Wuhan, China). Oxidized low-density 
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lipoprotein was measured using a Rat OxLDL ELISA Kit from Cusabio (Wuhan, 
China). Serum total antioxidant capacity was measured using Randox reagents on a 
Beckman Coulter AU analyzer, with a blank measurement being taken of each sample 
before reagents were added. This allows subtraction of any contribution from urate, 
ascorbate, and albumin. Liver total protein was measured using the Pierce
®
 BCA protein 
assay kit from Thermo Scientific (Rockford, IL, USA). Hematocrit was measured on a 
Coulter LH750 hematology analyzer (Coulter, Brea, CA, USA). 
Immune system assays  
Leukocyte subset analysis 
Total leukocyte count was determined after erythrocyte lysis using a Hemocue 
leukocyte analyzer with a DNA intercalating dye. The major subsets (granulocytes, 
lymphocytes, monocytes) were determined by analysis on a Beckman Coulter LH750 
hematology analyzer. The percentages of T cells and CD4+ and CD8+ T-cell subsets 
were determined by flow cytometry. The antibody matrix and fluorescent labels were as 
follows: CD8, fluorescein isothiocyanate (FITC); CD3, phycoerythrin (PE); CD4, 
phycoerythrin cyanin 5 (PC5) (Beckman Coulter, Miami, FL, USA). Antibody staining 
and erythrocyte lysis were performed as previously described (274), and analysis was 
performed on a Beckman-Coulter EPICS XL flow cytometer. Lymphocytes were 
resolved and gated from granulocytes and monocytes by scatter properties (FSC/SSC). T 
cells (CD3+) were resolved and gated from unstained cell populations by plotting CD3 
versus side scatter from the lymphocyte gate. CD4+ and CD8+ T cells were plotted and 
enumerated from the T-cell gate.  
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T-cell blastogenesis 
  T cells were activated by culturing 100 µl of heparinized blood in 1.0 ml RPMI 
medium and 0.5 µg/ml each of anti-CD3 and anti-CD28 for 24 hours to trigger the T-cell 
receptor (TCR) and provide co-stimulation (anti-CD28) (286). Cultured whole blood 
was then stained as described above, using an anti-CD25-FITC, CD3-PE, CD4-PC5 
antibody matrix. Lymphocytes were resolved and gated from granulocytes/monocytes by 
scatter properties (FSC/SSC). T-cell subsets were resolved and gated from unstained cell 
populations by plotting CD3 versus CD4 from the lymphocyte gate. Finally, CD25 
expression for both the CD4+ and CD8+ (defined as CD4 negative) T-cell subsets were 
plotted from the appropriate gates.  
Mitogen-stimulated cell cultures 
 Whole-blood cultures (heparinized blood) were set up as described above, with 
mitogenic stimulation generated by 0.5 µg/ml anti-CD3 and 0.5 µg/ml anti-CD28 
antibodies (T cells), 10 ng/ml PMA+ 2.0 µg/ml ionomycin (a stronger stimulus affecting 
all cell populations), or 10 µg/ml lipopolysaccharide (monocytes). Cultures were 
incubated for 48 h to allow for cytokine production and accumulation. After 48 h, 
supernatants were removed and frozen until they were analyzed.  
Cytokine analysis 
Concentrations of soluble cytokines, from either plasma or mitogen-stimulated 
culture supernatants, were determined by using bead-array technology and a Luminex-
100 analyzer. The analysis array was obtained from R&D Systems, Inc., and consisted of 
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separate bead-based cytokine analysis reagents for IL-1b, IL-6, TNFα, IL-2, IFNγ, IL-4, 
and IL-10.  
Fecal and colon analyses 
All fecal and colon analyses were performed and data analyzed by the Turner lab 
group at Texas A&M University. 
Short-chain fatty acid analyses 
 Frozen fecal samples were ground, mixed with an internal standard (2-
ethylbutyric acid), and extracted in 70% ethanol. After centrifugation, the supernatant 
was removed and mixed with a second internal standard, heptanoic acid, before it was 
injected into an HP-FFAP column (Agilent Technologies, Santa Clara, CA, USA) in a 
Varian 3900 gas chromatograph (Walnut Creek, CA, USA). Concentrations of short-
chain fatty acids were calculated based on comparison of sample peak areas with those 
produced by a commercially available mix of standards (287). 
 Gene expression using quantitative real-time PCR  
Total RNA was isolated from mucosal samples using Phase Lock Gel™ tubes (5 
Prime, Gaithersburg, MD) and the ToTALLY RNA™ Kit (Ambion, Austin, TX, USA) 
followed by DNase treatment (DNA-free™ Kit, Ambion, Austin, TX, USA) (285). RNA 
quality was assessed using an Agilent Bioanalyzer before storage of the treated samples 
at -80°C. First-strand cDNA was synthesized using random hexamers, oligo dT primer 
(Promega, Madison, WI, USA), and Superscript™ III Reverse Transcriptase, following 
the manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). RT-PCR was 
performed on select genes (TOLLIP, TFF3, Slc16a1, IL-6, IL-1β, TNFα, TNFα1a, 
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TNFα1b, RipK1, SLC5A8, TGFβ, TLR9, TLR5, TLR4, TLR2, MyD88, NF-κB, COX-2 
[PTGS2]) using Taqman® Array Micro Fluidic Cards (Applied Biosystems, Foster City, 
CA, USA) and an ABI 7900 HT thermocycler (Applied Biosystems, Foster City, CA, 
USA). Expression levels were normalized to GAPDH gene expression. 
Myeloperoxidase assay 
 Myeloperoxidase (MPO) concentration was measured in scraped mucosa 
according to the manufacturer’s instructions (Cell Technology, Inc., Mountainview, CA, 
USA). Mucosa samples were weighed and homogenized in 250 µl of 1X assay buffer 
containing 10 mM N-ethylmaleimide then aspirated through a 23-gauge needle twice, 
and centrifuged at 12,000 x g at 4°C for 20 min. The resulting proteinaceous pellet was 
homogenized in 500 µl 1X assay buffer containing 0.5% HTA-Br (w/v), sonicated 
(Sonic Dismembrator, Fisher Scientific, Pittsburgh, PA, USA), and subjected to two 
cycles of freezing and thawing before being centrifuged at 8,000 x g at 4°C for 20 min. 
The supernatant was incubated with 20 mM 3-amino-1,2,4-triazole (Sigma Chemical, St. 
Louis, MO, USA) for 60 min, followed by incubation in the dark at room temperature 
with 50 µl reaction cocktail for 60 min. Fluorescence was measured at 530-570 nm 
excitation and 590-600 nm emission wavelengths in a fluorescent plate reader with the 
1X assay buffer serving as a negative control. 
Statistical analyses 
Statistical analyses were performed using Stata IC software (v 12.1, StataCorp, 
College Station, TX, USA) and setting 2-tailed α to reject the null hypothesis at 0.05. 
Some dependent variables required log transformation to satisfy the required statistical 
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assumptions. The variables requiring transformation are indicated in the tables. Overly 
influential observations (i.e., statistical outliers) were excluded from analysis if the 
standardized residual exceeded ± 1.96 units away from the mean (also identified in the 
tables).  
Data were analyzed by 2-way ANOVA with diet and radiation as the main 
factors. Pairwise comparisons of all possible pairs were made for all analytes. Pearson 
correlations were performed on select analytes. For RT-PCR, 2-way ANOVA was run 
on change in expression (2
-∆CT
) relative to reference gene (GAPDH) as the dependent 
variable. On completion of all analyses, the uncorrected P-values were submitted to a 
single multiple-testing correction (810 hypothesis tests) using the Krieger false 
discovery rate (FDR) method (288). The FDR was set at 10%, thereby accepting that up 
to 10% of the rejected null hypothesis may be a result of type 1 error. As this was a 
small study examining a wide range of analytes, the use of a more conservative FDR 
value or method (Bonferroni) is not warranted. Unadjusted P-values are presented in the 
tables and text with an asterisk indicating that the results remained significant after 
adjusting for multiple comparisons. The residuals from Anti: CD3-IFNγ, PMA: IL-1β, 
and Plasma: IFNγ, IL-10, IL-1β, and IL-4 could not be normalized and therefore 
statistical analyses were not performed on these assays.  Nonetheless, the data are 
presented in Table 15. All data are presented as mean ± SD. 
Results 
The following data were collected and analyzed at Johnson Space Center to 
determine the independent and combined effects of exposure to gamma radiation and 
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elevated body iron stores on markers of oxidative damage and antioxidant status. 
Additionally, these data were collected to determine the relationships between oxidative 
damage markers and markers of immune and liver enzyme function. 
Neither high dietary iron nor the radiation exposure changed food intake or body 
mass gain (data not shown). There were no differences in liver weights at the time of 
termination [11.07 ± 1.35 g (CON), 10.72 ± 2.02 g (IRON), 11.69 ± 1.33 g (RAD), 
12.50 ± 2.51 g (IRON+RAD).  
Iron metabolism was significantly altered as a result of both high dietary iron and 
radiation, as evidenced by both blood (Table 13) and liver analyses (Table 14). Plasma 
iron concentration increased by 37% in IRON+RAD relative to CON (P = 0.007). Liver 
iron concentrations increased as a result of diet alone (P = 0.004), with a 17% increase in 
the IRON group relative to CON and a 36% increase in the IRON+RAD group relative 
to RAD. Liver iron and plasma iron were positively correlated for all groups (r=0.36, P = 
0.044, data not shown). In addition to the changes in iron status, several markers of 
plasma and liver oxidative stress were affected by the dietary iron and radiation 
exposures. High dietary iron increased plasma catalase (P = 0.0008) and liver GPX 
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Table 13. Blood markers of iron status and oxidative stress. Mean ± SD. 
 
 
 
 
 
 
 
 
 
 
 
 
Outliers CON IRON RAD IRON+RAD Main Effect
Test . Diet Rad Inter
Serum
ALT, U/l 1 25 ± 4 a 24 ± 4 a 21 ± 5 ab 19 ± 2 b* <0.01*
AST, U/l 1 102 ± 29 a 113 ± 50 a 87 ± 37 a 82 ± 22 a
Transferrin, mg/ml 0 1.3 ± 0.2 a 1.4 ± 0.1 a 1.4 ± 0.2 a 1.4 ± 0.1 a
Ferri tin, ng/ml 1 130 ± 70 a 166 ± 45 ab 213 ± 86 b 241 ± 87 b* <0.01*
Hepcidin, ng/ml 0 33 ± 6 a 34 ± 11 a 30 ± 13 a 26 ± 9 a
Oxidized LDL, ng/ml 0 51 ± 16 a 52 ± 21 a 49 ± 20 a 48 ± 18 a
C-reactive protein, mg/l 0 372 ± 50 a 322 ± 50 b 325 ± 45 b 324 ± 35 b
N-telopeptide, nM 1 142 ± 37 a 142 ± 25 a 161 ± 44 a 166 ± 46 a
Whole Blood
Hemoglobin, g/l 0 143 ± 6 ab 145 ± 5 b 138 ± 6 a 143 ± 4 ab
Hematocri t, % 0 42 ± 2 a 42 ± 1 a* 40 ± 2 b 41 ± 2 ab <0.05
Oxidized Glutathione, µM 1 7 ± 3 a 9 ± 4 a 10 ± 5 a 9 ± 5 aOxidized/Reduced 
Glutathione Ratio 1 73 ± 35 a 61 ± 15 a 67 ± 21 a 53 ± 42 aRBC Glutathion 
Peroxidase, U/g hgb 0 507 ± 22 a 484 ± 26 a 498 ± 27 a 481 ± 22 a <0.05RBC Glutathione 
Peroxidase, U/ml 0 72 ± 2 a 70 ± 3 ab 69 ± 2 b 69 ± 2 b* <0.05
RBC Folate, ng/ml 0 936 ± 66 942 ± 59 978 ± 54 899 ± 81 
Plasma
Iron, µmol/l 1 25 ± 6 a 32 ± 7 ab 34 ± 12 b 47 ± 10 c* <0.01* <0.001*
Copper, µmol/l 0 15 ± 2 a 16 ± 1 a 15 ± 2 a 16 ± 2 a
Selenium, µmol/l 0 7 ± 1 a 7 ± 1 a 6 ± 1 a 6 ± 1 a
Zinc, µmol/l 0 21 ± 3 a 22 ± 4 a 25 ± 4 a 24 ± 4 aSuperoxide dismutase, 
U/ml 0 22 ± 10 a 22 ± 4 a 19 ± 6 a 22 ± 6 a
Catalase, nmol/min/ml  § 1 41 ± 14 a 54 ± 15 ab 41 ± 9 a 70 ± 23 b* <0.001*Total  antioxidant 
capacity, mmol/l 0 1.2 ± 0.1 a 1.2 ± 0.1 ab 1.1 ± 0.0 b 1.1 ± 0.1 ab <0.05
Heme, µmol/l 2 18 ± 3 a 21 ± 6 a 21 ± 6 a 20 ± 5 a
a, b, c - di fferent letters  indicate the unadjusted pairwase comparison found a  s igni ficant 
di fference between groups , P <0.05. comparisons . 
* Remained significant after adjusting for multiple compariosns, § log transformed
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Table 14. Liver markers of iron status and oxidative stress. Mean ± SD. 
 
 
 
Outliers CON IRON RAD IRON+RAD Main Effect
Test . Diet Rad Inter
Catalase, µmol/mg 
protein 0 1.2 ± 0.3 a 1.2 ± 0.3 a 1.2 ± 0.3 a 1.3 ± 0.4 a
Copper, µg/g dry wt. 1 19 ± 2 a 19 ± 4 a 20 ± 3 a 19 ± 1 a
Glutathion Peroxidase, 
U/g protein 0 32 ± 4 a 38 ± 7 ab 34 ± 7 a 41 ± 7 b* <0.01*
Iron, µg/g dry wt. 0 621 ± 123 ab 728 ± 140 a 559 ± 106 b 758 ± 169 a* <0.01*
Selenium, µg/g dry wt. 0 4 ± 1 a 4 ± 1 a 4 ± 1 a 4 ± 1 a
Superoxide Dismutase, 
U/mg protein 2 64 ± 12 a 75 ± 16 a 74 ± 14 a 75 ± 17 a
Total  Antioxidant 
Capacity, mmol/g  protein 0 0.6 ± 0.1 a 0.7 ± 0.1 b 0.8 ± 0.1 b* 0.8 ± 0.1 b* <0.05
Total  Protein, mg/ml 0 12 ± 4 a 13 ± 3 a 11 ± 2 a 13 ± 3 a
Zinc, µg/g dry wt. 0 114 ± 12 a 105 ± 15 a 112 ± 13 a 112 ± 16 a
a, b, c - di fferent letters  indicate the unadjusted pairwase comparison found a  
s igni ficant di fference between groups , P <0.05. comparisons . 
* Remained significant after adjusting for multiple compariosns
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(P = 0.005). Liver GPX was positively correlated with liver iron for all groups (r=0.47, P 
= 0.006) (Figure 13). Radiation exposure increased serum ferritin (P = 0.007) and 
decreased alanine transaminase (ALT) (P = 0.002), erythrocyte GPX (P = 0.02), 
hematocrit (P = 0.03), and plasma total antioxidant capacity (TAC) (P = 0.03). There 
was a tendency for both aspartate transaminase (AST) and hemoglobin to be lower in the 
radiation-treated groups, but these did not reach statistical significance. Dietary iron and 
radiation had an interactive effect on liver TAC (P = 0.03), in that liver TAC increased 
in the IRON group relative to the CON group (P = 0.03), but dietary iron did not further 
increase liver TAC in the IRON+RAD group beyond that which occurred with radiation 
alone (RAD).  
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Figure 13. An increase in liver iron was correlated with an increase in liver glutathione 
peroxidase, indicating that oxidative load on the liver increased as a result of increased 
iron stores.  
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Both radiation exposure and a high-iron diet resulted in alterations to both 
cellular distribution and functional aspects of the immune system (Table 15). Diet and 
radiation had an interactive effect on leukocytes (P = 0.02). The percentage of 
leukocytes increased in the IRON group relative to the CON group (P = 0.003); 
however, diet had no significant effect in the radiation group (IRON+RAD relative to 
RAD).  
Radiation induced alterations to the immune cell subset percentages, including an 
increase in the granulocyte percentage (P = 0.001), a decrease in total lymphocyte 
percentage (P = 0.0009), and a reduction in percentage of CD4+ T cells (P < 0.0001) and 
an increase in percentage of CD8+ T cells (P < 0.0001), which corresponded to an 
overall decrease in the CD4+:CD8+ T-cell ratio (P < 0.0001). There was a significant 
correlation between serum ferritin and CD4+ T cells (r = -0.44, P = 0.01, Figure 14), 
CD8+ T cells (r = 0.45, P = 0.01), and the CD4+:CD8+ ratio (r = -0.45, P = 0.01). Diet 
had no main effect on these T-cell subset percentages. Generally the plasma 
concentrations of the inflammatory and adaptive immunity cytokines that were measured 
were not altered. However, radiation did decrease the plasma concentration of TNFα    
(P = 0.03), which was decreased in the IRON+RAD group relative to CON and IRON. 
As a measure of functional capability, cytokine production was determined after 
T-cell stimulation via triggering of the TCR and co-stimulation (anti-CD3/CD28). 
Radiation induced a significant stimulatory effect on T-cell cytokine production. 
Cytokines IL-6 and TNFα both increased as a result of radiation after co-stimulation 
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Figure 14. An increase in serum ferritin concentrations was correlated with a decrease in 
CD4+ T cells, indicating that an inflammatory response was affecting T-cell distribution.  
 
with anti-CD3/CD28 (P = 0.002; P = 0.009). Production of IL-10 and IL-4 after co-
stimulation showed an interactive effect (P <0.0001;
 
P = 0.02): a significant increase 
occurred in IL-10 and IL-4 production in the RAD group relative to the CON group 
(P < 0.0001; P = 0.006), but production of these cytokines in the IRON+RAD group was 
not significantly different from production in the CON or IRON group (P < 0.0001; P = 
0.02). The high-iron diet seemed to ameliorate the effect of radiation. However, after 
anti-CD3/CD28 stimulation, T-cell production of IL-2 actually decreased as a result of 
diet (P < 0.001) and was reduced to the greatest extent in the IRON+RAD group. 
Cytokine profiles were also determined after pan-leukocyte activation using a 
more powerful pharmacologic stimulus consisting of PMA (PKC activator) and 
ionomycin (calcium ionophore). A suppressive effect was observed after radiation. 
Radiation decreased IFNγ, IL-4, IL-6 and TNFα (P = 0.0005, P = 0.0005, P = 0.01;  
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Table 15. Immune markers. Mean ± SD. 
 
 
 
Outliers CON IRON RAD IRON+RAD Effect
Test . Diet Rad Inter
Leukocytes , 
count § 0 4 ± 1 a 7 ± 3 b* 3 ± 1 a 3 ± 1 a <0.05
Granulocytes , 
% 0 14 ± 12 a 13 ± 16 a 30 ± 5 b* 28 ± 12 b <0.01*
Lymphocytes , 
% 1 76 ± 18 a 90 ± 8 b* 68 ± 6 a 67 ± 11 a <0.001*
Monocytes , % 1 0.2 ± 0.1 a 0.4 ± 0.9 a 0.5 ± 0.8 a 0.6 ± 0.8 a
CD4+ T cel l s 0 62 ± 6 a 60 ± 4 a 53 ± 4 b* 51 ± 5 b* <0.001*
CD8+ Tcel l s 0 35 ± 8 a 37 ± 4 a 45 ± 4 b* 47 ± 6 b* <0.001*
CD4+/CD8+, 
ratio 0 2 ± 1 a 2 ± 0 ab 1 ± 0 b* 1 ± 0 b* <0.001*
T cel l  function 
CD4+ 0 7.0 ± 1.6 a 7.6 ± 2.5 a* 4.3 ± 2.4 b 6.4 ± 2.7 ab <0.05
T cel l  function 
CD8+ 0 1.9 ± 0.6 a 1.7 ± 0.5 a 1.2 ± 0.9 a 1.8 ± 1.3 a
Plasma Concentrations
IFNγ, pg/ml  
plasma 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 †
IL-10, pg/ml  
plasma 0 0.2 ± 0.5 0.3 ± 0.7 3.2 ± 6.2 0.1 ± 0.3 †
IL-1b, pg/ml  
plasma 0 15 ± 37 0 ± 0 2 ± 4 7 ± 15 †
IL-2, pg/ml  
plasma § 0 3 ± 2 a 8 ± 11 a 6 ± 5 a 9 ± 10 a
IL-4, pg/ml  
plasma 0 0.2 ± 0.4 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 †
IL-6, pg/ml  
plasma § 0 8 ± 13 a 21 ± 42 a 22 ± 27 a 6 ± 11 a
Tnfα, pg/ml   
plasma § 0 4 ± 4 a 10 ± 11 a 7 ± 10 ab 1 ± 1 b <0.05
Anti CD3/CD28
IFNγ, pg/ml  
supernatant 0 3.9 ± 8.0 1.3 ± 3.7 53.7 ± 56.8 4.7 ± 12.0 †
IL-10, pg/ml  
supernatant § 0 4 ± 4 a 3 ± 1 a 88 ± 95 b* 3 ± 4 a <0.001*
IL-1b, pg/ml  
supernatant § 0 2 ± 4 a 1 ± 2 a 22 ± 25 a 14 ± 25 a
IL-2, pg/ml  
supernatant § 0 28 ± 13 a* 16 ± 5 a 58 ± 53 a* 9 ± 13 b <0.001*
IL-4, pg/ml  
supernatant § 0 0.2 ± 0.2 a* 1.7 ± 3.8 a 5.3 ± 5.5 b 1.1 ± 2.0 a* <0.05
IL-6, pg/ml  
supernatant § 0 62 ± 44 a* 45 ± 36 a* 1,525 ± 1,849 b 927 ± 1,233 ab <0.01*
Tnfα, pg/ml  
supernatant § 0 3.6 ± 4.2 a 2.4 ± 1.2 a 45.0 ± 43.8 b* 7.3 ± 8.8 a <0.01*
PMA/Ionomycin
IFNγ, pg/ml  
supernatant 1 81 ± 26 a* 65 ± 40 a*c 18 ± 7 b 38 ± 36 bc <0.001*
IL-10, pg/ml  
supernatant  § 0 27 ± 39 a* 10 ± 26 b 5 ± 4 ab 12 ± 16 a <0.01*
IL-1b, pg/ml  
supernatant 0 13 ± 19 10 ± 20 0 ± 0 0 ± 1 †
IL-2, pg/ml  
supernatant 0 857 ± 330 a 471 ± 229 b* 259 ± 75 b* 428 ± 394 b* <0.05*
IL-4, pg/ml  
supernatant § 0 3 ± 3 a 1 ± 1 ab 0 ± 0 b*c 0 ± 0 c* <0.001*
IL-6, pg/ml  
supernatant § 0 255 ± 287 a 162 ± 346 ab 34 ± 23 b* 53 ± 39 b <0.05*
Tnfα , pg/ml  
supernatant § 0 37.0 ± 54.4 a 12.3 ± 16.4 ab 4.7 ± 4.0 b* 5.2 ± 4.2 b* <0.001*
LPS
IFNγ, pg/ml  
supernatant§ 0 12 ± 21 a 0 ± 0 c* 10 ± 13 b 3 ± 3 ab <0.01* <0.001*
IL-10, pg/ml  
supernatant § 0 40 ± 16 a 23 ± 6 b 22 ± 7 b* 18 ± 13 b* <0.05* <0.01*
IL-1b, pg/ml  
supernatant 0 56 ± 10 a 60 ± 13 a 52 ± 9 a 47 ± 16 a
IL-2, pg/ml  
supernatant § 0 17.3 ± 12.2 a 10.6 ± 6.3 a 17.9 ± 11.8 a 9.4 ± 6.5 a
IL-4, pg/ml  
supernatant § 0 0.2 ± 0.2 a* 0.4 ± 0.9 a 0.7 ± 0.4 b 1.4 ± 1.8 b* <0.001*
IL-6, pg/ml  
supernatant 0 408 ± 187 a 322 ± 138 a 270 ± 98 a 338 ± 297 a
Tnfα, pg/ml  
supernatant 0 52 ± 15 a 58 ± 11 a 66 ± 12 a 57 ± 22 a
a, b, c - di fferent letters  indicate the unadjusted pairwise comparison found a  s igni ficant 
di fference between groups , P <0.05. 
* Remained s igni ficant after adjusting for multiple comparsons . § log transformed. 
†Insufficient s ignal  to run ANOVA.
Staphlyococcus Entertoxin
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P = 0.001). There was an interactive effect of diet and radiation for IL-10 and IL-2 
production (P = 0.01; P = 0.01). There was a significant decrease in IL-10 and IL-2 in 
the IRON group relative to the CON group (P = 0.007; P = 0.01) but no decrease in the 
IRON+RAD group relative to RAD. IL-2 decreased in both RAD and IRON+RAD 
relative to CON (P < 0.0001; P = 0.007). After monocyte stimulation with bacterial 
endotoxin (lipopolysaccharide, LPS), production of IFNγ and IL-10 was decreased with 
both high dietary iron and radiation exposure (P = 0.0002, P = 0.005; P = 0.006, P = 
0.02), whereas IL-4 production increased with radiation exposure (P = 0.0006). An 
increase in plasma iron was correlated with a decrease in IL-10 production after LPS 
stimulation (r = -0.54, P = 0.002, Figure 15).  
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Figure 15. An increase in plasma iron was correlated with a decrease in IL-10 
production after LPS stimulation, indicating that adaptive Th1 and Th2 responses to 
pathogens may be diminished after either radiation exposure or increased dietary iron. 
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The following data were collected and analyzed by the Turner lab group at Texas 
A&M University to determine independent and combined effects of exposure to gamma 
radiation and elevated body iron stores on functional indicators of the modification of 
colon bacteria by examining changes in short-chain fatty acid concentrations in feces. 
Furthermore, this data was collected to identify any alterations to expression of butyrate 
transporters, TLR and their downstream inflammatory mediators, and localized 
inflammatory state (i.e., myeloperoxidase (MPO) activity) in colon mucosa.  
Feces analysis showed significant changes in SCFA in response to dietary iron 
and radiation (Table 16). Both diet and radiation had significant main effects on SCFA; 
both treatments caused a decrease in total SCFA (P = 0.04), which was greatest in the 
IRON+RAD group relative to CON. Additionally, dietary iron decreased fecal butyric 
acid (P = 0.051), and dietary iron and radiation combined decreased isovaleric acid 
concentration (P = 0.05, P = 0.04).  
Dietary iron and radiation had significant effects on expression of selected gene 
targets in the scraped colon mucosa (Table 17). There was a reduction in expression of 
TLR9 (P < 0.001), TNFα (P = 0.001) and IL-6 (P < 0.001) with radiation exposure. 
Dietary iron decreased expression of TLR4 (P = 0.03) and TFF3 (P = 0.04). Expression 
of TNFα1b increased with dietary iron (P = 0.01) but decreased with radiation exposure 
(P < 0.001). Slc5a8 expression was affected by iron and radiation interactively (P = 
0.004). With a reduction in expression of Slc5a8 in the IRON group relative to the CON 
group, but no decrease as a result of diet in the IRON+RAD relative to the RAD 
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Table 16. Short chain fatty acids. Mean ± SD. 
 
 
 
  
 
 
 
group. MPO activity, an inflammatory marker in the colon mucosa, increased with 
radiation exposure (P = 0.04), with the IRON+RAD group being significantly higher 
than the CON group (P = 0.04, Table 17).  
Discussion 
The combined effects of increased dietary iron and radiation have implications 
for astronauts on long-duration space flights. Recent reports have documented a 
relationship between iron stores, oxidative damage, and bone health in astronauts (289), 
along with animal studies of radiation and bone health (290-292). We report here an 
animal model for the combined effects of iron and radiation, with implications for 
Outliers, no.; CON IRON RAD IRON+RAD Effect
Test transform . Diet Rad Inter
Acetic acid, 
µmol/g wet wt. 0 68 ± 18 a* 61 ± 15 ab 60 ± 18 ab 48 ± 11 b
Propionic acid, 
µmol/g wet wt. 0 23 ± 6 a* 20 ± 7 ab 20 ± 5 ab 15 ± 6 b
Isobutyric acid, 
µmol/g wet wt. 0 5 ± 1 a* 4 ± 1 ab 4 ± 1 ab 4 ± 1 b
Butyric acid, 
µmol/g wet wt. 0 19 ± 4 a* 16 ± 3 ab 16 ± 5 ab 14 ± 4 b
Isovaleric acid, 
µmol/g wet wt. 0 10 ± 1 a* 9 ± 2 ab 9 ± 3 ab 7 ± 2 b <0.05 <0.05
Valeric acid, 
µmol/g wet wt. 0 8 ± 1 a* 7 ± 1 ab 7 ± 3 ab 5 ± 2 b
Total  fatty 
acids , µmol/g 
wet wt. 0 134 ± 29 a* 116 ± 24 ab 116 ± 31 ab 93 ± 23 b <0.05 <0.05
a, b, c - di fferent letters  indicate the unadjusted pairwise comparison found 
a  s igni ficant di fference between groups , P <0.05. 
* Remained s igni ficant after adjusting for multiple comparisons .
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Table 17. Change in gene expression in colon relative to GAPDH [(2
^-Ct
)*1000] and MPO concentration. Mean ± SD. 
 
 
 
Outliers CON IRON RAD IRON+RAD Effect
Test . Diet Rad Inter
TLR2 0  1.39 ± 0.68 a  1.37 ± 0.71 a  1.27 ± 0.41 a  1.26 ± 0.42 a
TLR4 0  10.93 ± 2.69 a*  6.98 ± 1.14 b  11.18 ± 3.45 a*  10.63 ± 3.39 a <0.05
TLR5 0  4.23 ± 1.75 a  5.38 ± 2.94 a  4.70 ± 1.55 a  4.09 ± 2.21 a
TLR9 § 0  0.44 ± 0.25 a  0.65 ± 0.30 a  0.13 ± 0.06 b*  0.18 ± 0.15 b* <0.001*
MyD88 0  14.16 ± 2.54 a  11.99 ± 1.13 a  13.26 ± 2.33 a  12.27 ± 2.33 a
IκB 0  17.89 ± 4.10 a  16.89 ± 2.26 a  17.10 ± 4.01 a  15.26 ± 2.23 a
NFκB 0  22.24 ± 3.78 a  18.23 ± 1.45 b  20.16 ± 4.12 ab  19.70 ± 3.96 ab
TNFα § 0  0.42 ± 0.41 ac  0.83 ± 0.80 a  0.10 ± 0.15 b*  0.12 ± 0.10 bc <0.01*
TNFα1α § 0  20.15 ± 7.06 a  18.06 ± 4.01 a  17.78 ± 4.68 a  17.83 ± 2.55 a
TNFα1b § 0  1.35 ± 0.53 a  1.85 ± 0.50 b*  1.03 ± 0.21 a  1.17 ± 0.18 a <0.05* <0.001*
Tol l ip 0  8.86 ± 1.78 a  8.13 ± 0.83 a  8.18 ± 1.74 a  8.53 ± 1.19 a
Ripk1 0  8.46 ± 1.45 a  8.93 ± 1.09 a  8.86 ± 1.42 a  7.99 ± 0.85 a
Tff3 § 0  684.85 ± 97.83 a  564.48 ± 151.12 a  748.23 ± 259.02 a  596.01 ± 129.14 a <0.05
TGFβ 0  2.36 ± 0.92 a  2.93 ± 0.84 a  2.73 ± 0.83 a  2.29 ± 1.10 a
IL-1b § 0  0.32 ± 0.17 a  0.53 ± 0.39 a  0.32 ± 0.11 a  0.28 ± 0.11 a
IL-6 0  0.10 ± 0.04 ab  0.14 ± 0.05 a*  0.06 ± 0.02 b  0.06 ± 0.05 b <0.001*
Ptgs2 (COX-2) 0  1.62 ± 0.53 a  1.39 ± 0.39 ab  1.41 ± 0.41 ab  1.17 ± 0.35 b
Slc16a1 1  88.49 ± 14.16 a  85.91 ± 10.50 a  86.85 ± 12.60 a  81.77 ± 6.62 a
Slc5a8 0  30.43 ± 7.40 a  17.09 ± 3.30 b*  27.53 ± 5.39 a  27.84 ± 7.35 a <0.01*
.
Myeloperoxidase, 
U/mg 0 3,979 ± 1,752 a 4,239 ± 855 ab 4,789 ± 809 ab 5,333 ± 1,324 b <0.05
a, b, c - di fferent letters  indicate the unadjusted pairwase comparison found a  s igni ficant di fference between groups , P <0.05. 
* Remained s igni ficant after adjusting for multiple compariosns . § log transformed.
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hepatic and immune system function, and gastrointestinal health.  Studies such as these 
will be critical in understanding integrated physiological responses to space flight and 
ultimately in developing countermeasures to any pathologic adaptations, particularly in 
light of the emerging field of osteoimmunology, which links perturbations in immune 
health with bone loss (293). 
Iron status 
The relatively short-term high dietary intake of iron increased iron stores as well 
as liver iron content. Increased iron stores and liver iron content reflect an increase in 
total body iron, as has been shown in humans (294). This relationship is important 
because some of the markers of oxidative stress observed in this study are not limited to 
effects on liver tissue alone. In this study, liver iron increased 17% in the IRON group, 
the same percentage increase observed for body iron (estimated from ferritin and 
transferrin receptors) in the first 15-30 days of long-duration space flight (289).  
The increase in serum iron observed in the high-iron diet groups further indicates 
an increase in the iron load. Plasma iron was also increased in the radiation group, 
causing an additive effect in the IRON+RAD group, but liver iron (and thus total body 
iron) was not affected by radiation exposure. One remaining question pertains to the 
source of the increased serum iron shown to result from radiation. One possibility may 
be an inhibition of erythrocyte formation. It is known that hematopoietic stem cells are 
radiosensitive and are easily disrupted by radiation exposure (295). In this study, this 
phenomenon seems to have occurred in radiation-exposed animals as evidenced by 
lower hematocrit levels and decreased erythrocyte GPX. If radiation prevents new 
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erythrocytes from forming, then the age of circulating erythrocytes will increase and as a 
result, the cellular GPX will seem to decrease, which was observed in this study.  
Oxidative stress markers 
Increasing dietary iron increased iron status, and the increase was related to 
markers of oxidative stress. Liver iron was correlated with serum catalase (r=0.49, 
P=0.005), and both increased with high dietary iron. This relationship could be caused 
by an increase in oxidative stress from the increase in TBI or by liver damage, which is 
also known to increase serum catalase (296). Nonetheless, increasing dietary iron 
increased serum catalase, indicating that an increase in oxidative stress occurred as a 
result of high dietary iron. Liver iron was positively correlated with liver GPX (r=0.47, 
P=0.006; Figure 13), indicating that a greater oxidative load on the liver was associated 
with increased iron stores. Also supportive of potential liver damage or aging of the cell 
population was the decrease in liver enzymes (ALT, with a trend for AST) with radiation 
exposure. This ALT response to radiation has been observed in previous studies in 
which radiation doses ranged from 5 Gy to 25 Gy; the ALT response is dose-dependent 
for doses lower than 15 Gy (297). 
Radiation induced an acute-phase inflammatory response, as indicated by an 
increase in serum ferritin. In addition to being an iron storage protein, ferritin is also an 
acute-phase protein that is upregulated during an inflammatory response (298). C-
reactive protein (CRP), another acute-phase protein, did not increase in response to 
radiation. Ferritin significantly increased with radiation but not with dietary iron, 
indicating that the ferritin response was most likely due to inflammation resulting from 
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radiation exposure and not to increased iron load. The timing of any change in CRP 
expression may have been missed in this study with only one time point, or CRP may 
behave differently when the radiation dose is fractionated over 16 days (299-301). 
Systemic immune response 
The immunological monitoring for this study consisted of determining basic 
leukocyte distribution and plasma cytokine levels, to monitor both in vivo immune 
activation and various mitogen-stimulated cytokine production profiles and detect 
dysregulation of cellular functional capacity. The data indicated that the IRON group 
alone had an elevated leukocyte count but a normal subset distribution relative to the 
CON group. Both radiation groups, independent of diet, had an increase in granulocyte 
percentage, which may protect against radiation injury (302-303). Both radiation groups 
had a decrease in the total percentage of lymphocytes and a decrease in the T-cell 
CD4:CD8 ratio. The decrease in CD4+ T cells was expected because of the radiation 
dose given: 3 Gy. A ~10% decrease corresponded to ~3% per Gy (304). The decrease in 
CD4+ T cells also correlated with an increase in serum ferritin concentrations (r= -0.44 
p=0.01, Figure 14), indicating that a radiation-induced inflammatory response was 
affecting T-cell distribution.  
Alterations in plasma cytokine levels may indicate constitutive immune 
activation. After radiation treatment, the plasma concentration of TNFα was significantly 
reduced, and this response paralleled the observations from the colon mucosal cells (to 
be discussed later). Other studies have indicated that plasma TNFα increases after 
radiation exposure (305). This discrepancy could be due to the fractionated radiation 
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doses of 0.375 Gy, which is a lower single dose than is typically administered. Although 
it was not statistically significant because of the large error bar, TNFα increased in the 
IRON group to a magnitude similar to that observed by Tsay et al. (306) in their iron 
overload study. No further alterations occurred in the plasma levels of cytokines 
associated with inflammation or adaptive immune processes. 
The absence of constitutive immune activation may have diminished cellular 
functional capacity, resulting in an increased health risk. Previous studies showed that 
radiation alone has a negative effect on early blastogenesis of T cells but a positive effect 
on T-cell function in a murine model (307-308). For this study, whole-blood cultures 
were stimulated with cell-specific mitogen to produce in vitro cellular activation, and 
supernatant cytokine levels were measured as an indicator of functional capacity. 
Whole-blood culture is perceived to more closely represent in vivo conditions, as all 
potential cell-cell interactions are preserved and plasma soluble factors are present. 
T cells were stimulated by triggering the TCR and costimulatory molecule; these 
actions model in vivo activation via an antigen-presenting cell. Elevated dietary iron 
reduced T-cell IL-2 production, whereas radiation increased T-cell production of TNF 
and IL-6. The RAD group showed an increase in IL-4 and IL-10, but the IRON+RAD 
group negated this increase. This diet effect was not observed in the sham group. Thus, a 
high-iron diet seems to inhibit both constitutive immune functional responses and the 
elevated functional responses observed after radiation treatment. 
Radiation exposure resulted in demonstrable alterations in leukocyte cytokine 
production after mitogenic stimulation with PMA-I. This mitogen, consisting of a 
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phorbol ester/PKC activator and calcium ionophore, bypasses much of the signal 
transduction used by surface molecule mitogens, and is more powerful. Radiation 
resulted in decreased production of TNF, IL-6, IFN, and IL-4, a grouping that spans 
both inflammatory, Th1, and Th2 cytokine categories. The decrease in TNF and IL-6 in 
these cells, again, parallels the observations from the colon, suggesting that radiation has 
systemic as well as localized impacts on immune function. Production of some cytokines 
(IL-2 and IL-10) was also diminished in the IRON group compared to CON, although 
this diet effect was not observed when comparing the RAD and IRON+RAD group.  
 LPS generally serves as an activator of monocytes and B cells. After culture of 
whole blood in the presence of LPS, IL-10 and IFNγ production decreased with as a 
result of radiation exposure and high dietary iron. Production of IL-4 actually increased 
as a result of radiation exposure. Plasma iron concentration was negatively correlated 
with IL-10 after LPS simulation (r=-0.54, p=0.002; Figure 15). These data generally 
indicate that adaptive Th1 and Th2 responses (IFNγ and IL-10, respectively) to 
pathogens may be diminished after either radiation exposure or increased dietary iron. 
With respect to radiation exposure, however, the elevation in IL-4 production may be 
considered discordant with this conclusion. Diminished cytokine production profiles are 
consistent with recent reports of space flight-associated immune dysregulation in 
astronauts. 
“Colon responses” and “Colonic mucosa gene expression and inflammatory 
markers” sections were contributions by the Turner lab group at Texas A&M University. 
 
 125 
 
Colon responses 
The total concentration of all SCFA analyzed (acetic, propionic, isobutyric, 
butyric, isovaleric, and valeric acid) decreased in other groups relative to the CON 
group, with a maximum decrease occurring in the IRON+RAD group. Changes in the 
concentration of fecal SCFA could be caused by alterations in the bacterial populations 
and/or changes in bacterial metabolism after an increase in dietary iron or exposure to 
radiation. To our knowledge, no studies have shown an effect of high dietary iron or 
radiation on intestinal bacterial metabolism, although it is known that butyrate-producing 
bacteria strongly depend on iron as a cofactor for butyrate production (309). Independent 
studies have reported that radiation therapy (4.3-5.4 Gy) and dietary iron depletion 
variably promote and inhibit the microbiota, including taxa that are known butyrate 
producers (310-311). It has been reported that cecum SCFA concentrations and the 
proportion of butyrate-producing bacteria can be increased when iron-depleted animals 
are fed diets fortified with iron (311); however, no reports describe the effect of high 
dietary iron on the microbiota or bacterial metabolism. Another potential explanation for 
the observed reduction in fecal SCFA is an alteration in the absorption of SCFA into 
colonocytes, which was not directly assessed in this experiment. However, we observed 
alterations in gene expression of SCFA transporters (described below), which may 
contribute to the observed fecal SCFA concentrations. 
Colonic mucosa gene expression and inflammatory markers 
Exposure to genotoxic stress, including ionizing radiation and oxidative ROS, 
can initiate physiological responses in the intestine such as cell cycle arrest, diminished 
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epithelial integrity, inflammatory infiltration, altered gene transcription, and a perturbed 
luminal environment by variably suppressing or supporting the growth of certain 
bacterial populations (310, 312-321). The mucosal surface of the small and large 
intestine has shown increased propensity for radiation-induced mucosal injury because 
of its high proliferative capacity (312). Thus, we were interested in understanding the 
effect of high dietary iron and gamma radiation exposure on gene expression in colonic 
mucosa for pathways associated with microbial signaling, SCFA transport and repair. 
SCFA are absorbed from the lumen passively through ionic diffusion, or through 
transporters such as Slc16a1 and Slc5a8 (322-323). We observed a significant decrease 
in expression of Slc5a8 in the IRON group relative to the other three groups, whereas 
Slc16a1 demonstrated minimal changes with either treatment. The highest Slc5a8 and 
Slc16a1 expression and SCFA concentration observed in the CON group may have 
resulted from the same effects that induce the reported promotion of Slc16a1 expression 
in a colonic epithelial cell line, where increased butyrate concentrations upregulated 
Slc16a1 mRNA and protein levels (322). A decrease in SCFA production and absorption 
could be detrimental to astronauts’ gastrointestinal health, as these metabolites have 
been reported to have pleiotropic effects on colonocytes, including anti-inflammatory 
activity, the induction of gene expression, cellular differentiation, apoptosis, cell cycle 
arrest, and interference with transcription factors critical for proinflammatory cytokine 
production (62, 324-328). 
Expression of four gene targets involved in bacterial recognition and 
inflammatory responses was reduced by radiation exposure. These targets were TLR9 (a 
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bacterial recognition receptor), TNFα (a cytokine involved in systemic inflammation) 
and its receptor, TNFα1b, and IL-6 (an interleukin with both proinflammatory and anti-
inflammatory effects). Additionally, TLR4 and TFF3 expression decreased when rats 
were exposed to high dietary iron. The gene expression patterns indicate that changes 
occurred in the bacterial recognition signaling pathway (TLR) as a result of dietary iron 
and radiation, although the treatments had differential effects on mediators of this 
pathway. Observed effects on TLR expression could also be attributed to changes in the 
composition of the intestinal microbiota, compromised barrier integrity, or a chronic 
inflammatory state, all of which have been documented to alter expression of these 
receptors (329-331). In this study, suppressed luminal SCFA concentrations may 
indicate that the microbiota was altered by radiation exposure and high dietary iron, 
which could have contributed to the differential effects on TLR4 and TLR9 expression. 
Microbial-derived signaling through pattern-recognition receptors affects gene 
expression, transepithelial electrical resistance, and colonocyte proliferation in normal 
tissues (332), and plays a pivotal role in maintaining homeostasis between commensal 
microbiota and the host immune system (333). Alterations in the TLR signaling pathway 
directly affect the immune response, specifically through downstream activation of the 
transcription factor NF-κB (334). NF-κB activation alters expression of localized 
cytokines (IL-1β, IL-10, IL-6, TNF, IFNγ, and TGFβ) and proinflammatory molecules 
(COX-2) during an inflammatory response (261). Although we did not observe a 
significant diet or radiation effect on expression of NF-κB or other proteins mediating 
the TLR signaling cascade, we did observe a significant radiation effect on TNFα and 
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IL-6 expression. Additionally, we observed a significant main effect of diet and radiation 
on TNFα receptor 2 expression (TNFα1b), with significantly upregulated expression in 
IRON rats. TNFα1b signaling is known to activate the transcription of proinflammatory 
cytokines through NF-κB (335), which could be one explanation for significant 
upregulation of IL-6 and upregulation of IL-1b and TNFα expression in IRON animals 
relative to other groups. 
Radiation, in addition to having significant effects on expression of inflammatory 
cytokines IL-6 and TNFα, induced an increase in MPO concentrations in colon mucosa. 
MPO, a biomarker of inflammation, is an enzyme found in neutrophils that conjugates 
bactericidal compounds in the phagosome (336). Increased infiltration of neutrophils 
into the epithelium occurs in response to an immune challenge, which could explain the 
observed increase in mucosal MPO concentration in IRON, RAD and IRON+RAD 
animals in this study. The inflammation may result from the increased presence of ROS 
in the lumen and in the epithelial cells after radiation or from elevated exposure to 
oxidants. Additionally, if the epithelial barrier is compromised by these environmental 
stresses, bacteria and antigens could translocate through the epithelial membrane and be 
responsible for an increased infiltration of neutrophils and activation of inflammatory 
mechanisms (317, 320). In this study we observed a significant diet effect on expression 
of Trefoil factor 3 (TFF3), which is a protein expressed on the apical side of the 
intestinal epithelial barrier and reported to be involved in epithelial repair and cellular 
migration (337). An effect of dietary iron on expression of TFF3 could suggest that the 
luminal environment, specifically a high oxidant-load diet, may have an effect on 
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epithelial repair or barrier restitution after injury. Persistent inflammation by aberrant 
TLR signaling, upregulated expression of cytokines such as IL-6, or infiltration of 
neutrophils into the mucosa can have numerous deleterious effects and increase 
oxidative stress, which can cause oxidative DNA adducts (338) and nitrative DNA 
lesions (339). Also, as mentioned previously, chronic inflammation and dysbiosis of the 
intestinal microbiota is known to persist in intestinal diseases such as inflammatory 
bowel disease and could increase an astronaut’s risk of colorectal cancers (267-269). 
Moreover, the local colonic inflammatory responses to diet and radiation may further 
stimulate the systemic alterations in immune function and cytokines discussed earlier. 
Conclusion 
 Increased iron status and radiation exposure combined lead to oxidative stress, 
immune system dysregulation, alterations of colon microbial metabolism, and changes in 
intestinal gene expression. Radiation exposure consistently induced dysregulation of 
both leukocyte distribution and functional capacity of the immune system. To a lesser 
degree, the elevated iron diet also negatively influenced immunocyte functional 
responses, at times in an interactive fashion with radiation exposure. Significant 
radiation effects on localized mucosal cytokine expression (TNFα and IL-6) and reduced 
levels of the same cytokines in circulation could indicate that the intestinal tract, which 
harbors the largest and most complex immune cell population in the body, could have an 
effect on systemic inflammatory responses after radiation exposure. Astronauts are 
exposed to both increased iron stores and radiation during flight, and this exposure raises 
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concerns about crew health. These concerns will be greater on exploration missions 
beyond low Earth orbit, with longer durations and greater exposure to radiation.  
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CHAPTER V 
IMPLICATIONS OF THE SPACE ENVIRONMENT ON INTESTINAL 
HOMEOSTASIS: CHARACTERIZING ALTERATIONS TO THE INTESTINAL 
MICROBIOTA AND MUCOSAL ENVIRONMENT 
 
Introduction 
Spaceflight exposes astronauts to environmental inputs that are different from 
that on earth including a typically elevated iron diet, microgravity, and radiation 
exposure. NASA is concerned with the health risks associated with these environmental 
insults, particularly radiation exposure, as they have been shown to have deleterious 
effects on numerous organ systems, and increase the risk of heart disease, cataracts, and 
can cause bone loss (340-342).  
Linear energy transfer (LET), or the amount of energy that is transferred to a 
substance as the radiation passes through, impacts the extent of radiation exposure on 
biological systems (118). Low LET radiation, such as gamma and x-rays, is more likely 
to have indirect effects on cells through the formation of free radicals (e.g., H•, •OH, 
H2O2, and e
-
aq ), while high LET radiation will directly damage cellular components 
(118, 125). Both high and low LET radiation exposure can compromise plasma and 
organelle membrane integrity and cause DNA damage (i.e., base loss, base modification, 
single or double strand break, and the formation of dimers) (21, 118, 125). Once a cell 
becomes irradiated (directly or indirectly) the outcome can be mutations, division delay, 
cellular arrest, and transformation to a possibly carcinogenic cell (21, 119). 
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Reactive oxygen species are generated within cells immediately after exposure to 
radiation and could be exacerbated by other environmental factors, including nutrient 
status.  For example, oxidative stress can a be propagated in the intestine by 
consumption of a diet containing pro-oxidants, such as excess iron, which increases the 
risk of forming cytotoxic compounds and free radicals (343). Deleterious effects to the 
intestinal tract have been documented with increased dietary iron such as barrier 
damage, hyperproliferation, downregulating repair mechanisms, as well as altering the 
microbiota and luminal concentration of short chain fatty acids (SCFA) (111-113).  
Very little research has been done to understand the effect of lose dose radiation 
exposure (<1 Gy) and microgravity on the luminal environment and intestinal epithelium 
function. Previous studies looking at large doses of radiation (>8 Gy) have demonstrated 
exposure can cause detrimental effects such as direct mucosal toxicity, delayed gastric 
emptying and secretion, and villous shortening (21-22, 120, 129, 344). Additionally, 
preliminary studies have indicated that radiation exposure can affect the intestinal 
microbiota, and the presence and composition of these commensal bacterial groups has 
an effect on radiation induced-lethality (114, 130, 133, 137, 345). Furthermore, our lab 
group has reported that consumption of a diet with elevated dietary Fe, by itself and in 
combination with low LET radiation exposure can alter the concentration of fecal SCFA, 
suggesting alterations to the composition of the intestinal microbiota or a functional 
change in microbial metabolism. An understanding of how the aforementioned 
environmental insults affect the microbiota is of utmost importance, as alterations to 
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commensal bacterial groups have been implicated in the onset and recurrence of chronic 
intestinal inflammation and gastrointestinal diseases (172-173).  
Mitigating the effects of oxidative stress caused by radiation exposure and 
elevated dietary iron are important areas of research, as no current countermeasures have 
been thoroughly studied. Moreover, results from this research would also benefit not 
only astronauts, but others exposed to radiation sources such as medical diagnostic tests, 
occupational radiation exposure, and doses encountered by airline crews. To our 
knowledge, no study has characterized the effect of fractionated, low doses (<1-3 Gy) of 
both low and high LET radiation exposure in combination with microgravity on the 
luminal environment and intestinal epithelium. We hypothesized that the space 
environment will alter the microbiota and intestinal epithelium, and that a differential 
response will be observed in these bacterial populations and the mucosal environment 
following each insult (i.e., high Fe diet, received radiation dose (high vs. low LET) and 
weightlessness (HLU and spaceflight)). Therefore the aim of this study was to describe 
the effect of 1) low LET radiation exposure and high Fe diet, 2) simulated lunar 
microgravity and high LET radiation exposure, and 3) short term spaceflight, on the 
intestinal microbiota, mucosal expression of gene targets associated with microbial 
signaling and epithelial repair, and measurements of colonic injury and inflammation.  
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Materials and Methods 
Animals and diets 
Experiment 1 fractionated low LET gamma radiation and high dietary iron in rats   
Astronauts total body iron stores are increased following space flight.  Excess 
iron stores, in combination with radiation exposure during space flight, can cause 
oxidative stress and increase the risk of health problems including cancer. 
 Thirty two, 12 week old, male Sprague-Dawley rats were acclimated to an 
adequate iron diet (45 mg iron (ferric citrate)/kg diet) for 3 wk and then assigned to one 
of four groups: adequate Fe diet/no radiation (CON), adequate Fe diet/radiation (RAD), 
high Fe diet (650 mg iron (ferric citrate)/kg diet)/no radiation (IRON), and high Fe 
diet/radiation (IRON+RAD). Animals received the assigned diet for 4 wk. On d 14 of 
the experiment, animals were exposed to a 0.375 Gy fractionated radiation dose of Cs-
137 every other day for 16 d (3 Gy total dose). Animals in both the sham and radiation 
groups were placed in a restraint tube (Battelle, Geneva, Switzerland) for about 10 min 
per session to be either irradiated or sham treated. On day 29 (24 h after last radiation 
exposure), animals were euthanized using isoflourane vapor. The colon was resected, 
feces removed, and colonic mucosa scraped. The aim of Experiment 1 was to 
characterize fecal bacterial populations using amplification and 454 pyrosequencing of 
bacterial 16S rDNA. 
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Experiment 2 high LET silicon particle exposure and hind limb unloading (HLU) (1/6 G) 
in mice 
During space flight astronauts are exposed to galactic cosmic radiation (GCR) 
and low gravity environments. Partial gravity (1/6 G) will be experienced while on the 
lunar surface, and little is known regarding the effect of partial gravity and high LET 
radiation exposure on the GI tract. 
 Twenty-eight, 3 mo old, female BalbC/ByJ mice were acclimated to single 
housing conditions and a standard chow diet for 14 d. After acclimation, half of the 
animals were suspended in cages by the tail and shoulders. The suspension spring was 
adjusted to only allow for 1/6 weight bearing (LUN) on all four limbs as described 
previously (346). The remaining animals served as full weight bearing (WB) controls. 
Half of the LUN and WB were exposed to one dose of high LET 300 MeV ionizing 
silicon (50 cGy), simulating GCR, at Brookhaven National Laboratory, NY. All animals 
were euthanized 21 d following radiation (RAD) exposure by decapitation. The colon 
was resected, feces removed, and the colonic mucosa scraped. The aim of Experiment 2 
was to 1) Characterize fecal bacterial populations using amplification and 454 
pyrosequencing of bacteria 16S rDNA and 2) analyze alterations in the expression of 
genes involved in microbial signaling and tissue repair. 
Experiment 3 combined high LET and low LET radiation exposures and microgravity 
conditions during short term space flight in mice 
 Fourteen, 49 day old, female C57BL/6 mice were acclimated to standard mouse 
diet and water for 2 wk. All animals were then loaded into animal enclosure module’s 
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(AEM) and given ad libitum access to food and water for the remainder of the study. 
Half of the animals were flown on Atlantis shuttle mission STS-135 for a period of 13 d. 
Following landing (3-7 hr), all animals were anesthetized by isoflurane gas and 
euthanized by decapitation. The colon was resected, feces removed, and a 1 cm section 
was removed for histological preparations and the remainder was scraped. The aim of 
Experiment 3 was to 1) Characterize fecal bacterial populations using amplification and 
454 pyrosequencing of bacteria 16S rDNA, 2) characterize alterations to gene expression 
in genes involved in microbial signaling and tissue repair, and 3) assess colonic 
epithelial injury and inflammation. 
Sample collection and processing 
Scraped mucosa 
After fecal material was removed, the colon was washed twice in RNase free 
Phosphate-Buffered Saline (PBS) and scraped on a chilled RNase free surface. 
Experiment 1 & 2. Mucosa was transferred to an RNase free homogenization 
tube along with 500 l of Denaturation Solution (Ambion, Austin, TX), homogenized by 
pipetting 6-7 times, snap frozen, and then stored at -80°C.  
Experiment 3. Mucosa was transferred to an RNase free homogenization tube 
along with 500 l of RNAlater (Ambion, Austin, TX), snap frozen, and then stored at -
80°C.  
Feces collection and microbial DNA isolation 
Upon resection of the colon at termination, fresh fecal samples were collected 
immediately, transferred to sterile cryotubes, snap frozen, and then stored at -80°C. 
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DNA was isolated from homogenized fecal samples using a FastDNA SPIN kit 
according to the manufacturer’s instructions (MP Biomedicals, Solon, OH) (Appendix 
B). Purified DNA was stored at -80°C. A negative control containing H2O instead of 
sample was purified in parallel to each set of extractions to screen for contamination of 
extraction reagents.   
 Experiment 1 & 3. Bacterial DNA isolated from each sample was used for 
pyrosequencing and further phylogenetic analysis (described below). 
Experiment 2. An aliquot of extracted bacterial DNA was taken from each 
animal and combined into a composite sample for each experimental group for 
pyrosequencing and further phylogenetic analysis (i.e., WB/sham irradiated (SHAM); 
WB/RAD; LUN/SHAM, and LUN/RAD). 
Inflammation and injury histological scores 
A 1 cm segment was removed from the distal end of the colon and fixed in 70% 
EtOH solution prior to embedding in paraffin. The degree of inflammation and 
morphological injury was assessed by H&E staining. Histologic examination was 
performed in a blinded manner by a board-certified pathologist, and the degrees of 
inflammation (score of 0–3) and epithelial injury (score of 0–3) in microscopic cross 
sections of the colon were graded as described previously (150) (Appendix B).  
Measurement of gene expression using real-time PCR 
Total RNA was isolated from scraped mucosal samples using Phase Lock Gel™ 
tubes (5 Prime, Gaithersburg, MD) and the ToTALLY RNA™ Kit or RNAqueous® kit 
(Ambion, Austin, TX) followed by DNase treatment (DNA-free™ Kit, Ambion, Austin, 
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TX). RNA quality was assessed using an Agilent Bioanalyzer prior to storage at -80°C. 
First strand cDNA was synthesized using random hexamers, oligo dT primer (Promega, 
Madison, WI), and Superscript™ III Reverse Transcriptase following manufacturer’s 
instructions (Invitrogen, Carlsbad, CA).  
Real-time PCR was performed on select genes (TFF3, Slc16a1, IL-6, IL-1β, 
TNFα, SLC5A8, TGFβ, TLR9, TLR4, TLR2, MyD88, NF-κB, COX-2) using Taqman® 
Array Plates (Applied Biosystems, Foster City, CA) and a ABI 7900 HT thermocycler 
(Applied Biosystems, Foster City, CA) (Assay IDs for all primers compiled in Appendix  
B). To screen for potential contamination of PCR reagents, a negative PCR control of 
H2O instead of cDNA template was used. Expression levels were normalized to GAPDH 
gene expression for Experiment 1, and 18S gene expression in Experiment 2 and 3. 
16S rRNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) 
Initial amplification of the V1-V2 region of the bacterial 16S rDNA was 
performed on total DNA isolated from fecal samples. Master mixes for these reactions 
used the Qiagen Hotstar Hi-Fidelity Polymerase Kit (Qiagen, Valencia CA) with a 
forward primer composed of the Roche Titanium Fusion Primer A (5’-
CCATCTCATCCCTGCGTGTCTCCGACTCAG -3’), a 10 bp Multiplex Identifier 
(MID) sequence (Roche, Indianapolis, IN) unique to each of the samples, and the 
universal bacteria primer 8F (5'-AGAGTTTGATCCTGGCTCAG-3') (199). 
Incorporation of MID sequences to the PCR amplicons essentially “barcodes” samples 
and allow for multiplexed assays. Samples are pooled prior to the pyrosequencing 
reaction. The reverse primer was composed of the Roche Titanium Primer B                                                                                                   
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(5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG -3’), the identical 10 bp MID 
sequence as the forward primer and the reverse bacteria primer 338R (5’-
GCTGCCTCCCGTAGGAGT-3’) (200) which span the V1-V2 hypervariable region of 
the bacterial 16S rDNA.  The thermal profile for the amplification of each sample had an 
initial denaturing step at 94°C for 5 minutes, followed by a cycling of denaturing of 
94°C for 45 seconds, annealing at 50°C for 30 seconds and a 90 second extension at 
72°C (35 cycles), a 10 minute extension at 72°C and a final hold at 4°C.  Each sample 
was individually gel purified using the E-Gel Electrophoresis System (Life 
Technologies, Invitrogen).  To ensure equal representation of each sample in the 
sequencing run, each barcoded sample was standardized by calculating equimolar 
amounts prior to pooling. Pooled samples of the 16S rDNA multiplexed amplicons were 
sequenced on a Roche 454 Genome Sequencer  FLX Titanium instrument (Microbiome 
Core Facility, Chapel Hill NC) using the GS FLX Titanium XLR70 sequencing reagents 
and protocols.   
bTEFAP data analysis 
Analysis of deep sequencing data was carried out using the QIIME pipeline 
(201). Briefly, the combined raw sequencing data plus metadata describing the samples 
were de-multiplexed and filtered for quality control. Next, data were denoised using 
Denoiser software as described previously (202).  Chimeric sequences were depleted 
from the trimmed data set using Chimera Slayer (203). Sequences were grouped into 
OTUs (Operational Taxonomic Units) at a 97% level to approximate species-level 
phylotypes using Uclust (204). OTU sequences were aligned and OTU tables containing 
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the counts of each OTU in each sample were used to calculate mean species diversity of 
each sample (alpha diversity) and the differentiation among samples (beta diversity). 
Alpha and beta diversity measures were used to calculate a Chao species richness 
estimate and a Shannon Weaver diversity index for each OTU. To evaluate the 
similarities between bacterial communities a combination of Unifrac significance, 
principal coordinate analysis (PCoA) using Fast Unifrac (205) and network analysis 
(206-207) were performed to compare samples based on sample time and treatment. 
ANOVA, the G test of independence, Pearson correlation, or a paired t-test were used 
within Qiime to identify OTUs that are differentially represented across experimental 
treatments or measured variables.  
Statistical analysis  
Data were analyzed using two-way analysis of variance (ANOVA) or one sample 
ttest (TTEST) in SAS 9.1 (SAS Institute, Inc.) considering a p-value of <0.05 as 
significant. Data sets from Experiment 3 that were not normally distributed were 
analyzed using Kruskal-Wallis test considering a p-value of <0.05 as significant.  
Results 
Experiment 1  
Body weight and experimental diet intake 
 Neither high dietary iron nor the radiation exposure changed body mass or food 
intake (data not shown). 
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Microbial taxonomic structure analysis 
The number of OTUs classified in the Bacteroidetes phylum were numerically 
elevated and OTUs in the Firmicutes phylum were significantly lower in the RAD group 
compared to CON (p=0.0392) (Table 18). IRON rats had a numerically increased 
proportion of OTUs classified as Bacteroidetes (17%) and decreased proportion of 
Firmicutes (31%) compared to CON. Upon further phylogenetic classification we 
observe a significant radiation effect on the Lactobacillales and Clostridiales orders 
(p=0.03 and p=0.02, respectively) (Table 18 & Figure 16). The proportion of OTUs 
classified in the Lactobacillales order was numerically higher in RAD and IRON+RAD 
compared to sham irradiated rats, with IRON+RAD having a significantly higher 
proportion compared to CON and IRON (p<0.05). Additionally, radiation exposure 
numerically decreased the proportion of OTUs classified in the Clostridiales order for 
both experimental diets, with CON having significantly higher proportion compared to 
RAD and IRON+RAD. In general, radiation exposure had a significant effect on the 
proportion of Unknown OTUs in the Bacteroidetes phylum (p=0.0324) with 
IRON+RAD having significantly higher Unknown OTUs (p<0.05) compared to CON, 
RAD, and IRON groups (Table 18). 
Diversity and species richness comparisons 
We observe no significant differences in species diversity (Shannon Weaver 
index) across all experimental groups (Table 19). Species richness (Chao index) was 
numerically higher in IRON+RAD rats compared to CON and RAD groups, and 
significantly higher than IRON rats (p=0.033, Table 19). 
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Mucosal gene expression 
 Gene expression of gene targets associated with TLR signaling pathways, 
epithelial repair, and SCFA transporters were assessed in a previous study (Chapter IV). 
 
 
 
 
 
 
 
Figure 16. Phylogenetic classification of OTUs (%) at the order level from Experiment 
1. The proportion of OTUs classified in the Lactobacillales order was significantly 
higher in IRON+RAD compared to CON and IRON (p<0.05). The proportion of OTUs 
classified in the Clostridiales order was significantly higher in CON compared to RAD 
and IRON+RAD (p<0.05). Actual values in Table 18. 
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Table 18. Phylogenetic classification of OTUs (%) from Experiment 1. 
 
 
 
 
 
Phylum Family Order CON (N=8) RAD (N=8)  IRON (N=8)
IRON+RAD 
(N=8) Diet Radiation
Diet*  
Radiation
Bacteroidetes 55.18±5.88a 68.82±4.22a 66.30±4.65a 64.26±5.77a
Bacteroidia Bacteroidales 45.33±7.04a 58.27±5.90a 57.68±4.26a 43.06±9.53a 0.057
Unknown Unknown 9.86±1.89a 10.55±2.29a 8.62±1.36a 21.20±4.90b 0.032 0.053
Firmicutes 39.55±5.62b 25.41±3.67a 27.46±3.41ab 29.25±4.70ab
Bacilli Lactobacillales 0.1±0.03a 3.30±0.28ab 0.08±0.03a 6.05±0.27b 0.03
Clostridia Clostridiales 37.56±5.20b 21.19±3.06a 26.64±3.58ab 21.54±4.44a 0.02
Erysipelotrichi Erysipelotrichales 1.27±0.67a 0.37±0.10a 0.31±0.12a 1.33±0.85a
Unknown 1.85±0.17a 2.31±0.36a 2.54±0.47a 2.52±0.40a
Unassignable 2.94±0.22a 3.09±0.22a 3.44±0.86a 3.48±0.60a
Data are LS mean±SEM
Means without common superscripts differ (p<0.05)
Experiment 1
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 Table 19. Chao and Shannon Weaver indices for Experiment 1. 
 
 
 
CON (N=8) RAD (N=8) IRON (N=8)
IRON+RAD 
(N=8)
Shannon Weaver 2.7±0.11a 2.62±0.23a 2.67±0.23a 3.12±0.32a
Chao 68.19±2.49ab 67.22±5.15ab 62.7±4.24a 80.44±8.63b
Data are LS means ±SEM.
Means without common superscripts differ (p<0.05).
Experiment 1
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Experiment 2  
Microbial taxonomic structure analysis  
As an initial analysis of the effect of weightlessness and high LET radiation on 
the intestinal microbiota, aliquots of extracted microbial DNA from each animal was 
combined into a composite sample for each experimental group (i.e., WB SHAM, WB 
RAD, LUN SHAM, LUN RAD) and bacterial populations were phylogentically 
classified (Appendix A-6). Compared to WB SHAM, we observe an increase in OTUs 
classified in the Bacteroidetes phylum and decrease in the Firmicutes phylum in WB 
RAD (Figure 17A). When comparing SHAM and RAD groups within each 
environmental treatment (WB vs LUN), we observe differential effects of radiation 
exposure on the predominant phyla. RAD increased Bacteroidetes and decreased 
Firmicutes in WB, yet the inverse was observed in LUN RAD mice. Further taxonomical 
classification at the order level revealed the majority of OTUs classified in the 
Bacteroidetes phylum were Unknown (Other) at the order level (Figure 17B, Appendix 
A-6). In WB mice (SHAM and RAD groups) we observe a large proportion of OTUs 
classified in the Lactobacillales order (38-40%) and lower proportion classified in the 
Clostridiales order (10-13%) (Figure 17B). In contrast, LUN mice (SHAM and RAD 
groups) had high proportions in Clostridiales (33-38%) and low proportions in 
Lactobacillales order (3-7%).  
Diversity and species richness comparisons 
We observe little differences in bacterial diversity across all experimental groups, 
with LUN SHAM and LUN RAD mice having numerically higher indices than WB mice 
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(Table 20). RAD increases bacterial species richness in both WB and LUN groups (27% 
and 21%, respectively) with the greatest richness observed in LUN RAD mice (90.94).  
 
Table 20. Chao and Shannon Weaver indices for Experiment 2. 
 
 
 
 
 
 
 
Mucosal gene expression 
We do not observe a significant effect of diet or treatment on relative expression 
of any gene targets analyzed, or any significant differences between any experimental 
groups (Table 21). We observed a numerical elevation in relative expression of IL1b and 
TGFβ in the LUN SHAM group and TLR4, MyD88, RelA/p65 (regulatory element for 
NFκB), TFF3, and Slc5a8 in the LUN RAD group compared to WB mice (SHAM & 
RAD). 
 
 
 
WB SHAM 
(N=9)
WB RAD 
(N=9)
LUN SHAM 
(N=11)
LUN RAD 
(N=11)
Shannon 
Weaver
3.72 3.22 4.55 4.95
Chao 44.43 61.06 72.27 90.94
† Indices represent analysis of one composite 
sample containing aliquots from N animals in each
 group.
Data are LS means ±SEM.
Means without common superscripts differ (p<0.05).
 Experiment 2†
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Figure 17. A) Phylogenetic classification of OTUs (%) at the phylum level for Experiment 2. B) Phylogenetic classification 
of OTUs (%) at the order level for Experiment 2. See Appendix A-6 for actual values.
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Experiment 3  
Body weight and experimental diet intake  
Post flight, we observed significantly lower body weights in flight mice 
compared to ground controls (Figure 18A). Food intake was not significantly different 
between groups (not shown), however, water intake during flight was significantly 
suppressed in flight mice compared to ground mice (Figure 18B). 
Microbial taxonomic structure analysis 
Unifrac and principal components analysis (PCA) of all sequences for each 
sample, represented as a discrete data point without overlap, revealed distinct clustering 
of samples collected from ground and flight mice (Figure 19), yet we observe no 
significant differences in OTUs at the phylum level (Appendix A-7). Flight mice had a 
numerically higher proportion of OTUs classified in the Bacteroidetes (8%) and lower 
proportion of Firmicutes (14%) phylum compared to ground mice (Figure 20). Further 
phylogenetic classification also showed very few significances at the order level, with 
ground mice only having significantly higher proportion of OTUs classified as 
Erysipelotrichales compared to flight mice (p=0.0467, Figure 20). In flight mice, we 
observe a numerically higher proportion of OTUs classified in the Clostridiales order 
(60%) and numerically lower proportion of Lactobacillales (62%) compared to ground 
mice (Figure 20).  
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Diversity and species richness comparisons 
We observe no significant differences in species richness or diversity between 
ground and flight mice, with flight mice having a lower Shannon Weaver and Chao 
index compared to ground mice (Table 22). 
 
 
 
 
 
 
 
Figure 18. A) Mean body weight was significantly lower in flight mice compared to 
ground controls post-flight (p<0.05). B) Total water consumption was significantly 
lower in flight mice compared to ground controls. Means with * differ between ground 
and flight mice (p<0.05). Data are LS means ±SEM. 
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Table 21. Relative expression of selected gene loci for Experiment 2. No significant 
differences were observed (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 22. Chao and Shannon Weaver indices for Experiment 3. 
 
 
 
 
 
Ground 
(N=7)
Flight (N=7)
Shannon 
Weaver
4.46±0.27a 4.04±0.27a
Chao 84.81±4.74a 82.95±14.01a
Data are LS means ±SEM.
Means without common 
superscripts differ (p<0.05).
Experiment 3
WB SHAM 
(N=4)
WB RAD 
(N=5)
LUN SHAM 
(N=4)
LUN RAD 
(N=4)
TLR 2 1.56±0.41 1.63±0.12 1.09±0.66 1.17±0.76
TLR 4 0.39±0.10 0.32±0.10 0.30±0.11 0.49±0.09
TLR 9 0.08±0.02 0.06±0.02 0.06±0.02 0.08±0.04
MyD88 0.95±0.15 0.67±0.06 0.59±0.20 1.01±0.25
RelA 0.48±0.06 0.41±0.07 0.46±0.11 0.52±0.10
TNFα 0.04±0.01 0.03±0.01 0.04±0.02 0.04±0.01
IL6 0.01±0.003 0.02±0.057 0.02±0.004 0.02±0.008
IL1b 0.01±0.003 0.01±0.001 0.67±0.003 0.13±0.126
TGFβ 0.52±0.16 0.52±0.08 0.57±0.42 0.27±0.11
TFF3 291±71.5 198±39.8 198±52.5 379±134.9
Slc16a1 16.53±3.56 9.83±2.16 10.71±3.42 13.62±2.71
Slc5a8 3.70±0.44 3.84±1.30 3.05±1.14 6.32±1.68
† No significant differences observed (p<0.05)
Data are LS means ±SEM
BNL†
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Figure 19. PCA plot of samples from ground and flight mice. Flight mice data points 
cluster in the bottom right quadrant, illustrating differences in bacterial populations 
compared to ground controls.  
 
Mucosal gene expression 
We observe no significant differences in any gene targets analyzed, except 
TGFβ, which was significantly higher in flight mice compared to controls (p=0.0453, 
Table 23). Relative gene expression was numerically higher in TLR2, IL6 and Slc16a1 
in flight mice compared to ground control mice. 
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Table 23. Relative expression of selected gene loci for Experiment 3. Relative 
expression of TGFβ was significantly higher in flight mice compared to ground control 
mice. Relative expression of IL1b was not measurable. Means without common 
superscripts differ (p<0.05). 
 
 
 
 
 
 
 
Immunohistochemical analysis of distal colon 
To understand the effects of spaceflight (i.e., combined weightlessness and 
mixed radiation exposure) on intestinal injury and inflammation, distal colon was 
analyzed by a board certified pathologist. We observe no significant differences in 
intestinal injury and inflammatory infiltration between flight and ground mice (Figure 
21).  
Ground (N=6) Flight (N=5)
TLR 2 0.54±0.21 0.66±0.06
TLR 4 0.20±0.04 0.14±0.03
TLR 9 0.03±0.00 0.02±0.01
MyD88 0.30±0.07 0.26±0.04
RelA 0.18±0.03 0.15±0.03
TNFα 0.01±0.005 0.01±0.002
IL6 0.005±0.002 0.010±0.001
TGFβ 1.7±1.04a 4.1±0.37b
TFF3 107±23.4 102±18.6
Slc16a1 2.82±0.98 3.42±0.39
Slc5a8 0.84±0.19 0.65±0.15
Data are LS means ±SEM
STS-135
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Figure 20. Phylogenetic classification of OTUs from Experiment 3. Ground control mice had a significantly higher 
proportion of OTUs classified as Erysipelotrichales compared to flight mice (p<0.05). Flight mice had a numerically higher 
proportion of OTUs classified in the Bacteroidetes phylum and Clostridiales order, and a numerically lower proportion of 
OTUs in the Firmicutes phylum and Lactobacillales order compared to ground control mice. Taxa with * differ between 
ground and flight mice (p<0.05). See Appendix A-7 for actual values.
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Figure 21. Injury and inflammation scores of distal colon from flight and ground mice in 
Experiment 3. No significant differences were observed between flight and ground 
control mice (p<0.05). Values are LS mean ± SEM. 
 
Discussion 
Astronauts are exposed to different types of radiation from numerous sources 
including solar particle events, galactic cosmic rays, and charged particles held in the 
Van Allen belts. These types of radiation have varying LET, and consist of a 
combination of protons, alpha particles (hydrogen), and a small percentage of heavy ions 
(e.g., Fe and Si) and electrons, which can penetrate shielding and create secondary 
particles (21). Radiation exposure and other factors relating to space flight such as diets 
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high in iron and microgravity can elevate oxidative stress in the body, which has been 
shown to dysregulate the immune response and is a factor in bone demineralization, 
muscle atrophy, cardiovascular deconditioning and cataracts (347-351). Recent studies 
have shown that the intestinal bacterial populations, or microbiota, can be altered by 
oxidative stress and have been implicated in gastrointestinal diseases such inflammatory 
bowel disease (IBD) (97, 172, 217-218, 352). Furthermore, recent studies in our lab 
demonstrated that fecal microbial metabolite concentrations (i.e., short chain fatty acids 
(SCFA)) are affected by low LET radiation exposure and high dietary iron, suggesting 
alterations to the microbiota or microbial metabolism in response to space relevant 
conditions. The initiation and progression of intestinal inflammation is of upmost 
importance to astronaut health, as it known to increase the risk of colorectal cancers (3-
4, 353). Additionally, the effect of radiation on the body has been identified by NASA as 
one of the most significant risks associated with space flight, and their recent reports 
estimated that the “probability of causation” for colon cancer is 3rd highest following 
galactic cosmic radiation exposure (354-355).  
We utilized three experimental paradigms to characterize and compare how 
various insults associated with spaceflight may affect the colonic environment. 
Understanding how different radiation energies affects the intestinal tract is important, as 
previous studies have observed differences in cell survival, DNA repair, epithelial cell 
proliferation, differentiation, and tumor incidence following low and high LET radiation 
exposure (356-358). Additionally, our experimental design allowed us to compare 
simulated 1/6 G lunar microgravity (i.e., hind limb unloading (HLU)) to zero gravity of 
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space flight. Furthermore, it is important to elucidate the combined effects of radiation 
exposure and microgravity on the colonic environment, as recent studies report a 
synergistic effect between these exposures and miRNA expression, immune activation, 
and bone loss (359-361). Very little is known about how the space environment effects 
intestinal homeostasis, thus, the aim of this study was to characterize the effect of high 
and low LET radiation exposure, microgravity, and elevated dietary iron on the intestinal 
microbiota and gene targets associated with microbial derived signaling, metabolite 
transport, and epithelial repair. 
Historically studies have shown that the presence of commensal bacterial 
populations increased radiation induced lethality in conventionalized (i.e., presence of 
microbiota) compared to germ free animals (345), but a direct mechanism was not 
elucidated. More recent studies report alterations to the microbiota after low LET X ray 
exposure, and observed distinct differences based on received dose, amount of time 
following exposure, as well as presence of clinical signs such as radiation-induced 
diarrhea (114, 362). One small pilot study used denaturing gradient gel electrophoresis 
(DGGE) to identify changes in the bacterial diversity of patients suffering from acute 
post-radiotherapy diarrhea (total exposure of 4,300-5,400 cGy) (114). They observed 
that the microbial profiles of the individuals studied (i.e., no radiation, radiation with no 
diarrhea, and radiation with diarrhea) clustered in unique sets, suggesting that specific 
bacterial populations could be associated with risk or protection after radiation exposure. 
Subjects with clinical signs (i.e., diarrhea) had markedly higher proportions of Bacilli 
species and bacteria characterized in the Actinobacteria phylum compared to those 
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without diarrhea following radiation treatment (114). Another in vivo study 
demonstrated distinct differences in microbial populations based on length of time 
following 10 Gy X ray exposure. Hierarchical clustering of bacterial populations from 
samples collected 0, 4, 11, and 21 d post exposure suggested distinct differences in the 
bacterial populations over time (362). Following phylogenetic classification of bacterial 
groups, they report an increase in Proteobacteria following both 10 Gy acute and 18 Gy 
fractionated radiation exposure. Furthermore, the proportion of Clostridia in the feces of 
animals receiving an 18 Gy dose was 1/10 of the value observed in controls. This 
alteration was not observed in animals that received 10 Gy X ray, suggesting differences 
based off received dose (362).  Those findings suggest that radiation has an effect on the 
proportion of different bacterial groups present in the intestine. Unfortunately, little 
phylogenetic classification was performed in the pilot study, which could have provided 
more insight into which specific bacterial taxa might be involved in the etiology of 
intestinal dysfunction caused by radiation. Furthermore, these studies used large doses of 
low LET radiation exposures that are markedly higher than this study (5-22 Gy 
compared to 3 Gy, respectively), and do not include the effect of high LET radiation 
exposure on the microbiota. 
Phylogenetic classification of fecal intestinal bacterial populations at the phylum 
level revealed similarities across the various treatments (i.e., low LET radiation, high 
LET radiation, microgravity, elevated Fe diet). Following low LET radiation exposure 
(RAD), we observe an increased proportion of bacteria classified in the Bacteroidetes 
phylum and decreased Firmicutes phylum compared to CON. We also observe similar 
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alterations to these phyla in IRON animals. High LET radiation exposure and simulated 
microgravity (i.e., hind limb unloading (HLU)) also increased the proportion of 
Bacteroidetes and decreased Firmicutes in WB RAD, LUN SHAM and LUN RAD 
compared to WB SHAM. Unfortunately, since we analyzed a composite sample we were 
unable to statistically compare these proportions. We observe increased Bacteriodetes 
and decreased Firmicutes following HLU and high dietary iron exposures individually, 
however, we do not observe a synergistic effect of low LET radiation exposure and high 
dietary iron (Experiment 1), or high LET radiation exposure and 1/6 G HLU 
(Experiment 2). These results suggest that both high and low LET radiation exposure, as 
well as other environmental insults such as high dietary iron and microgravity, have 
similar effects on the proportions of bacterial populations at the phylum level. Similar to 
both experiment 1 and 2, animals exposed to 12 d of space flight had an increased 
proportion of Bacteroidetes and decrease in Firmicutes compared to ground controls. 
This suggests that mixed radiation exposure associated with space flight, comprised of 
both high and low LET radiation, produces similar effects to the predominant phyla as 
treatment with one energy (i.e., X ray or high charge (Z) energy (E) silicon nuclei 
(HZE)). 
 These global observations of the predominant bacterial groups are of interest, as 
dysbiosis to these phyla have been linked to elevated oxidative stress in the body 
associated with obesity and IBD (194, 210). Interestingly, increased proportions of 
Firmicutes and decreased Bacteriodetes have been reported in these studies, which 
contrast our observations following radiation exposure, microgravity, and an elevated 
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iron diet. Another contradiction to the results in this study is the report of elevated 
proportions of pathogenic bacteria in patients with IBD and following low LET X-ray 
exposure (8, 97, 191, 362). These studies indicated an increase in bacterial taxa (i.e., 
Enterobacteriaceae, Escherichia coli, Salmonella spp.) classified in the Proteobacteria 
phylum, which is a common constituent of the commensal intestinal flora but also 
contains numerous pathogenic species such as Vibrio, Helicobacter, Yersinia pestis, 
Klebsiella and Shigella. We observe ≤0.07% Proteobacteria in all experimental groups 
analyzed in this study, which is in contrast to previous studies reporting an elevation in 
this phylum following 10 and 18 Gy X-ray exposure (362). This suggests that the 
presence of these particular pathogenic bacteria is not a major constituent of the 
microbiota in our study, and that modulation of this bacterial group by radiation 
exposure might be dose dependant. This observation is positive, as the virulence of 
numerous pathogens, including Escherichia coli and Salmonella and Bacillus spp., have 
been reported to be increased following simulated microgravity and space flight (363-
366). Furthermore, it is thought that microgravity has an effect on fighting bacterial 
infections, as studies have reported that HLU animals have suppressed immune system 
function and increased lethality when exposed to pathogenic bacteria (e.g., Klebsiella 
pneumonia and Pseudomonas aeruginosa) (367-368). Furthermore, it was reported that 
HLU mice had elevated bacterial organ load  following administration of Klebsiella 
pneumonia compared to weight bearing controls, suggesting susceptibility to bacterial 
translocation from the bowel (367). 
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To better understand the implications of the observed altered proportions of 
Firmicutes and Bacteroidetes, we performed further phylogenetic classification and 
observe distinct differences at the order level across treatments. Within the Firmicutes 
phylum we observe differences in the Lactobacillales and Clostridiales orders in animals 
exposed to either low LET radiation or microgravity. Animals exposed to microgravity 
(both HLU and space flight) had an increased proportion of bacteria classified in the 
order Clostridiales and decreased proportion of Lactobacillales compared to WB or 
ground animals. This observation is independent of radiation exposure in experiment 2, 
as both LUN SHAM and LUN RAD demonstrate these population shifts. Similarly, 
animals exposed to 12 d space flight also demonstrate an increased proportion of 
Clostridiales and decreased proportion of Lactobacillales compared to ground controls. 
These reports are similar to those observed in patients with IBD, as it has been 
documented in numerous studies a suppression in lactic acid bacteria (LAB) species  as 
well as increased Clostridium spp (found in Lactobacillales and Clostridiales order, 
respectively) (100, 211). Results from experiment 1 contrast these observations, as RAD 
and IRON+RAD animals have numerically higher proportions of Lactobacillales and 
significantly lower proportion of Clostridiales compared to sham irradiated animals (i.e., 
CON & IRON). Observing lower proportions of Clostridiales in these animals may 
explain our previous observation of suppressed fecal butyrate, since this order harbors 
bacterial species known to have the capability to produce this metabolite (220-221). An 
increase in LAB is generally thought to be positive, as these bacterial populations have 
been shown to provide health benefits to the host (e.g., produce antimicrobial 
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substances, compete with pathogens for epithelial binding sites) and improves symptoms 
of chronic intestinal inflammation (123-124, 214-215). However, an increase in luminal 
H2O2 produced by these bacteria could exacerbate the effects of an elevated iron diet by 
creating highly reactive hydroxyl radicals through iron-mediated Fenton chemistry 
(343). Although this was not directly measured in this study, increased luminal and 
epithelial reactive oxygen species (ROS) could potentiate local oxidative stress.   
Enhanced oxidative stress has the potential to cause cellular damage and induce 
an inflammatory response in the colon, and we previously demonstrated that 
myeloperoxidase activity (i.e., a marker of neutrophil infiltration) is elevated in colonic 
mucosa following consumption of an elevated iron diet and exposure radiation (Chapter 
IV). Furthermore, alterations to the microbiota have been shown to initiate an 
inflammatory state by aberrant signaling through pattern recognition receptors such as 
toll-like receptors (TLR). We previously reported that low LET radiation exposure and 
elevated dietary iron altered mucosal gene expression in the TLR signaling cascade. 
Four gene targets involved in bacterial recognition and inflammatory responses were 
reduced by low LET radiation exposure; TLR9 (a bacterial recognition receptor), TNF-α 
(a cytokine involved in systemic inflammation) and its receptor, TNFα1b, and IL-6 (an 
interleukin with both pro-inflammatory and anti-inflammatory effects). Additionally, 
TLR4, TFF3 and Slc5a8 expression decreased when exposed to high dietary iron.  
Alterations in TLR expression could also be attributed to the observed changes in the 
microbiota, or other factors such as compromised barrier integrity, and colonic 
inflammation, all of which have been documented to alter expression of these receptors 
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(7, 187, 369). Microbial-derived signaling through pattern-recognition receptors affects 
gene expression, transepithelial electrical resistance, colonocyte proliferation in normal 
tissues (332), and serves as a pivotal role for maintaining homeostasis between 
commensal microbiota and the host immune system (73). Alterations in the TLR 
signaling pathway directly affects the immune response, specifically through 
downstream activation of the transcription factor NF-κB (334). NF-κB activation alters 
expression of localized cytokines (IL-1β, IL-10, IL-6, TNF-, IFN-γ and TGF-β) and 
pro-inflammatory molecules (COX-2) during an inflammatory response (261). Therefore 
to understand the implications of high LET radiation exposure and microgravity on these 
processes, we analyzed mucosal gene expression of gene targets associated with the TLR 
signaling cascade (i.e., TLR2, TLR4, TLR9, MyD88, NFκB, TNFα, IL6, IL1b), short 
chain fatty acid (SCFA) transport (i.e., Slc16a1, Slc5a8), and epithelial injury repair (i.e., 
TGFβ, TFF3) in experiment 2 and 3. 
Previous studies have shown that high LET radiation exposure and microgravity 
has a direct effect on gene expression in vitro and in muscle tissue (359, 370-373), but to 
our knowledge no analysis has been published describing these effects in the intestinal 
tract. We do not observe any significant effect of high LET radiation exposure or HLU 
for any targets associated with the TLR signaling cascade or SCFA transport. Previous 
studies have shown that low LET radiation exposure can upregulate the expression of 
pro-inflammatory cytokines (i.e., INFα, IL-6, IL-1, TNFα) in murine macrophages and 
increase their concentration in serum (368, 374-375), which contrasts our results from 
Experiment 1 described above. Zhou et al. reported that HLU acts synergistically with 
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radiation exposure to markedly elevate circulating INFα, IL-6, and TNFα  in mice (374). 
Although we did not analyze cytokine concentrations in plasma or other organs, we do 
not observe an increase in the relative expression of IL-6, IL-1b, COX-2 or TNFα in the 
colonic mucosa of experiment 2 and 3 animals (50 cGy silicon exposure ± HLU and 
spaceflight, respectively). Additionally, immunohistological assessment of distal colon 
does not reveal an increase in inflammatory cytokine or neutrophil infiltration following 
spaceflight. Differences in these observations could be due to the amount of time 
following radiation exposure and tissue collection in Experiment 2 (21 d), or the effect 
of low dose gamma irradiation compared to low dose HZE silicon exposure on pro-
inflammatory cytokine gene expression.  
For both experiment 2 and 3 we observe an upregulation of repair proteins. 
Relative expression of TFF3 was elevated in LUN RAD animals, which is a protein 
expressed on the apical side of the epithelial membrane and has been shown to be 
involved in cellular migration and repair (162). Flight mice had a significantly higher 
relative expression of repair protein TGFβ compared to ground controls, which acts on 
the basolateral side of the epithelial membrane (167). Previous studies have 
demonstrated that HLU can affect the ability to fight bacterial infection, and is thought 
to be due to impaired barrier integrity of the gastrointestinal tract (367, 374, 376). 
Immunohistological assessment of distal colon injury in flight animals does not indicate 
space flight significantly affects epithelial integrity, and these observations were 
generally described as discrete epithelial lesions with no surface erosion or presence of 
focal ulcerations. However, our results could suggest repair protein expression is 
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upregulated to mitigate the observed epithelial lesions following exposure to the space 
environment. It has been reported that immune system responses following radiation 
exposure differ across mouse strains and could be a factor when comparing our results to 
previous studies (377). Future studies with increased sample sizes could allow for more 
statistical power and further elucidate significant differences between experimental 
groups for gene targets associated with the TLR signaling cascade. Furthermore, 
alterations to the microbiota we observe directly following spaceflight may have the 
ability to initiate an inflammatory state and alter TLR expression if followed for an 
extended period after return to Earth. 
To our knowledge, this is the first study to analyze these experimental paradigms 
on the intestinal microbiota and colonic mucosal gene expression. Although minimal 
differences were observed in our selected gene targets, we have illustrated distinct 
differences in the microbiota following elevated dietary iron consumption, radiation 
exposure (i.e., high and low LET) and microgravity (HLU and space flight). Previous 
work in this field has analyzed the effect of radiation exposure on the microbiota after 
much larger doses of low LET radiation (114, 345, 362), and did not analyze the effect 
of high LET exposure. Furthermore, this is the first study to perform phylogenetic 
characterization of the intestinal microbiota in a microgravity environment. Comparing 
changes to the microbiota following various space flight insults is important, as it is now 
understood that we cannot directly compare observations across studies utilizing 
different radiation parameters (i.e., high and low dose; high and low LET). Furthermore, 
we observe distinct shifts in bacterial populations in animals exposed to microgravity 
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independent of radiation exposure. Across all experiments in this study we do not 
observe a marked dysbiosis to the predominant phyla, reduced bacterial diversity, nor an 
increased proportion of pathogenic genera previously reported during intestinal 
inflammation. These observations suggest unique alterations to the microbiota when 
exposed to a space environment compared to other sources of intestinal oxidative stress. 
A low dose, fractionated radiation exposure was chosen for experiments 1 and 2 to 
directly compare to the radiation exposure that astronauts experience during short space 
flight missions. Results from this study can also benefit airline crews and radiation 
workers who experience low dose exposures. Furthermore, characterizing the effect of 
high LET radiation exposure on the luminal environment is applicable to patients 
receiving heavy-ion cancer therapy. Understanding the implications on the intestinal 
microbiota and microbial signaling in these patients will be useful for estimating the 
incidence of secondary malignancies. Future studies analyzing alterations to the 
intestinal bacterial population’s genetic code, or metagenome, in patients receiving 
radiation therapy and astronauts would further elucidate how radiation exposure could 
affect intestinal homeostasis. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
Intestinal homeostasis can be altered in a variety of ways including UC and 
environmental factors such as radiation exposure and elevated dietary iron. It is well 
documented that there are alterations to the intestinal microbiota during bouts of 
inflammation and it is hypothesized that this dysbiosis is a direct contributor to 
progression of colonic inflammation (172, 211, 213). Mitigating an aberrant immune 
response and reoccurring bouts of inflammation is important to reduce GI disease 
progression and the increased risk of colitis associated cancers. Existing therapies for 
UC such as pharmaceuticals and biological agents may produce an initial response, yet, 
it is estimated less than 1/3 of patients gain full remission following these treatments 
(378). Altering dietary constituents has been shown to attenuate the effects of 
inflammation and treat UC, and those rich in bioactive compounds or plant polyphenols 
have received interest in recent years. This is thought, in part, due to their antioxidant 
and anti-inflammatory properties as well as altering bacterial populations (108, 121, 
146). Our lab previously reported that sorghum bran diets can increase endogenous 
antioxidant enzymes such as catalase and superoxide dismutase, and have the ability to 
reduce aberrant crypt foci in AOM induced colorectal cancer (24), yet, their effect on 
UC has not been studied.  
To our knowledge, this is the first study to demonstrate that sorghum based diets 
may have the ability to attenuate the symptoms of DSS induced colitis. Our results 
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indicate that by feeding bran based diets, it is possible to reduce the severity of epithelial 
injury and alleviate clinical symptoms such as diarrhea commonly associated with DSS 
induced colitis models and reported in patients suffering from UC. Furthermore, we 
demonstrate these diets may be able to mitigate colonic injury by upregulating epithelial 
repair protein (i.e., TFF3 and TGFβ) expression. Sorghum based diets significantly 
affected excreted fecal SCFA including propionate and butyrate, with Sumac bran 
having the lowest proportion of excreted butyrate compared total SCFA. Furthermore, 
we do not observe a decrease in fecal SCFA concentrations commonly reported in 
patients with UC. One explanation could be an increase in the relative expression of 
SCFA transporters (i.e., Slc16a1 and Slc5a8), which we observe in sorghum bran fed 
rats but not cellulose fed rats.  
In this body of work, we observe distinct differences in the intestinal microbiota 
following two experimental paradigms; one using a chemical inducer of 
inflammation/injury (DSS) and the other using various forms of radiation, 
weightlessness and diets commonly consumed in the space environment. 
Pyrosequencing of fecal microbial DNA allowed for deep analysis of the microbiota and 
we document numerous differential changes to the bacterial populations following each 
experiment. During DSS induced colitis, we observe that repeated exposures of DSS 
does alter the intestinal microbiota and produce alterations commonly observed in UC 
including reduced diversity and species richness. However, when fed a sorghum bran 
based diet we observe a restoration of both species richness and diversity following 
recovery from the third DSS exposure, with condensed tannin containing brans having 
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numerically higher indices at this time point compared to their diet matched controls. 
Furthermore, it has been shown that the Firmicutes to Bacteroidetes ratio is altered in 
patients with IBD with an increase in Firmicutes observed in these patients compared to 
controls. In this study we do not observe an increase in this ratio during DSS induced 
colitis when feeding a sorghum bran diet, suggesting we may be able to mitigate 
alterations to these bacterial phyla commonly observed in UC.  
To our knowledge, this is the first study to document the effect of the space 
environment on the intestinal microbiota. Although we do not observe a significant 
effect of a high iron diet on the fecal microbial populations identified in this study, we 
do observe significant alterations due to radiation exposure and microgravity. In 
experiment 1, we observe a significant effect of radiation on the bacterial orders 
Lactobacillales and Clostridiales. Lactobacillales was significantly higher in 
IRON+RAD animals compared to rats that were not irradiated (both low Fe and high 
Fe). Clostridiales was significantly reduced in rats exposed to radiation (both low Fe and 
high Fe) compared to CON rats, and this observation may be a reason for reduced 
concentrations of luminal SCFA with IRON+RAD rats having the lowest concentrations 
compared to all other experimental groups.  
 Interestingly, we observe a distinct effect of microgravity on the proportion of 
these bacterial populations with lower Lactobacillales and higher Clostridiales observed 
in animals exposed to both HLU and spaceflight. These observations may be 
independent of radiation exposure, as we observe these changes in SHAM and RAD 
animals in experiment 2. These observations suggest that there are alterations to the 
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microbiota specifically associated with the space environment and could be detrimental 
to astronaut health. Moreover, the effect of radiation on the intestinal microbiota that we 
observe in this study could have implications for patients receiving heavy-ion cancer 
therapy, airline crews, and radiation workers who experience low dose exposures similar 
to those utilized in these experiments. 
Future Studies 
Each experimental paradigm differentially altered the microbiota and mucosal 
environment and further studies are warranted to elucidate specific mechanisms by 
which these experimental paradigms alter GI homeostasis. To better understand the 
progression of disease and inflammation in DSS induced colitis, staggering terminations 
could further elucidate a phenotype during a more active disease state. Additionally, 
assessing microbes before feeding the experimental diets and over time would better 
describe changes by supplementing with sorghum bran. We observe distinct differences 
when fed sorghum bran diets compared to a cellulose control diet, suggesting that the 
bioactive compounds in the bran may have the ability to exert the clinical effects in this 
study. Metabolomics could identify if these bioactive compounds have a systemic effect, 
as well help elucidate the mechanism that allows these compounds to mitigate the effect 
of DSS induced colitis.  
We observe distinct differences in the microbiota following low dose, low LET 
radiation exposure and microgravity. Experiments in this study were designed to mimic 
radiation doses similar to what would be experienced during a short term space flight, 
however, the microgravity duration in these studies were significantly shorter (12-21 d) 
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than an International Space Station mission (90-180 days) or future missions extending 
into deep space. Furthermore, astronauts embarking on deep space missions would 
experience a much larger dose of radiation, particularly high LET HZE exposures. 
Therefore, studies analyzing larger doses of radiation and extended microgravity 
exposure on the microbiota and mucosal environment are warranted.  
Across all studies, performing nearest neighbor analysis would be useful to 
describe bacterial populations that are unclassified or unknown in the RDP database. 
Additionally, in order to better characterize which microbial populations have a direct 
affect on TLR signaling, analyzing mucosa microbiota instead of feces could help better 
understand these interactions. Previous studies have identified specific bacterial 
population associated with goblet cell mucin that differ from the fecal stream, therefore, 
characterization of these bacterial populations are warranted. Specific analysis of 
microbial butyrate producing gene targets would help link our SCFA observations to the 
microbial populations characterized in this study. Furthermore, analysis of the bacterial 
population’s genome, or metagenome, would give insight on the function of 
characterized populations and unidentified phylotypes, and further elucidate implications 
on intestinal inflammation. 
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APPENDIX A 
TABLES OF RESULTS 
 
Table A-1. Mean body weight (g) throughout the study. High Tannin control rats had higher body weights than Cellulose 
control rats on d 37, d 39, d 53, and d 58.  
 
 
 
 
 
 
 
 
 
Control DSS Control DSS Control DSS Control DSS
Initial d 1 61.70±1.89a 61.03±1.97a 62.36±1.89a 61.48±1.91a 63.54±1.65a 63.07±1.65a 62.77±1.50a 62.40±1.48a
Diet start d 19 156.11±1.89a 155.35±1.97a 157.54±1.89a 160.12±1.91a 159.25±1.65a 160.09±1.65a 161.78±1.50a 157.31±1.48a
 Intake #1 final  d 37 255.67±5.32a 261.50±3.58ab 261.48±3.54ab 264.75±2.84ab 267.54±5.03ab 262.62±4.23ab 268.66±4.05b 260.24±4.46ab
 Pre-DSS #1  d 39 269.49±5.80a 274.96±3.34ab 273.76±3.71ab 279.39±2.65ab 279.36±4.40ab 277.20±4.94ab 283.23±4.45b 273.81±4.4ab
 Pre-DSS #2  d 53 318.09±6.66a 324.76±5.25ab 321.66±5.94ab 329.01±4.04ab 333.17±7.06ab 322.30±6.38ab 337.88±5.74b 323.99±7.16ab
 Intake #2 final  d 58 329.37±6.59a 334.66±5.65ab 332.59±6.73ab 340.34±4.52ab 344.89±7.55ab 332.52±6.31ab 348.55±5.93b 335.32±8.26ab
 Pre-DSS #3  d 67 349.71±7.6a 356.31±7.04a 353.10±7.53a 361.56±4.74a 365.21±7.95a 353.80±7.01a 367.91±6.28a 356.45±9.04a
 Intake #3  d 77 369.60±9.05a 376.47±7.85a 373.73±8.04a 382.26±5.63a 386.37±8.89a 372.30±8.28a 390.26±8.11a 376.60±9.92a
Termination d 82 374.27±8.86
a 382.19±7.81a 379.03±7.95a 386.97±5.41a 391.24±8.9a 374.94±8.43a 394.8±8.08a 381.52±9.94a
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
DSS Diet
Diet*
DSS
Body 
Weight 
(g)
Cellulose Black bran Sumac bran High Tannin
 204 
 
 
Table A-2. SCFA production post DSS#2 on d 44 (umol/24 hr). Diet significantly affected 24 hr SCFA production for 
propionic, isobutyric, butyric, isovaleric, and valeric. We observe a diet*DSS effect on isobutyric acid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control DSS Control DSS Control DSS Control DSS
Acetic 89.24±6.70b 60.11±6.34ab 51.17±2.76a 61.65±2.17ab 67.89±2.98ab 68.91±5.52ab 46.41±2.05a 53.54±2.59a
Propionic 18.57±0.92a 23.40±1.11ab 20.51±1.22a 27.98±1.20abc 37.32±1.42c 33.40±1.82bc 22.03±0.86a 32.80±1.00bc 0.004
Isobutyric 2.45±0.16a 3.55±0.13ab 2.34±0.13a 2.91±0.15a 6.58±0.30c 4.75±0.28b 4.96±0.18bc 6.46±0.27c <0.0001 0.03
Butyric 34.47±2.54c 22.26±2.30abc 28.18±1.17bc 22.74±1.08abc 16.99±0.77ab 13.02±0.63a 22.70±0.85abc 22.78±1.16abc 0.0235
Isovaleric 4.67±0.39a 7.58±0.28a 5.86±0.31a 7.62±0.36a 17.21±0.81c 12.69±0.58b 12.81±0.50b 15.91±0.78bc <.0001
Valeric 7.60±0.40b 9.23±0.48b 7.45±0.70b 8.0±1.04b 1.38±0.96a 0.96±0.73a 12.99±0.99c 17.54±7.90d <0.0001
Total 157.00±9.62
a 126.13±9.35a 115.52±5.81a 130.92±5.53a 147.36±4.67a 133.73±7.49a 121.89±3.70a 149.03±8.97a
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Diet DSS 
Diet*
DSS
Total 
SCFA 
prod 
(umol)/ 
24 hr
Black branCellulose Sumac bran High Tannin
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Table A-3. SCFA production on d 66 (umol/24 hr). Diet significantly affected 24 hr SCFA production for propionic, 
isobutyric, butyric, isovaleric, and valeric. We observe a diet*DSS effect on acetic acid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control DSS Control DSS Control DSS Control DSS
Acetic 48.15±6.70b 29.06±6.34a 26.08±2.76a 35.66±2.17ab 33.01±2.98a 39.14±5.52ab 30.68±2.05a 31.63±2.59a 0.026
Propionic 10.73±0.92ab 6.61±1.11a 9.81±1.22ab 12.98±1.20b 19.39±1.42c 19.36±1.82c 14.09±0.86b 13.57±1.01ab <0.0001
Isobutyric 1.54±0.16a 1.28±0.13a 1.23±0.13a 1.53±0.15a 3.53±0.30b 3.13±0.28b 3.47±0.18b 3.80±0.27b <0.0002
Butyric 17.24±2.54bc 10.29±2.30a 16.61±1.17bc 20.55±1.08c 8.43±0.77a 7.09±0.63a 12.54±0.85ab 10.07±1.16a <0.0003
Isovaleric 2.75±0.39a 2.69±0.28a 2.92±0.31a 3.63±0.36a 8.95±0.81b 7.72±0.58b 8.67±0.50b 9.50±0.78b <0.0004
Valeric 4.16±0.40abc 11.01±0.48bc 4.14±0.70abc 4.90±1.04abc 0.53±0.96a 0.65±0.73a 9.04±0.99b 10.14±7.90b 0.0127
Total 84.57±9.62
a 60.94±9.35a 60.79±5.81a 79.23±5.53a 73.84±4.67a 77.09±7.50a 78.49±3.67a 78.69±8.97a
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Diet DSS 
Diet*
DSS
Total 
SCFA 
prod 
(umol)/ 
24 hr
Black branCellulose Sumac bran High Tannin
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Table A-4. SCFA production post DSS#3 on d 72 (umol/24 hr). Diet significantly affected 24 hr SCFA production for 
propionic, isobutyric, butyric, isovaleric, and valeric.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control 
(N=9) DSS (N=9)
Control 
(N=9) DSS (N=9)
Control 
(N=9) DSS (N=9)
Control 
(N=9) DSS (N=9)
Acetic 31.82±6.70bc 24.94±6.34c 21.92±2.76ab 27.07±2.17bc 26.70±2.98a 31.05±5.52c 28.89±2.05c 28.80±2.59c
Propionic 7.99±0.92a 9.58±1.11ab 9.77±1.22ab 12.65±1.20abc 17.64±1.42c 18.04±1.82c 13.69±0.86abc 15.29±1.01bc 0.0006
Isobutyric 1.22±0.16a 1.38±0.13a 1.16±0.13a 1.38±0.15a 3.06±0.30bc 2.67±0.28b 3.56±0.18bc 3.73±0.27c <0.0001
Butyric 15.96±2.54c 8.53±2.30ab 15.31±1.17c 14.75±1.08c 7.50±0.77ab 5.85±0.63a 12.34±0.85bc 11.56±1.16abc 0.002
Isovaleric 2.03±0.39a 2.67±0.28a 2.60±0.31a 3.09±0.37a 7.50±0.81bc 6.13±0.58b 8.73±0.50c 8.84±0.78c <0.0001
Valeric 3.69±0.40b 3.56±0.48b 3.85±0.70b 4.31±1.04b 0.60±0.96a 0.32±0.73a 9.41±0.99c 9.56±7.90c <0.0001
Total 62.71±9.62
a 50.67±9.35a 54.61±5.81a 63.25±5.53a 63.00±4.67a 64.07±7.50a 76.61±3.67a 77.78±8.97a
Values are LS mean ± SEM. 
Means without common superscripts differ (p<0.05).
Diet DSS 
Diet*
DSS
Total 
SCFA 
prod 
(umol)/ 
24 hr
Black branCellulose Sumac bran High Tannin
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Table A-5. Phylogenetic classification of OTUs (%) at the phylum level on d 47 and d 62. 
 
 
 
 
  
 
 
DSS   (n=9) DSS   (n=9) DSS (n=10) DSS (n=10) Diet
Actinobacteria 0.64±0.13b 0.12±0.04a 0.37±0.11ab 0.22±0.16a 0.0276
Bacteroidetes 2.37±0.81a 9.76±2.77b 19.44±2.75c 7.52±2.34ab 0.0001
Firmicutes 83.82±1.47c 69.10±4.94b 44.44±4.78a 63.90±5.63b <0.0001
Proteobacteria 0.70±0.18a 1.52±0.32ab 3.25±0.99b 2.56±0.57b 0.0364
Unknown 7.97±1.43a 10.88±1.69ab 16.49±2.38b 13.31±2.90ab
Unassignable 4.50±0.51a 8.51±0.91ab 15.95±1.73c 12.44±2.88bc 0.0007
Control 
(n=5) DSS (n=10)
Control 
(n=5) DSS (n=9)
Control 
(n=5) DSS (n=10)
Control 
(n=5) DSS (n=9) Diet DSS
Diet* 
DSS
Actinobacteria 0.52±0.16bc 0.80±0.19c 0.13±0.11ab 0.11±0.04ab 0.04±0.04a 0.02±0.02a 0.58±0.33bc 0.05±0.04a <0.0001
Bacteroidetes 0.55±0.29a 0.95±0.20a 6.06±0.84ab 6.53±1.72b 24.17±4.47d 13.56±1.15c 16.54±3.50c 7.97±0.72b <0.0001 0.0006 0.0026
Firmicutes 61.20±4.22e 49.12±3.25d 26.29±3.96bc 33.41±3.32c 23.59±3.46b 9.41±0.60a 53.05±4.62de 27.06±2.23bc <0.0001 <0.0001 <0.0001
Proteobacteria 0.18±0.11a 0.11±0.04a 0.61±0.17ab 0.99±0.36abc 4.29±0.40d 2.36±0.79c 3.49±1.20cd 2.13±0.63bc <0.0001
Unknown 20.61±3.28a 27.51±2.39b 39.43±2.55de 33.28±1.84cd 28.10±4.10bc 45.15±0.63e 15.80±2.35a 36.37±1.41d <0.0001 <0.0001 <0.0001
Unassignable 16.92±0.93
b 21.44±1.19c 27.48±1.03de 25.68±1.22d 19.80±3.41bc 29.50±1.26e 10.38±1.41a 26.28±0.87de <0.0001 <0.0001 <0.0001
†Data represents predominant phylogenetic groups (>1%) and are LS mean±SEM.
Means without a common superscript differ (p<0.05)
Day 62 (Post 
DSS#3): 
Phylum 
level 
classification 
(% OTUs) 
Cellulose Black Bran Sumac Bran High Tannin Bran
Day 47 (Post 
DSS#2): 
Phylum 
level 
classification 
(% OTUs) 
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Table A-6. Phylogenetic classification of OTUs (%) from Experiment 2.   
 
 
 
 
Table A-7. Phylogenetic classification of OTUs (%) from Experiment 3. 
 
 
 
 
Phylum Family Order
WB SHAM 
(N=9)
WB RAD 
(N=9)
LUN SHAM 
(N=11)
LUN RAD 
(N=11)
Bacteroidetes 24.66 37.89 32.33 29.58
Bacteroidia Bacteroidales 0.00 0.82 0.31 0.18
Unknown Unknown 24.66 37.07 32.02 29.40
Firmicutes 54.39 48.29 38.18 44.06
Bacilli Lactobacillales 40.08 37.67 3.00 7.15
Clostridia Clostridiales 13.36 10.10 34.80 33.24
Erysipelotrichi Erysipelotrichales 0.00 0.07 0.00 0.00
Unknown 17.15 10.48 22.09 18.95
Unassignable 3.79 3.34 7.39 6.70
† All proportions represent analysis of one composite sample containing aliquots from N animals in each group.
Data are LS mean±SEM.
Experiment 2†
Phylum Family Order
Ground 
(N=7)
Fight      
(N=7)
Bacteroidetes 45.99±5.71a 49.85±5.88a
Bacteroidia Bacteroidales 18.97±3.03a 29.85±4.80a
Unknown Unknown 27.02±4.49a 20.00±5.47a
Firmicutes 44.51±6.24a 37.43±7.09a
Bacilli Lactobacillales 26.25±6.77a 9.91±4.96a
Clostridia Clostridiales 10.85±2.10a 26.43±7.98a
Erysipelotrichi Erysipelotrichales 7.11±2.16b 0.44±0.24a
Unknown 3.42±0.38a 4.12±0.90a
Unassignable 5.40±0.73a 6.68±0.91a
Data are LS mean±SEM.
Means without a common superscript differ (p<0.05).
Experiment 3
 209 
 
APPENDIX B 
EXPERIMENTAL PROTOCOLS 
Chapter II & III Animals and Diets 
Eighty male Sprague-Dawley rats (21 d old) were stratified by body weight and 
assigned to one of four experimental diets (n=10/ diet).  The four diets contain 6% 
dietary fiber from 1) cellulose, or bran isolated from sorghum grains that contain: 2) high 
levels of 3-deoxyanthocyanins, 3) high levels of condensed tannins and low levels of 3-
deoxyanthocyanins, or 4) both 3-deoxyanthocyanins and condensed tannins. Diets were 
mixed using the following protocol: 
 
1.  Get cart, 2-3 5L jugs, tub big enough to fit jugs and ice, aluminum foil, bench 
papers, scissors, sharpies, napkins, weigh scale, plastic beaker.  
2.  Go to Dr. Chapkin’s lab to measure out corn oil, where it is also stored.  
When done, fill remaining barrel of oil with nitrogen gas, seal, date, and store 
back in freezer.  Record lot number.  
3.  Cover jugs with foil, label, and put on ice.  
4.  Bring 2 big stainless steel mixing bowls from lab to basement.  
5.  Measure out test compounds, add to mineral/vitamin, methionine/choline mix 
and mix well.  
6.  Start with Bowl 1 of a diet group. Mix by hand diet components . 
7.  Fit bowl onto electric mixer, cover, and mix dry components for 5 min at #1 
setting.  
8.  Still at setting #1, start mixer for 10 min.  During this time, pour oil into mix 
in 3 separate quantities and times.  To get all oil out from jug, use diet to mop it 
up.  
Control/Cellulose Sumac Brown TX430 Black 8830 High Tannin
INGREDIENT g/100g g/100g g/100g g/100g
Dextrose 51.06 44.49 46.11 42.76
Casein 22.35 20.73 20.97 20.76
DL-methionine 0.34 0.34 0.34 0.34
Mineral mix, AIN-76 A 3.91 3.91 3.91 3.91
Vitamin mix AIN-76A 1.12 1.12 1.12 1.12
Choline bitartrate 0.22 0.22 0.22 0.22
Cellulose 6.00 0.00 0.00 0.00
Sorghum bran 16.35 13.08 17.56
Lipid
   Corn oil 15.00 13.55 14.64 13.77
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9.  Scrape sides of bowl and blade, mix for 5 min more.  
10. Lower bowl, scrape sides of bowl and blade.  Put bowl back into position and 
mix for 10 min at #2 setting.  
11. Scrape diet off blade, lower and remove bowl.  Take a sample of diet mix 
from four locations in the bowl (send off to analysis).    
12. Scoop diet into labeled bags and double-bag.  Store in labeled plastic tubs in 
freezer.  
13. Repeat above diet process for all diet groups.  
14. Clean up.  
Notes:    Before starting on a new diet group, remember to wash bowls and 
scoops and change gloves to prevent cross-contamination.   Bowls and scoops 
need to be sprayed with 70% EtOH after washing and drying. The dry diet 
components are in powder form, so dust clouds form when pouring; pour slowly 
to reduce dust. Mineral mix, vitamin mix, and methionine are stored in the 
freezer, so put back in freezer after measuring out into tubs. The 
mineral/vitamin/methionine/choline mix might be lumpy, so it is best to use 
gloved hands to break up the lumps and mix uniformly. Diet samples are taken 
after mixing for analysis of composition.  The small vials are used to collect 
samples throughout the feeding period and at the end. 
 
Antioxidant capacity, total polyphenol content, tannin content, and proportions of 
soluble and insoluble fiber were quantified for each experimental diet. Prior to beginning 
the experimental diet (at 40 d old), animals were maintained on a standard chow diet for 
19 d in order to overcome shipping stress. 
After 14 d of experimental diets, half of the rats were exposed to three sequential 
48 h dextran sodium sulfate (DSS) (MP Biomedicals, Irvine, CA) treatments (3% DSS) 
in their drinking water, with 14 d between each DSS exposure. Between DSS exposures, 
distilled water was supplied to treated animals. The remaining half of the animals 
received distilled water throughout the course of the study.  
Body weight and food intake was routinely monitored. Rats were weighed upon 
arrival, prior to beginning experimental diets, before and after each DSS exposure, and 
prior to termination. Additionally, experimental diet consumption was measured prior to 
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the first DSS treatment, following the second DSS treatment, and prior to termination 
(following third DSS treatment). On day 82, animals were euthanized by CO2 
asphyxiation. The colon was resected, and two 1 cm sections were removed for 
histological preparations and the remainder will be scraped (see below). 
Chapter II & III tissue collection and processing 
Scraped mucosa  
After fecal material was removed from the colon, it was washed twice in RNase 
free Phosphate-Buffered Saline (PBS), scraped on a chilled RNase free surface, and 
transferred to an RNase free homogenization tube along with 500 l of Denaturation 
Solution (Ambion, Austin, TX) or 400 l of protein buffer (see below). Scraped mucosa 
for RNA analysis was homogenized in Denaturation Solution for 6-7 strokes and then 
transferred to a 2 ml epitube for storage at -80°C. Scraped mucosa was placed into a 
homogenizer along with 400 µl of buffer.  Protein buffer (10 ml) was mixed on the day 
of the kill, just prior to use.  The protein buffer contained: 1 ml of 500 mM Tris-HCl (pH 
7.2) (Sigma), 2.5 ml of 1.0 M Sucrose (Sigma), 100 µl of 200 mM EDTA (pH 7.6) 
(Sigma), 100 µl of 100 mM EGTA (pH 7.5) (Aldrich), 1.25 µl of 0.4 M NaF (Sigma), 
4.554 ml of water; 1 ml of 10% Triton X-100 (Sigma), 100 µl of 10 mM orthovanadate 
(Sigma), and 400 µl of Protease Inhibitor (Sigma). Mucosa and protein buffer was 
homogenized for at least 7 strokes (on ice) and transferred into a 2 ml epitube.   The 
sample was aspirated through a 12 gauge needle twice and then incubated on ice for 30 
minutes prior to centrifugation at 15,000 g for 20 minutes.  The supernatant was 
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transferred, and the volume was split among the aliquot tubes and then placed into a –80 
freezer for storage.  
Tissue fixation for immunohistological processing 
The two, 1 cm segments removed from the distal end of the colon were fixed in 
either a 4% PFA (PFA solution was mixed a day before the killing. 50 ml of 10X PBS 
was dilute to 400 ml with ddH2O, and then 100 ml of 20% PFA was added. PFA solution 
was refrigerated overnight.) or 70% EtOH solution prior to embedding in paraffin. 
Tissue fixed in 70% EtOH was stored at room temperature until embedded in paraffin. 
Tissue fixed in PFA was incubated on ice for 4 h in a 4% PFA solution, then rinsed and 
stored at 4°C in 70% EtOH until embedded in paraffin. 
Chapter II fecal collections and processing 
 Fresh fecal samples were collected for fermentation metabolite analysis prior to 
DSS exposure, and 48 h after each DSS exposure. After the colon was resected from the 
rat at termination, it was opened longitudinally and fecal samples from the distal and 
proximal segments of the colon were collected, placed into a tube, and stored on ice. The 
samples were then immediately placed into a –80°C freezer until further analysis. 
Dry matter analysis 
Fecal samples were thawed and placed into a weighed pan prior to drying in a 
60°C oven for 72 h. Samples were cooled in a vacuum dessicator for 24 h before being 
weighed. This procedure was repeated until weight became static. 
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Short chain fatty acid (SCFA) analysis  
Fresh fecal samples were collected immediately following defecation. Samples 
were transferred to sterile cryotubes, snap-frozen in liquid nitrogen, and stored at -80°C. 
Fecal samples were prepared for analysis by grinding in a mortar and pestle chilled by 
immersion in liquid nitrogen. The powdered sample (~0.20 g) was weighed into a 1.5-
mL centrifuge tube containing 750 mL of the internal standard, 2-ethylbutyric acid 
(Sigma-Aldrich, St. Louis, MO), in 70% ethanol. Samples were vigorously vortexed and 
incubated overnight at 47°C to extract the SCFA. To prepare the extracted samples for 
gas-liquid chromatography, samples were ﬁrst shaken vigorously for 20 min and then 
centrifuged at 11,500 g for 20 min at 47°C. A 100 mL aliquot of the supernatant was 
removed and combined with 100 mL of the second internal standard, 3 mmol/L 
heptanoic acid prepared in 70% ethanol. Immediately before injection into the gas 
chromatograph (GC), 20 mL of 0.1mmol/L phosphoric acid was added to the sample and 
vortexed. One microliter of sample containing the phosphoric acid was then injected into 
a Varian 3900 gas chromatograph (Walnut Creek, CA) with a splitless capillary inlet and 
ﬂame ionization detector equipped with a 30 m, 0.53 mm i.d. deactivated glass capillary 
precolumn (Supelco,Bellfonte, PA). Data were integrated and plotted with a Hewlett 
Packard Series II Integrator. The GC conditions used were as follows: injector 
temperature, 1657C; detector temperature, 2207C; column ﬂow, 2.21 mL/min He; make-
up ﬂow, 28 mL/min nitrogen; and oven temperature, 1857C (gradient). Standards and a 
blank were run before and after the daily sample runs to facilitate calibration and data 
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calculations. Fecal production measurements were used to calculate 24-h SCFA 
excretion. 
 
Chapter II, III, and IV inflammation and injury histological scores 
The degree of inflammation and morphological injury was assessed by H&E 
staining. Histologic examination was performed in a blinded manner by a board-certified 
pathologist, and the degrees of inflammation (score of 0–3) and epithelial injury (score 
of 0–3) were scored on microscopic cross sections of the colon. The presence of 
occasional inflammatory cells in the lamina propria was assigned a value of 0; increased 
numbers of inflammatory cells in the lamina propria as 1; confluence of inflammatory 
cells, extending into submucosa, as 2; and transmural extension of the infiltrate as 3. For 
epithelium injury, no mucosal damage was scored as 0; discrete lymphoepithelial lesions 
were scored as 1; surface mucosal erosion or focal ulceration was scored as 2; and 
extensive mucosal damage and extension into deeper structures of the bowel wall was 
scored as 3. 
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Chapter II immunohistological measurement of proliferation 
Cell proliferation was measured using a monoclonal antibody to proliferating cell 
nuclear antigen (PCNA; Anti-PC-10, Covance, Emeryville, CA). Bound primary 
antibodies were detected by applying a peroxidase-conjugated antibody to biotinylated 
anti-mouse immunoglobulin using a Vectastain ABC Elite Kit (Vector Lab, Burlingame, 
CA) and sequenza slide rack using the following protocol: 
1.  Deparaffinize slides: xylene (5' x 3), 100% EtOH (5' x 2), 95% EtOH (3' 
x 2), 70% EtOH (3’), H2O (3'). 
2.  Leave slides in 3% H2O2 for 30 min to remove endogenous peroxidase 
activity. 3% H2O2: 20 ml of 30% H2O2 made up to a final volume of 200 ml with 
methanol. 
3.  Wash in PBS 5 min, 3 times. Mount slides onto coverplates using PBS and 
insert into sequenza. 
4.  Prepare Vectastain Blocking Serum by adding 3 drops of stock Normal Serum 
(yellow label) to 10 ml of PBS in yellow mixing bottle. 
5.  Add 3 drops* to each coverplate in sequenza and replace top to maintain 
humidity.  Let stand for 20 min. * Note: 1 drop = 50 l 
6.  Wash with PBS by filling each coverplate in the sequenza with one ml of PBS. 
7.  Add 150 l of anti-PC10 (use the optimal dilution obtained by dilution series: 
1:200) to each coverplate in sequenza and replace top.  For the negative control 
slide use PBS instead of anti-PC10.  Let stand for 1 hour. 
8.  Wash with PBS by filling each coverplate in the sequenza to the top with PBS.  
Let stand for 5 min. 
9.  Prepare Vectastain biotynylated anti-mouse IgG by mixing 3 drops of stock 
normal serum with 10 ml PBS in Blue mixing bottle, then add 1 drop of stock 
biotinylated antibody (blue labe), Mix Gently.  (or use 5 ml of serum solution 
form step 4, mix with 25 l of stock biotinylated antibody). 
10.  Add 3 drops to each coverplate in sequenza and replace top.  Let stand for 
45 min.   
11.  Prepare ABC reagent in advance to be used in step 13.  The ABC reagent is 
prepared by adding 2 drops of reagent A (gray label) to 5 ml PBS in the ABC 
Reagent large mixing bottle.  Then add exactly 2 drops of Reagent B (gray label) 
to the same mixing bottle, mix immediately, and allow ABC Reagent to stand for 
about 30 minutes before use.  This should be done in a darkened area. 
12.  Wash with PBS by filling each coverplate in the sequenza to the top with 
PBS.  Let stand for 5 min. 
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13.  Apply Vectastain ABC reagent that had been prepared in step 11.  Add 3 
drops to each coverplate in sequenza, replace top, and let stand for 30 min. 
14.  Wash with PBS by filling each coverplate in the sequenza to the top with 
PBS.  Remove slides form sequenza and place in PBS for 5 min. 
15.  Prepare DAB solution. For 200 ml: 2 ml stock DAB (50 mg/ml) bring volume 
up to 200 ml with PBS. Immediately before staining, add 100 uL of 30% H2O2. 
16.  Leave slides in DAB solution for 1 min, agitate twice. 
17.  Wash with H2O 5 min, 3 times. 
18.  Deactivate all DAB materials (glassware, pipet tips, used stock vials, stir 
bars) and used DAB solutions with bleach overnight, and flush with excess water 
in drain next day. 
19.  Counterstain with Hematoxyline  < 1 sec. 
20.  Wash with H2O 2 min, 2 times. 
21.  Dehydrate slides: 1 x 1 min 70% ETOH, 1 x 1 min 95% ETOH, 1 x 1 min 100% 
ETOH, 1 x 2 min Xylene. 
22.  Apply permount and cover glass. 
 
Negative control slides were prepared in conjunction by substituting anti-PC 10 
with a like volume of PBS. Only cells with intense PCNA staining were measured. The 
total number of proliferating cells, position of the highest proliferating cell and total cell 
number/crypt column (crypt column height) was assessed in 25 crypt columns/rat. 
Chapter II measurement of apoptosis 
Paraffin section of the 4% PFA fixed tissues was used to measure apoptosis using 
the TUNEL assay (EMD Millipore, Billerica, MA ) using the following protocol: 
***Put 200 ml PBS for Prot. K in 37 C oven and begin bleach rinse. 
1.  Deparaffinize and rehydrate tissue: Xylene (3X 5 min), let xylene just dry, 
circle sections w/ PAP pen, dry 1 min, 100% EtOH (2x5 min), 95% EtOH (1X3 
min),70% EtOH (1X3 min), PBS (1X5 min). (Get Equilibration Buffer and 
Reaction Buffer out of freezer-put on ice). 
2.  Pretreat tissue – 3 min, in 37 Proteinase K (10 g/ml PBS)  = 0.1 ml 
Proteinase K (Ambion # 2546) in 200 ml PBS. 
3.  Wash in dH2O (2x2 min). 
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4.  Quench Endogenous Peroxidase: 0.3% H2O2 in 100% Methanol: 3.0 ml 30% 
H2O2 in 297 ml 100% Methanol or 2.0 ml in 198 ml (add fresh H2O2 immediately 
before quenching).  30 min, RT 
5.  Wash in dH2O (2x5 min). 
6.  Wash all slides in PBS 5 min. 
7.  Gently tap off PBS and carefully blot around sections.  (Do this step and 
following step one slide at a time to avoid drying out sections) 
8.  Apply EQUILIBRATION BUFFER to all sections:  incubate in humidified 
chamber for 15 sec to 1 hr @ RT. (# of slides X 150 l) (9 slides X 150l = 1.35 
ml)  
9.  Tap off equilibration buffer and immediately apply reaction buffer (- 
controls) or working strength TdT Enzyme with dilution ratio 1/30 (enzyme 
/reaction buffer).  (Get TdT directly from freezer & keep on ice) Apply only 
reaction buffer to negative control sections:(# sections) X 40l. For normal 
sample sections (# sections X 40l):1080 l reaction buffer (for 9 slides),36 l 
TdT enzyme (for 9 slides).Incubate in a humidified chamber at 37C, 1 hr. 
(Prepare Stop/Wash so it can warm to RT) 
12. Put slides in coplin jar with Working Strength Stop/Wash Buffer (1ml + 34 ml 
dH2O).  Agitate for 15 sec; incubate 10 min, RT.Take aliquot of ANTI-
DIGOXIGENIN PEROXIDASE (# slides X 125 l) and allow to warm to room 
temperature (9 slides x 125l = 1.125ml). 
13.  Wash slides in PBS (3X1min). 
14.  Blot dry the slides quickly (do one slide at a time) and apply ANTI-
DIGOXIGENIN PEROXIDASE to all sections; incubate 30 min. in humidity chamber 
@ RT. 
15.  Wash in PBS (4X2min). Prepare DAB peroxidase (1:50, substrate:dilution 
buffer) (#slides x 150l) and warm to room temperature.  Protect from light.   
16.  Blot dry the slides quickly (do one slide at a time) and stain sections with 
DAB until light brown color shows up  (< 20 sec). 
17.  Wash in dH2O (3X1 min). Leave in 4
th  for 5 min. During wash deactivate 
remaining DAB solution w/ bleach – leave overnight. 
18. Counterstain w/ Methyl Green (reusable): Dip quickly into Methyl green. 
Rinse in dH2O 5X; dip 1x in the 1
st 2 changes and briefly agitate. Dip 10 x in 3rd & 
leave ~ 30 sec. Leave in the last 2 for 1 min w/o agitation. 
19. Dehydrate: 70% EtOH (1X1 min), 95% EtOH (1X1 min), 100% EtOH (1X1 
min), Xylene (3X2 min)  (dip 10 times/ea). 
20. Wet mount w/ Permount (80:20, Permount:Xylene). 
 
Positive control tissues were run in conjunction with each assay. As a negative 
control, PBS was substituted for ‘TdT’ in the working solution. Total number of 
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apoptotic cells and total number of cells/crypt column will be determined in 50 crypt 
columns/rat, and an apoptotic index (apoptotic cells/crypt column height) was 
determined for each crypt. 
Chapter II activated NF-κB measurement 
Activated NF-κB was assessed from scraped mucosa protein supernatant using 
the manufacturer’s protocol for whole cell lysates with the TransAM™ NF-κB Chemi 
Lysis buffer (Active Motif, Carlsbad, CA).   A 20 microliter aliquot of activated NF-κB 
extract and 30 ul of Complete Binding Buffer was added to a kit provided, 
oligonucleotide covered plate. The plate was covered and then placed on a rocking plate 
at room temperature for 1 h. Each well was washed three times with 200 microliters 
Wash Buffer. Following the wash step, 100 microliters of diluted NF-κB antibody 
(1:1,000 dilution in 1X Antibody Binding Buffer) was added to each well. The plate was 
covered and incubated at room temperature for 1 h. Each well was washed three times 
with 200 microliters Wash Buffer. Following the second wash, 100 microliters of 
Developing Solution was added to each well. The plate was incubated in the dark for 5 
minutes. Following incubation, 100 microliters of Stop Solution was added to each well. 
Absorbance was read at 450 nm with a reference wavelength of 655 nm. Only activated 
NF-κB subunits can bind to the oligonucleotide coated plate and are accessible to 
primary antibodies for detection. A standard curve of working stock recombinant protein 
diluted in Chemi Lysis buffer (10, 5, 2.5, 1.25, 0.0625, 0.312, 0.156, and 0 nanograms 
per well) was used to quantify activated NF-κB in each sample.  A nuclear extract of 
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Jurkat cells (2.5 micrograms) was used as a positive control for the p65 NF-κB subunit. 
An aliquot of protein and lysis buffer was run as a negative control. 
Chapter II & IV measurement of gene expression using real-time PCR 
Scraped mucosal samples were obtained at termination, placed into RNA 
protective solution and stored at -80°C until further analysis. Total RNA was isolated 
from mucosal samples using Phase Lock Gel™ tubes (5 Prime, Gaithersburg, MD) and 
the ToTALLY RNA™ Kit (Ambion, Austin, TX) followed by DNase treatment (DNA-
free™ Kit, Ambion, Austin, TX). Epitubes containing homogenized scraped mucosa and 
Denaturation Solution were removed from -80°C storage and thawed on ice.  Total RNA 
was isolated using the following protocol: 
1. In hood, add 1 vol. (starting volume) phenol/CHCl3 :IAA (lower phase). 
2.  Shake vigorously for 1 min.; store on ice for 5 min.  Prepare Heavy PLG 
tubes by centrifuging for 30 sec at 14000 X g . 
3.  Tranfer to prepared Phase Lock Gel Tube (Heavy 2 ml  version- Cat # 
2302830). 
4. Centrifuge 16,000 x g, 5 min., 15°C. 
5. Transfer upper phase to new 2.0 ml eppie tube. If there is no supernatant add 
250 l more of phenol/CCH3 and re-centrifuge. 
6.  Add 1/10 vol. sodium acetate; (Remember to check  approx. vol.) Mix by 
shaking or inversion for about 10 sec. 
7. Add 1 vol ACID:phenol/CHCl3 #2  (Starting volume) Do not add more than 
one starting volume even if the volume of the lysate is greater than the starting 
volume. 
8. Shake vigorously for 1 min.; store on ice for 5 min. 
9. Transfer to new Phase Lock Gel tube (Heavy 2 ml  version- Cat # 2302830). 
10. Centrifuge 16,000 x g, 5 min. 15°C. 
11.  Transfer upper phase to new tube 2.0 ml eppi tube. 
12. Measure and record the volume.   
13.  Add an equal vol. (from previous step, i.e., volume sucked off) isopropanol. 
Mix well. 
14.  Store at -20°C, at least 30 min. to overnight. 
15.  Centrifuge 14,000 x g, 15 min. 4°C. 
16.  Discard supernatant. 
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17. Wash pellet with 300 l of 70% ethanol; flick or gently vortex for ~0.5-3 
min. 
18. Centrifuge for 5-10 min at low speed  (~3000 X g or 7,500 rpm in a 
microfuge) @RT or 4C. 
19. Carefully remove supernatant and discard.  Respin briefly, remove 
supernatant. Cover w/ Kimwipe and air dry for ~ 5 min. 
20.  Re-suspend RNA pellet in 50 µl Nuclease Free Water (Applied Biosystems 
AM9937)  If necessary heat to 55-70 and vortex occasionally for all RNA to go 
into solution. 
DNase treatment: 
1. To RNA, add 0.1 vol 10X  DNase I buffer (Ambion DNA free kit, Applied 
Biosystems AM####) and 3 µl DNase.  Mix gently and incubate at 37°C for 20-
30 min.   
2.  Add 0.1 vol DNase inactivation reagent (after resuspending it).  Incubate at 
RT for 2 min, flicking a few times during incubation.   
3. Centrifuge tube ~1 min.  Remove supernatant to new tube, leaving reagent 
behind.  
4. Add 0.1 volume (~5 µl) 0.1 mM EDTA in DEPC treated water (Applied 
Biosystems  AM9912). Store at -80°C.  
 
  RNA quality was assessed using an Agilent Bioanalyzer prior to storage at -
80°C. First strand cDNA was synthesized using random hexamers, oligo dT primer 
(Promega, Madison, WI), and Superscript™ III Reverse Transcriptase (Invitrogen, 
Carlsbad, CA) using the following protocol:  
1.  Add the following components to a nuclease-free microcentrifuge tube: 1 µl 
of oligo(dT)20 (50 µM), 50–250 ng of random primers, 10 pg–5 µg total RNA, 1 
µl 10 mM dNTP Mix (10 mM each dATP, dGTP, dCTP and dTTP at neutral 
pH), sterile, distilled water to 13 µl. 
2.  Heat mixture to 65°C for 5 minutes and incubate on ice for at least 1 minute.  
3.  Collect the contents of the tube by brief centrifugation and add: 4 µl 5X First-
Strand Buffer , 1 µl 0.1 M DTT, 1 µl RNaseOUT™ Recombinant RNase 
Inhibitor (Cat. no. 10777-019, 40 units/µl),  1 µl of SuperScript™ III RT (200 
units/µl).  
4.  Mix by pipetting gently up and down. If using random primers, incubate tube 
at 25°C for 5 minutes.  
5.  Incubate at 50°C for 60 minutes.   
6.  Inactivate the reaction by heating at 70°C for 15 minutes. cDNA was used 
directly in a PCR reaction or stored at -20°C. 
Real-time PCR was performed on select genes (TOLLIP, TFF3, ZO-1, Slc16a1, IL-6, 
IL-1β, IL-12b, TNFα, SLC5A8, TGFβ, TLR4, TLR2, MyD88, NF-κB, COX-2) using 
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Taqman® Array Micro Fluidic Cards (Applied Biosystems, Foster City, CA) and a ABI 
7900 HT thermocycler (Applied Biosystems, Foster City, CA) using the following 
protocol: 
1. For each sample, determine the total number of reservoirs to be filled, based 
on the format of your TaqMan Array card. Prepare the PCR reaction mix (cDNA 
+ master mix). Fill the TaqMan Array card with the reaction mix. Centrifuge the 
TaqMan Array card. Seal the TaqMan Array card. 
2. Calculate the total volume required for each reaction component. 
3. If frozen, thaw the cDNA samples on ice. Resuspend the cDNA samples by 
inverting the tube, then gently vortexing. 
4. Mix the master mix thoroughly by swirling the bottle. 
5. For each sample, label a 1.5-mL microcentrifuge tube, then add the required 
components to the labeled tube. 
6. Cap the microcentrifuge tubes, then gently vortex the tubes to thoroughly mix 
the solution.  
7. Briefly centrifuge the tubes to spin down the contents and eliminate air 
bubbles.  
8. Fill each fill reservoir with sample-specific PCR mix made from a single 
cDNA sample (1000 ng) + nuclease-free water, 50.0 microliters TaqMan® Gene 
Expression Master Mix. 
9. Allow the TaqMan Array card to reach room temperature, then carefully 
remove it from its packaging. A minimum of 15 minutes at room temperature is 
required to equilibrate the card.  
10. Place the TaqMan Array card on a lab bench, with the foil side down. 
11. Load 100 μL of the desired sample-specific PCR reaction mix into a 100-μL 
micropipette. 
12. Hold the micropipette in an angled position and place the tip in the fill port 
(the larger of the two holes) IMPORTANT! Do not allow the tip to contact and 
possibly damage the coated foil beneath the fill port. 
13. Dispense the sample-specific PCR reaction mix so that it sweeps in and 
around the fill reservoir toward the vent port. IMPORTANT! Pipette the entire 
100 μL into the fill reservoir. Be careful when pushing the micropipette plunger 
to its second stop position (to expel the sample-specific PCR reaction mix from 
the tip). If a large amount of air is released, it can push the reaction mix out of 
the fill reservoir via the vent port or introduce bubbles into the fill reservoir. 
14. After the fill reservoirs have been filled with the sample-specific PCR 
reaction mix, centrifuge the TaqMan Array card to distribute the reaction mix to 
the reaction wells. IMPORTANT! You must use a Sorvall® or Heraeus 
centrifuge with the Sorvall/Heraeus Custom Buckets and card holders. The 
Custom Buckets and card holders are custom-made for the TaqMan Array cards. 
Do not use any other centrifuge or bucket/card holder system for this procedure.  
15. Place TaqMan Array cards into the Sorvall/Heraeus buckets: 
a. Obtain an empty Sorvall/Heraeus Custom Bucket and card holder.  
b. Place the bucket on a lab bench, with the label facing you. 
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c. Insert TaqMan Array cards into the card holder, making sure that the 
fill reservoirs project upwards out of the card holder and the reaction 
wells face the same direction as the “This Side Out” label. You use blank 
balance cards to fill any open positions in the card holder. Use the blank 
balance cards provided with the installation kits. IMPORTANT! Be sure 
to use the blank balance cards to fill any open positions. The blank 
balance cards will balance the centrifuge and prevent damage to the card 
holder. If the card holder is not completely filled, the TaqMan Array card 
may become displaced during centrifugation, resulting in uneven filling. 
d. Place a filled card holder in the bucket so that the “This Side Out” label 
faces out.  
16. Set the centrifuge: 
a. Power on the centrifuge. 
b. Use the front panel controls to set the bucket type to 15679. 
IMPORTANT! To ensure that the maximum rotational speed stays within 
the manufacturer’s specified limits, be sure to set the correct bucket type. 
c. Use the front panel controls to set the following operations parameters: 
Parameter EASYSet (touchpad), Up ramp rate 9, Down ramp rate 9, 
Rotational speed 1200 rpm (331 × g) 1200 rpm, Centrifugation time 2 × 1 
min. 
17. Place the buckets into the centrifuge: 
a. Press the Open button on the centrifuge to open the centrifuge cover. 
b. Place each loaded bucket onto an open rotor arm of the centrifuge. 
Make sure each bucket can swing easily within its slotted position on the 
rotor arm. IMPORTANT! The manufacturer recommends running the 
centrifuge with all four buckets. If the buckets are not fully loaded with 
TaqMan Array cards containing the sample-specific PCR reaction mix, 
place blank balance cards and card holders into the buckets. Make sure 
the buckets and their contents are balanced; opposing buckets should 
have matching weights.  
c. Close the centrifuge cover. 
 
 
18. Run the centrifuge: 
a. Press the Start button. The centrifuge starts, then automatically stops 
after 1 min, per the programmed sequence. 
b. Repeat step a so that the TaqMan Array cards are centrifuged for a total 
of two consecutive, 1minute spins. IMPORTANT! To ensure complete 
distribution of the PCR reaction mix, you must centrifuge the TaqMan 
Array cards for a total of two consecutive, 1-minute spins. 
19. Remove the TaqMan Array cards: 
a. Press the Open button. 
b. When the cover has fully opened, remove the buckets from the 
centrifuge, then remove the card holders from the buckets. 
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c. Remove all TaqMan Array cards from the buckets by gently lifting 
them by their carrier sides. 
20. Examine the TaqMan Array cards to be sure filling is complete. The amount 
of PCR reaction mix remaining in the fill reservoirs should be consistent from 
reservoir to reservoir. 
21. Seal the TaqMan Array Card. Position the sealer: 
a. Place the sealer on a sturdy lab bench, approximately waist high so that 
it can be easily used.  
b. Turn the sealer so that the front end (the “starting position” shown 
below) is closest to you and the back end is farthest from you. In the 
correct position, the arrows on the sealer are pointing away from you. 
c. Place the sealer’s carriage in its starting position. IMPORTANT! Never 
insert a TaqMan Array card into the sealer if the carriage is not in its 
starting position. The TaqMan Array card will be irreparably damaged if 
the carriage is moved across it toward its starting position. 
 
22. Insert a TaqMan Array card into the sealer: 
a. Orient the TaqMan Array card in the proper direction over the sealer’s 
insert plate. The card’s fill reservoir end should be the end closest to the 
arrows etched in the base of the sealer. 
b. Line up the card’s rear pin grooves, foil side up, to the stylus pins on 
the sealer. 
c. Gently place the card on top of the insert plate and ensure that the front 
end of the card is held securely in place by the spring clips. 
d. Gently push the card until it is seated securely in the insert plate. Note: 
When properly seated, the TaqMan Array card’s foil surface should be 
level with the base of the sealer. The four spring clips ensure that the card 
is held in the proper position. 
e. Push the carriage across the base of the sealer in the direction of the 
arrows. Use a slow, steady, and deliberate motion to push the carriage 
across the entire length of the TaqMan Array card until the carriage 
reaches the mechanical stops. It is important to avoid moving the carriage 
rapidly across the card. The sealer has mechanical stops at both ends to 
prevent the carriage from coming off. Therefore, do not use excessive 
force or speed when pushing the carriage. IMPORTANT! Do not move 
the carriage back before removing the TaqMan Array card. 
23. Remove the sealed TaqMan Array card by grasping its sides and lifting it off 
the sealer’s insert plate. In the middle of the sealer’s insert plate, there is a thumb 
slot to help you easily access one side of the card. 
24. Inspect the TaqMan Array card for proper sealing. The indentations from the 
stylus assembly should match up with the card’s main channels. If the 
indentations do not match up, or if the foil is in any way damaged, do not use the 
TaqMan Array card. 
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25. Using scissors, trim the fill strip from the TaqMan Array card. Use the edge 
of the card’s carrier as a guide. After the TaqMan Array cards have been loaded 
and sealed, they are stable for at least 64 hours.  
26. Set Up the SDS Plate Document. Start SDS Software v2.1 or later. 
27. Select File, New.  
28. Complete the New Document dialog box: 
a. From the Assay dropdown menu, select ΔΔCT (RQ) or Relative 
Quantification. 
b. From the Container dropdown menu, select 384 Wells TaqMan Low 
Density Array. 
c. Complete the remaining fields as shown, then click OK. 
29. Import the SDS Setup File (*.txt) into the new SDS plate document: 
a. In the CD drive, insert the Array Information CD that shipped with 
your TaqMan Array card. 
b. In the SDS software, select FileImport. In the SDS software, set up the 
experiment (SDS plate document), using the SDS Setup File included on 
the Array Information CD (this page). 
c. In the Import dialog box, navigate to the SDS Setup File for your 
TaqMan Array card, then click Import. The SDS software imports 
information from the SDS Setup File into the SDS plate document. Note:  
The SDS software uses the information from the SDS Setup File to 
automatically configure the plate grid and setup table with detector, 
detector task, marker, and sample data. For details on the SDS Setup File, 
see page 26. IMPORTANT! Modifying the contents of the SDS Setup 
File can corrupt the file, making the file unusable (that is, you will not be 
able to access information for the TaqMan Array card). 
30. Save the SDS plate document: 
a. Select File, Save As. 
b. Navigate to a save location. 
c. Enter a name for the SDS plate document. 
d. For Files of Type, select SDS 7900HT Document (*.sds) or SDS 
7900HT Template Document (*.sdt).Note: You can save the plate 
document as an SDS plate document (*.sds) or SDS template (*.sdt). 
Saving the plate document as an SDS template is recommended when you 
want to create duplicate plate documents for a series of TaqMan Array 
cards with identical assay configurations. For  
e. Click Save. 
31. Open the SDS plate document in the SDS software. 
32. Select the Instrument tab. 
33. Use the default thermal cycling conditions, as shown in the Thermal Cycler 
tab. Note: When you selected 384 Well TaqMan Low Density Array, the SDS 
software automatically set the appropriate thermal cycling conditions for the 
TaqMan Array cards. 
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34. Select the Real-Time tab. If the software is not connected to the instrument, 
click Connect to Instrument. 
35. If the instrument tray is inside the instrument, click Open/Close to rotate the 
instrument tray to the OUT position. 
36. Verify that the TaqMan Array Micro Fluidic Card Thermal Cycling Block is 
installed in the instrument tray. 
37. Place the prepared TaqMan Array card in the instrument tray with: Well A1 
at the top left corner of the tray and the notched corner at the top right and the 
barcode toward the front of the instrument. 
38. Click Start Run. The instrument tray rotates to the IN position. During the 
run, the instrument displays real-time status information in the Instrument Real-
Time tabs and records the fluorescence emissions. During the run, you can view 
the data (as the data are generated in real-time). 
39. When the Run Complete dialog box appears, click OK to close the dialog 
box, click Open/Close, then remove the TaqMan Array card from the instrument 
tray. 
 Expression levels were normalized to 18S gene expression. 
Table B-1. Assay ID for selected gene targets in Chapter II. 
 
Chapter III and V microbial DNA isolation 
Fresh fecal samples were collected immediately following defecation or at 
termination. Samples were transferred to sterile cryotubes, placed on ice, then stored at -
80°C. DNA was isolated from homogenized fecal samples using a FastDNA SPIN kit 
Gene symbol Alias Assay ID
Tollip Rn01479669_m1
Tff3 ITF, TREFOIL Rn00564851_m1
Tjp1 ZO-1 Rn02116071_s1
Slc16a1 MCT 1 Rn00562332_m1
Il6ra Rn00566707_m1
Il1b Rn01514151_m1
Il12b Rn00575112_m1
tnf TNFα Rn00562055_m1
Slc5a8 Rn01503812_m1
Tgfbi Rn01442102_m1
Tlr4 Rn00569848_m1
Tlr2 Rn02133647_s1
Myd88 Rn01640052_g1
Rela NFκB Rn01502266_m1
Ptgs2 COX-2 Rn01483828_m1
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for Feces according to the manufacturer’s instructions (MP Biomedicals, Solon, OH).  
Fecal samples were weighed and then homogenized in the FastPrep 24 instrument with 
kit provided buffers (825 ul Sodium Phosphate Buffer, 275 ul PLS solution, 122 ul MT 
Buffer) in Lysing Matrix E tubes. 
 Following homogenization, tubes were centrifuged at 14,000 x g for 5 min, and 
the supernatant was transferred to a clean 2.0 ml centrifuge tube. Proteins were 
precipitated from the supernatant by adding 250 ul PPS solution and incubating at 4°C 
for 10 min. Solution was centrifuged at 14,000 x g for 2 min, and the supernatant was 
transferred to 15 ml conical tubes containing 1 ml Binding Matrix Solution and placed 
on a plate rocker for 3 min. Following a 2 min centrifugation at 14,000 x g, the 
supernatant was decanted and remaining pellet resuspended with 1 ml Wash Buffer #1. 
This solution was transferred into a kit provided SPIN filter tube and centrifuged for 1 
min at 14,000 x g. A 500 ul aliquot of Wash Buffer #2 was added to the SPIN filter and 
all flow through was discarded following a 2 min centrifugation at 14,000 x g. The SPIN 
filter was then transferred to a clean catch tube. To elute purified DNA, 50 ul of TES 
was added to the SPIN filter and the tubes were centrifuged at 14,000 x g for 2 min.  
Purified DNA was stored at -80°C. A negative control containing H2O instead of sample 
was purified in parallel to each extraction batch to screen for contamination of extraction 
reagents. 
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Table B-2. Assay ID for selected gene targets in Chapter V. 
 
 
 
 
Gene symbol Alias Assay ID
Il1b Mm00434228_m1
Il6ra Mm00439653_m1
Myd88 Mm00440338_m1
Rela NFkB, p65 Mm00501346_m1
Slc16a1 MCT 1 Mm01306379_m1
Slc5a8 Mm00520629_m1
Tff3 ITF, TREFOIL Mm00495590_m1
Tgfbi TGFβ Mm00493634_m1
Tlr 9 Mm00446193_m1
Tlr2 Mm00442346_m1
Tlr4 Mm00445273_m1
tnf TNFα Mm00443260_g1
GAPDH Mm99999915_g1
